data_2nb4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nb4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 73.35 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.098 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.02 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.45 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.3 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.05 110.909 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 74.13 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 74.32 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 73.23 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 55.3 111.167 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.34 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.05 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 73.45 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.13 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.43 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.2 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 73.1 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.4 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.924 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 64.14 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.3 111.132 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.842 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.23 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.194 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.948 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.42 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.23 111.181 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.23 112.449 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 74.13 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.32 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.34 112.544 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.2 111.075 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 64.25 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 72.51 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 73.23 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.098 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 64.43 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.11 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.145 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.51 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.23 110.912 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.43 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.13 111.143 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.52 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.02 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.932 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.108 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.23 110.838 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.866 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 74.31 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.4 110.912 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.52 111.145 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.3 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.881 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.887 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.13 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 73.23 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.896 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 75.51 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.54 111.152 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.126 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.55 111.074 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.02 110.876 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 71.41 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.137 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.05 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.13 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 74.02 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.33 111.118 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 61.53 111.118 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.32 110.883 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.3 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 64.23 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 73.53 111.111 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.52 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 70.33 111.105 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.13 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.43 111.16 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.52 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 74.41 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 75.45 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 74.31 110.848 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 70.44 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.24 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 70.15 111.135 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 73.41 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 65.34 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.55 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.24 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.23 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.53 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 65.34 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.03 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 75.54 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 72.24 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 74.15 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 63.3 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 54.52 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.14 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.03 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.903 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.3 111.154 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 55.12 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.12 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.44 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.936 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.35 111.131 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 71.22 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.3 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 74.42 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.34 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.861 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.25 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.51 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.11 111.1 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 44.13 111.111 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.34 110.928 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.55 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.4 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.32 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.3 110.907 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 74.31 111.092 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 52.15 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 74.22 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 73.33 110.928 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.04 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.143 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 72.31 111.134 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.15 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 73.04 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.43 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.03 110.88 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 73.53 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 75.23 111.098 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.109 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.4 111.105 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.15 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 72.24 111.138 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 73.23 110.929 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.35 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.33 111.065 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.14 110.849 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 70.44 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 75.43 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.54 111.092 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.33 111.121 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 74.31 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.848 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.54 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 73.43 111.115 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 65.31 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.14 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.33 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.51 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.24 111.132 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.32 111.122 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.12 111.16 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.21 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.11 110.85 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 75.15 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.41 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.134 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.24 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.31 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 72.01 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 73.33 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.53 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.13 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 73.55 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 70.14 111.127 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.11 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 74.51 110.855 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.22 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.32 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.2 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 70.4 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 71.52 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.32 111.151 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.01 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.936 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.174 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 75.55 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.116 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.896 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.21 111.164 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.3 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.04 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.33 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 73.21 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.04 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 63.44 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.1 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.84 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.14 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 72.35 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.31 111.066 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.13 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.05 111.091 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 73.11 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.11 110.907 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 75.13 111.117 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 73.02 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 75.11 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.43 110.943 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.23 111.064 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.897 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.55 110.909 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.21 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.34 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.45 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 64.41 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 74.32 111.119 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.141 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.875 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.939 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.24 111.117 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 44.23 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 71.25 110.915 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.42 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 73.13 111.117 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.24 111.129 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 74.02 111.127 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 74.34 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 60.1 110.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.139 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 75.43 110.857 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 75.15 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.1 111.071 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.34 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.11 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.156 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.079 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 74.23 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.1 110.923 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.32 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.4 111.106 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.31 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.15 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 72.54 111.135 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 74.31 111.127 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.129 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 63.32 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 73.31 110.908 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.53 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.22 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 73.12 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.23 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.13 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.01 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.53 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 74.4 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 64.44 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 74.23 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.04 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.44 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 73.12 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.11 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.34 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.32 111.133 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.23 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.52 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.177 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 70.31 111.165 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.53 111.114 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 71.53 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 74.14 110.843 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.33 110.9 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 71.5 112.514 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.51 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.11 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 71.45 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.88 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.21 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 75.02 111.101 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.1 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 70.2 111.119 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.12 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.14 110.911 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 61.41 111.099 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.34 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.32 110.849 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.902 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.35 111.131 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 71.43 110.821 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.43 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 75.41 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 72.24 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 74.33 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 74.52 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.33 111.16 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.13 110.848 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.1 110.922 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.35 111.067 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.12 110.863 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.33 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 62.32 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 65.32 111.121 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.109 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.43 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.139 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.44 110.851 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.24 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 74.3 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.14 111.081 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.3 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.11 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.31 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.52 111.137 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 74.53 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.54 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.44 110.863 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 74.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.14 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 74.44 111.145 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.43 111.147 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.41 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.05 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 75.42 111.114 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 71.45 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.44 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.03 110.893 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 74.52 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 65.13 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.13 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.52 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 71.02 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 74.14 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.44 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.41 111.113 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 62.43 111.141 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 72.31 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 74.41 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.24 110.887 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.2 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 75.24 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.01 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 74.34 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.53 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.42 111.148 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.981 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.149 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.23 110.898 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.915 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.05 111.109 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.14 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.43 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.15 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.52 110.882 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 74.53 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 62.42 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 62.1 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.02 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.864 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.52 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 75.21 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.53 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.52 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 55.14 111.058 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.04 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 75.24 110.939 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.24 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.42 111.125 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 65.25 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.41 110.844 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.54 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.02 111.113 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.861 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.52 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.1 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.13 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.14 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.11 111.1 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.45 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 72.15 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.906 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 62.33 111.134 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.31 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.33 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.089 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.43 111.138 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.092 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.13 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.843 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.21 111.098 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.34 110.915 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.22 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 64.03 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.03 111.136 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.859 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 65.21 111.122 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.13 112.347 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.53 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.144 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.53 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.897 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 75.15 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.41 111.121 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 63.21 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.52 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.24 111.142 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.065 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 71.14 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.22 110.871 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 74.42 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.55 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.51 111.133 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 71.4 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 75.24 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.43 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 74.53 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 62.44 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 73.22 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.3 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.14 111.114 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.43 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 74.21 111.148 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.11 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 74.25 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.4 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.25 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.31 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.52 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.33 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.23 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.01 111.142 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.53 110.919 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.33 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.01 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 72.11 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.35 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.917 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.4 111.163 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.51 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.11 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 65.05 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.44 110.859 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.33 112.482 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.3 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.42 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.14 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.871 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 62.52 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 70.44 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.43 111.134 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 63.11 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.2 111.07 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.22 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.21 110.892 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 75.5 111.112 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.31 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 74.14 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.949 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.31 110.96 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 74.13 111.101 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.51 110.861 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.32 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 75.1 110.914 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.106 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.895 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.42 110.919 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 71.34 111.122 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 65.41 111.14 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.05 110.866 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.44 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.14 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 71.13 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.118 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.31 111.083 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.05 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 74.23 111.102 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 72.43 110.868 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.12 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.3 111.122 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.892 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.51 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 72.11 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 64.2 111.115 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 64.42 111.117 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.35 110.843 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.02 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.42 111.122 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.41 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.4 111.119 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.13 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.52 111.145 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 75.02 111.102 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 73.15 110.881 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 74.12 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.429 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.05 110.908 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.155 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.13 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 75.35 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 65.21 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.5 110.919 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.12 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 72.42 110.859 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 72.53 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.41 111.125 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.34 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.24 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.11 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 75.24 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.33 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.24 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.31 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 45.31 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 75.44 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.44 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.11 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 74.12 110.873 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.55 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.44 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.3 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 71.44 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.88 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.15 111.155 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.52 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 75.14 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.21 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 71.43 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 16.1 m-80 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.14 110.925 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.14 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.22 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 75.43 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.33 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 75.45 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 70.23 110.858 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.13 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 73.44 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.22 111.127 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.22 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.45 111.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 63.41 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.54 110.901 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.45 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.14 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 64.5 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.871 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 63.21 111.109 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.13 110.852 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.55 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.14 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 72.2 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.31 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 73.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.41 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.43 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.952 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.11 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 75.15 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 73.15 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.089 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.44 111.152 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.35 111.124 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.42 110.879 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 74.34 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 73.34 111.074 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.873 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.32 111.12 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.21 112.358 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.131 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.04 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.13 110.838 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 74.45 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 75.11 111.065 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.13 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 74.44 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 75.11 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.43 111.182 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.148 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.107 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 63.15 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.14 110.907 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 74.32 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.9 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.13 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 74.32 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.13 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.53 110.972 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 65.1 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.41 110.906 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.42 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.31 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.44 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.42 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.52 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.45 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.31 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.54 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.3 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.03 110.873 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 73.23 111.119 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 74.43 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.92 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.42 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 71.14 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 73.14 111.126 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 72.45 111.114 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 55.44 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 74.4 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 74.41 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.44 112.442 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.14 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.3 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.21 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.895 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.24 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 64.2 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.091 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.23 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.33 111.093 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.4 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.2 110.908 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 73.22 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.13 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.54 111.161 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.54 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.864 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 74.24 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 51.31 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 74.41 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.131 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 70.01 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 72.15 111.18 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 62.33 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 64.02 110.858 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.52 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.12 111.082 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.03 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.1 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.45 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.44 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 61.13 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 64.34 111.095 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.904 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.34 111.147 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.21 110.89 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 74.24 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 51.41 110.846 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 72.23 111.106 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.4 112.336 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.4 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 63.44 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.34 111.095 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.54 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.41 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 72.43 111.133 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.12 111.119 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.21 111.121 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.03 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.41 110.93 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 64.35 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 63.05 111.195 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.43 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 73.53 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.21 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 75.43 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 73.13 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 75.3 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.34 111.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.34 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.21 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.51 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.42 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 62.31 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.21 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.35 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.41 111.126 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.895 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.51 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.932 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.11 111.147 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.41 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.43 111.118 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 45.13 112.537 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 75.2 110.851 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.04 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 73.22 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.11 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.876 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 73.24 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.04 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.34 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.21 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.1 111.133 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 61.31 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 65.2 110.922 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.22 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.23 110.882 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.33 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.35 110.891 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.13 111.098 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.889 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 72.1 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 62.3 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 72.13 110.927 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 64.41 111.157 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 75.35 111.114 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 75.23 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.13 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.4 110.944 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.118 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 55.33 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.854 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.03 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.42 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.03 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 65.05 111.115 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.31 111.113 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.894 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.849 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 53.03 111.134 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 72.41 110.857 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.33 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.04 111.11 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.01 110.888 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.4 111.133 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 75.0 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.14 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.34 110.849 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.32 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.54 111.16 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 75.12 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.34 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.35 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.12 111.132 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 75.25 111.107 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.02 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.1 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.31 110.933 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.45 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.124 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 71.22 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.43 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.52 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 55.45 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.13 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.4 111.111 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.31 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.4 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 74.04 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 74.54 110.881 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 74.21 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.2 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.45 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.35 111.137 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.21 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 74.22 111.139 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.894 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.877 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.32 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.164 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.132 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 75.33 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.21 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.52 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.32 110.829 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.513 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 61.33 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 64.11 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.54 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.35 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 71.54 111.087 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.23 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.31 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 75.14 111.095 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 73.52 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.2 110.918 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.42 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 55.23 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.11 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.13 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.963 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 73.45 111.114 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.917 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.4 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.21 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.23 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 74.31 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.124 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.15 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.05 110.892 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.03 111.058 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 62.23 111.09 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.21 110.89 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 74.11 111.131 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 62.15 111.086 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.44 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 71.22 111.143 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.31 110.842 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 61.15 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.31 111.091 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.23 110.908 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 75.41 111.161 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.33 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.35 111.14 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.01 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 70.24 110.925 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.35 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 74.14 110.915 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 53.22 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.34 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.33 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.34 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.118 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.079 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.3 111.181 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 70.01 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.31 110.855 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 62.0 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.158 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 74.33 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.22 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 75.23 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.33 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.12 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.43 111.153 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 75.3 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 73.5 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 75.21 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.23 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 51.32 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.43 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 74.42 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 62.14 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.936 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 74.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.13 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.52 110.888 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 75.3 111.12 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.43 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.953 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.32 111.169 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.32 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.32 111.138 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.34 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.52 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.32 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.2 112.506 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.02 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.34 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.4 110.891 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.13 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.11 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 74.23 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.24 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.42 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.35 110.907 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.04 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 52.22 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.45 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.954 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.53 111.122 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.91 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.905 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.14 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.34 110.952 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.44 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.52 111.086 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.14 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 74.25 110.917 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.21 111.052 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 72.34 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.865 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 72.23 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.14 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.02 111.125 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.24 111.095 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.2 110.897 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 74.01 111.172 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 72.31 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.41 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.33 111.1 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.13 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.55 111.119 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.23 112.318 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.138 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 72.23 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.841 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.53 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 72.1 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.1 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.14 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.14 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 75.23 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.168 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.138 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 71.44 110.879 -179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.13 112.401 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.92 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.54 111.163 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 74.04 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.04 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.54 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.02 110.937 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 70.24 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.35 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.24 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.35 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 71.02 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 71.05 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.24 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.22 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.14 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.11 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.11 111.134 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.04 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.43 111.143 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.45 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.1 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.167 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.51 111.159 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.4 111.146 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.3 112.492 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 63.2 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.13 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.01 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 63.31 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.3 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 62.1 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.929 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.13 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 63.41 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.21 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.45 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.11 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.15 111.116 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 71.22 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.14 110.922 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.44 111.128 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.33 110.84 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.11 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 71.23 111.137 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.898 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.902 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.23 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.41 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 75.05 110.916 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 74.1 111.096 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.937 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 53.5 111.084 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.893 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.136 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.048 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.31 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.03 111.162 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 74.35 110.833 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 74.44 112.361 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.13 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.101 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 62.03 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 71.22 111.146 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 63.23 112.368 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.107 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 73.43 110.907 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.23 110.89 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.04 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.21 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 75.15 111.107 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.01 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.52 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 72.01 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.24 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.21 111.096 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.51 111.108 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.34 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.31 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.23 110.914 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 73.25 112.348 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.54 110.912 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.25 111.131 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.14 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.14 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.915 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.42 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.24 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.14 111.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.11 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.04 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.01 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.32 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 64.11 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.21 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.04 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.45 111.155 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.897 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.41 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.34 111.139 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.44 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.32 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.24 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.42 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.01 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 62.45 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 72.23 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 63.21 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.505 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.34 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.31 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.4 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.1 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.076 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 72.31 110.935 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 73.42 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.41 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 75.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.11 110.936 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 74.21 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.33 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.35 110.873 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.23 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.13 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 75.52 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.02 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.33 111.16 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.914 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.44 111.166 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.21 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.01 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.23 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 72.2 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.41 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.096 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 73.13 111.09 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.42 111.132 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.42 110.886 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 74.12 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.41 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.52 111.118 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.22 110.864 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 73.11 111.173 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.11 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 63.32 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 74.33 111.141 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.862 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.01 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 74.41 111.159 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.34 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.43 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 73.04 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.33 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.53 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 70.42 111.096 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.15 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.1 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 64.5 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.44 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.873 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.145 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.1 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.44 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.11 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.11 110.917 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 75.54 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.22 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.21 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.54 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.11 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 74.13 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.35 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 64.53 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.31 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.35 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 71.43 111.132 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.13 110.923 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.03 111.129 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 74.05 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.01 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 71.42 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 72.45 111.132 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.948 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.127 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.41 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 50.21 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 73.13 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.913 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.23 112.482 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.35 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.04 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.33 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 45.13 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 75.43 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.23 111.109 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.3 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.05 111.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 75.11 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 74.11 110.899 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.22 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 41.34 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.32 110.864 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.882 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.02 110.925 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.11 111.143 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.819 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 73.03 110.898 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 71.42 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 73.45 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.02 110.958 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 73.41 111.131 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.118 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 74.5 111.129 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.43 110.898 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 72.43 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.21 111.06 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.86 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.51 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.141 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.059 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 75.52 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.21 110.873 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 74.1 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 72.04 111.095 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.85 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 74.33 111.126 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.51 112.338 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.04 111.175 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.11 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.05 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.04 110.832 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.33 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.3 111.161 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 71.33 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.03 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 61.12 111.121 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.23 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.15 111.084 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.01 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 72.53 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.12 110.894 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 74.22 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.891 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.52 111.084 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 73.53 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.15 110.947 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.03 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 74.21 110.856 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 72.54 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 73.42 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.24 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 74.44 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.21 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.35 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.05 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.43 110.917 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.15 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.14 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.03 112.467 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.15 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.21 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.23 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.14 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.14 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 75.53 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.43 111.095 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 73.14 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.42 111.109 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.34 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 73.44 110.915 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.12 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.14 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.34 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.112 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.894 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.892 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 60.11 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.44 110.933 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.34 111.119 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 75.44 111.105 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.45 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.896 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.886 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.44 111.109 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.52 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.43 110.851 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 73.04 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 74.12 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 70.24 111.116 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 62.45 111.113 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 74.44 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.12 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 63.14 111.116 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 75.11 110.882 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 75.22 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.44 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.24 111.123 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.42 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.44 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.3 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.24 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 75.2 110.871 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.04 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.31 111.193 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.43 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 64.32 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 65.54 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.41 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.31 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.44 111.12 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.35 111.081 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.13 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 62.4 110.911 -179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.35 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.45 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.162 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 73.13 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.3 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 74.33 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 63.5 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.43 111.121 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.51 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 73.43 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 73.25 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.03 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 64.03 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.12 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 65.21 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.3 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 73.4 110.936 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.53 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.23 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.895 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.52 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.43 111.123 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.871 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.155 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.11 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.15 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 63.04 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.03 110.858 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 72.43 112.494 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 54.24 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 60.31 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.858 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.52 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.53 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.42 111.117 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 71.35 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 63.12 111.068 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.3 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 74.33 110.936 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.53 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 52.55 111.131 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.41 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 70.04 111.13 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.907 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.14 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 70.3 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.42 111.148 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 70.34 111.149 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.52 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 74.23 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.121 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.54 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.93 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 65.45 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.12 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.4 111.15 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.11 111.111 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.51 111.121 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 74.55 110.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 73.33 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.34 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.2 110.801 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.42 111.156 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 72.44 112.345 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.45 111.114 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.51 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.12 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.85 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.53 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 71.1 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 64.41 111.129 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.51 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 75.21 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.14 111.176 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.23 111.095 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.31 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.34 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.34 110.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.22 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.938 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.113 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 75.42 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.895 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 72.21 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.11 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.1 111.163 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.12 111.09 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.44 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 74.34 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.44 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.13 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.35 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.21 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.894 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.02 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.42 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.02 111.121 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.935 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.43 111.122 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.03 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.24 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.55 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.03 112.451 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 65.21 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.1 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.89 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 74.42 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 73.2 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 64.3 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 71.33 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.32 111.109 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 72.42 110.916 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.34 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.52 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.4 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.03 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.897 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.35 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.42 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.43 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 75.44 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 75.51 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.104 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.34 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.14 111.085 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 64.21 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.42 110.868 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.43 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.12 111.095 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.02 111.12 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.23 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.31 111.114 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.22 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 75.1 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.3 111.082 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.34 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.02 111.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 75.35 112.316 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.24 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.866 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.45 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.872 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.13 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 74.12 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 73.31 111.112 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.52 111.153 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 50.11 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.22 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.1 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.107 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 74.01 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 75.42 110.909 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.23 112.337 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.416 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.24 111.155 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.34 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 75.52 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.1 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.099 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.11 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.21 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 75.13 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.2 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.55 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.34 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.34 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.32 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.101 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 74.3 110.943 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.34 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.04 111.138 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.925 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.152 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.23 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 73.52 111.121 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 72.13 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 74.32 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 11.0 m-80 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.03 110.846 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 73.13 112.488 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 72.42 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 65.34 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.11 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 54.24 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.44 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 70.25 111.097 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.24 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.32 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 65.43 111.077 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.32 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 74.13 110.906 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.03 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 75.33 111.096 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 72.43 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.903 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.934 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.192 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.54 110.852 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 75.35 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 70.13 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 73.1 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 74.15 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.11 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.152 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 75.25 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 70.5 111.111 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.11 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.914 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.41 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.15 111.165 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 74.42 111.126 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.091 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.52 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.878 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 75.45 111.123 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.44 110.886 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.13 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.44 111.066 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.885 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 71.32 111.115 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.54 112.343 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 72.05 111.107 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.146 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.03 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 62.31 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.54 110.905 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.13 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 75.25 111.117 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.45 111.125 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.53 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.21 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.12 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.23 111.128 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.133 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.53 111.093 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.51 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.44 110.891 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 71.45 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.54 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.31 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.43 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 65.4 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.03 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.926 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.03 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.31 110.899 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.125 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 75.53 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.12 111.139 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.21 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 71.45 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 61.25 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 74.23 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 74.11 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.121 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.938 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.167 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.32 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 71.33 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.1 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 73.42 111.108 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 73.33 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 74.43 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.54 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.13 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.11 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.32 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.55 110.871 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 74.22 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.14 111.112 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.04 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.34 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.41 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.55 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 74.44 110.922 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.147 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.03 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.5 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 73.52 110.913 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.907 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 72.43 111.137 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 72.51 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.14 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 65.03 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.4 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.33 110.893 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.51 111.098 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.11 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 71.01 111.126 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.33 110.893 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.965 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.094 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.35 111.12 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.51 110.881 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.41 110.931 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.13 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.143 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.41 111.156 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.43 111.113 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.42 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 74.41 110.88 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.44 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.04 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.54 111.136 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.903 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 75.1 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 75.11 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.52 111.166 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.03 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.03 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 75.22 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.14 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 55.51 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.12 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.33 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 70.24 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.117 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.32 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.14 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.04 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.04 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 74.3 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.55 111.156 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.35 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 74.44 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 74.12 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.54 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.13 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 75.41 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 74.52 110.864 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.128 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.55 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.1 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.1 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 74.04 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.31 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 74.12 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 74.55 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 71.31 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 74.41 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.112 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.912 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.167 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.03 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.33 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 75.34 111.176 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.897 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.138 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.04 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 75.52 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 74.0 110.819 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.44 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.11 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 74.01 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.02 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.904 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 44.11 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 74.24 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 73.12 111.049 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 71.03 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.14 111.108 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 64.31 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 72.31 110.961 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.23 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.43 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.03 110.887 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 65.24 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.152 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.03 110.896 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.871 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.05 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.55 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.41 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.33 111.132 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.131 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.52 110.931 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.14 111.127 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.083 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.841 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.899 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.15 111.117 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.21 111.115 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.44 111.073 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.55 111.12 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.23 110.874 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.35 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.31 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.02 111.108 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.15 110.866 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 75.22 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.11 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.42 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 74.4 111.132 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.52 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.876 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.01 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.04 111.13 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 74.24 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.04 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.155 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 63.22 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.22 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.42 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 73.35 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.098 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.02 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.45 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.3 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.05 110.909 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 74.13 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 74.32 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 73.23 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 55.3 111.167 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.34 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.05 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 73.45 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.13 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.43 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.2 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 73.1 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.4 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.924 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 64.14 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.3 111.132 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.842 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.23 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.194 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.948 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.42 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.23 111.181 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.23 112.449 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 74.13 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.32 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.34 112.544 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.2 111.075 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 64.25 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 72.51 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 73.23 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.098 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 64.43 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.11 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.145 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.51 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.23 110.912 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.43 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.13 111.143 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.52 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.02 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.932 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.108 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.23 110.838 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.866 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 74.31 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.4 110.912 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.52 111.145 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.3 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.881 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.887 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.13 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 73.23 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.896 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 75.51 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.54 111.152 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.126 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.55 111.074 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.02 110.876 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 71.41 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.02 111.137 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.05 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.13 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 74.02 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.33 111.118 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 61.53 111.118 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.32 110.883 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.3 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 64.23 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 73.53 111.111 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.52 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 70.33 111.105 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.13 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.43 111.16 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.52 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 74.41 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 75.45 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -92.46 -27.62 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 74.31 110.848 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -143.14 95.03 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.2 110.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 70.4 110.86 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 70.44 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.24 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 70.15 111.135 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 73.41 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 65.34 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.55 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.24 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.23 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.53 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 65.34 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.03 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 75.54 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 72.24 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 74.15 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 63.3 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 54.52 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.14 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.03 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.903 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.3 111.154 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 55.12 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.12 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.44 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.936 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.35 111.131 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 71.22 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.3 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 74.42 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.34 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.861 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.25 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.51 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.11 111.1 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 44.13 111.111 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.34 110.928 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.55 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.4 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.32 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.3 110.907 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 74.31 111.092 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 52.15 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 74.22 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 73.33 110.928 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.04 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.143 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 72.31 111.134 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.15 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 73.04 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.43 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.03 110.88 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 73.53 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 75.23 111.098 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.109 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.4 111.105 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.15 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 72.24 111.138 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 73.23 110.929 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.35 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.33 111.065 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.14 110.849 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 70.44 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 75.43 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.54 111.092 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.33 111.121 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 74.31 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.848 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.54 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 73.43 111.115 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 65.31 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.14 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.33 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.51 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.24 111.132 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.32 111.122 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.12 111.16 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.21 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -81.41 -36.6 29.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.11 110.85 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.12 86.21 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.34 110.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 65.55 110.867 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 75.15 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.41 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.134 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.24 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.31 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 72.01 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 73.33 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.53 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.13 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 73.55 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 70.14 111.127 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.11 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 74.51 110.855 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.22 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.32 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.2 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 70.4 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 71.52 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.32 111.151 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.01 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.936 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.174 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 75.55 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.116 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.896 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.21 111.164 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.3 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.04 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.33 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 73.21 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.04 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 63.44 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.1 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.84 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.14 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 72.35 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.31 111.066 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.13 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.05 111.091 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 73.11 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.11 110.907 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 75.13 111.117 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 73.02 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 75.11 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.43 110.943 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.23 111.064 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.897 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.55 110.909 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.21 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.34 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.45 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 64.41 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 74.32 111.119 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.141 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.875 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.939 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.24 111.117 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 44.23 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 71.25 110.915 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.42 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 73.13 111.117 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.24 111.129 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 74.02 111.127 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 74.34 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 60.1 110.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.139 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 75.43 110.857 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 75.15 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.1 111.071 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.34 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.11 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.156 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.079 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 74.23 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.1 110.923 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.32 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.4 111.106 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.31 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.15 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 72.54 111.135 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 74.31 111.127 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.129 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 63.32 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.3 -36.77 13.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 73.31 110.908 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.12 87.19 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.927 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.01 110.821 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.53 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.163 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.22 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 73.12 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.23 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.13 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.01 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.53 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 74.4 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 64.44 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 74.23 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.04 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.44 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 73.12 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.11 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.34 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.32 111.133 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.23 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.52 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.177 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 70.31 111.165 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.53 111.114 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 71.53 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 74.14 110.843 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.33 110.9 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 71.5 112.514 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.51 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.11 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 71.45 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.88 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.21 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 75.02 111.101 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.1 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 70.2 111.119 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.12 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.14 110.911 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 61.41 111.099 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.34 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.32 110.849 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.902 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.35 111.131 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 71.43 110.821 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.43 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 75.41 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 72.24 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 74.33 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 74.52 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.33 111.16 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.13 110.848 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.1 110.922 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.35 111.067 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.12 110.863 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.33 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 62.32 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 65.32 111.121 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.109 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.43 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.139 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.44 110.851 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.24 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 74.3 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.14 111.081 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.3 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.11 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.31 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.52 111.137 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 74.53 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.54 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.44 110.863 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 74.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.14 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 74.44 111.145 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.43 111.147 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.41 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.05 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 75.42 111.114 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 71.45 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.44 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.11 -36.48 81.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.03 110.893 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -174.89 170.41 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.923 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.896 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 74.52 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 65.13 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.13 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.52 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 71.02 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 74.14 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.44 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.41 111.113 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 62.43 111.141 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 72.31 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 74.41 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.24 110.887 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.2 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 75.24 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.01 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 74.34 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.53 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.42 111.148 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.981 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.149 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.23 110.898 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.915 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.05 111.109 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.14 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.43 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.15 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.52 110.882 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 74.53 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 62.42 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 62.1 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.02 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.864 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.52 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 75.21 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.53 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.52 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 55.14 111.058 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.04 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 75.24 110.939 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.24 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.42 111.125 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 65.25 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.41 110.844 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.54 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.02 111.113 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.861 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.52 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.1 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.13 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.14 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.11 111.1 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.45 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 72.15 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.906 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 62.33 111.134 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.31 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.33 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.089 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.43 111.138 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.092 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.13 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.843 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.21 111.098 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.34 110.915 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.22 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 64.03 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.03 111.136 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.859 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 65.21 111.122 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.13 112.347 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.53 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.144 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.53 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.897 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 75.15 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.41 111.121 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 63.21 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.52 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.24 111.142 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.065 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 71.14 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -29.43 60.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.22 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mp -143.58 150.31 38.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.88 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.915 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 74.42 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.55 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.51 111.133 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 71.4 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 75.24 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.43 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 74.53 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 62.44 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 73.22 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.3 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.14 111.114 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.43 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 74.21 111.148 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.11 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 74.25 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.4 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.25 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.31 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.52 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.33 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.23 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.01 111.142 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.53 110.919 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.33 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.01 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.88 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 72.11 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.35 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.917 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.4 111.163 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.51 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.11 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 65.05 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.44 110.859 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.33 112.482 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.3 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.42 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.14 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.871 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 62.52 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 70.44 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.43 111.134 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 63.11 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.2 111.07 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.22 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.21 110.892 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 75.5 111.112 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.31 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 74.14 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.949 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.31 110.96 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 74.13 111.101 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.51 110.861 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.32 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 75.1 110.914 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.106 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.895 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.42 110.919 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 71.34 111.122 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 65.41 111.14 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.05 110.866 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.44 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.14 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 71.13 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.118 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.31 111.083 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.05 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 74.23 111.102 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 72.43 110.868 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.12 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.3 111.122 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.892 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.51 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 72.11 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 64.2 111.115 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 64.42 111.117 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.35 110.843 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.02 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.42 111.122 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.41 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.4 111.119 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.13 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.52 111.145 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 75.02 111.102 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -26.61 35.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 73.15 110.881 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.63 63.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.3 110.856 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 75.03 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 74.12 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.05 110.908 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.155 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.13 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 75.35 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 65.21 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.5 110.919 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.12 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 72.42 110.859 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 72.53 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.41 111.125 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.34 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.24 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.11 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 75.24 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.33 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.24 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.31 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 45.31 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 75.44 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.44 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.11 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 74.12 110.873 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.55 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.44 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.3 110.856 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 71.44 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.88 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.15 111.155 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.52 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 75.14 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.21 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 71.43 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 16.1 m-80 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.14 110.925 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.14 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.22 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 75.43 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.33 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 75.45 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 70.23 110.858 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.13 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 73.44 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.22 111.127 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.22 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.45 111.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 63.41 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.54 110.901 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.45 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.14 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 64.5 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.871 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 63.21 111.109 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.13 110.852 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.55 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.14 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 72.2 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.31 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 73.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.41 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.43 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.952 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.11 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 75.15 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 73.15 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.089 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.44 111.152 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.35 111.124 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.42 110.879 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 74.34 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 73.34 111.074 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.873 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.32 111.12 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.21 112.358 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.131 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.04 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.13 110.838 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 74.45 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 75.11 111.065 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.13 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 74.44 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 75.11 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.43 111.182 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.148 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.107 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 63.15 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 -36.26 14.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.14 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.93 144.07 30.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.95 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.35 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 74.32 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.9 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.13 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 74.32 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.13 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.53 110.972 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 65.1 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.41 110.906 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.42 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.31 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.44 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.42 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.52 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.45 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.31 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.54 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.3 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.03 110.873 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 73.23 111.119 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 74.43 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.92 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.42 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 71.14 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 73.14 111.126 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 72.45 111.114 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 55.44 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 74.4 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 74.41 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.44 112.442 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.14 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.3 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.21 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.895 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.24 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 64.2 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.091 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.23 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.33 111.093 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.4 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.2 110.908 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 73.22 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.13 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.54 111.161 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.54 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.864 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 74.24 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 51.31 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 74.41 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.131 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 70.01 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 72.15 111.18 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 62.33 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 64.02 110.858 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.52 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.12 111.082 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.03 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.1 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.45 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.44 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 61.13 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 64.34 111.095 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.904 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.34 111.147 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.21 110.89 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 74.24 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 51.41 110.846 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 72.23 111.106 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.4 112.336 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.4 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 63.44 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.34 111.095 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.54 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.41 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 72.43 111.133 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.12 111.119 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.21 111.121 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.03 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -88.23 -15.01 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.41 110.93 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -142.61 95.41 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 75.03 110.91 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.54 110.889 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 64.35 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 63.05 111.195 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.43 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 73.53 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.21 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 75.43 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 73.13 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 75.3 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.34 111.114 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.34 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.21 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.51 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.42 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 62.31 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.21 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.35 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.41 111.126 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.895 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.51 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.932 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.11 111.147 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.41 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.43 111.118 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 45.13 112.537 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 75.2 110.851 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.04 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 73.22 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.11 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.876 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 73.24 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.04 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.34 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.21 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.1 111.133 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 61.31 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 65.2 110.922 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.22 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.23 110.882 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.33 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.35 110.891 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.13 111.098 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.889 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 72.1 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 62.3 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 72.13 110.927 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 64.41 111.157 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 75.35 111.114 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 75.23 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.13 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.4 110.944 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.118 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 55.33 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.854 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.03 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.42 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.03 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 65.05 111.115 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.31 111.113 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.894 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.849 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 53.03 111.134 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 72.41 110.857 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.33 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.04 111.11 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.01 110.888 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.4 111.133 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 75.0 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.14 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.34 110.849 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.32 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.54 111.16 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 75.12 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.34 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.35 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.12 111.132 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 75.25 111.107 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.02 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.1 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -91.28 -28.21 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.31 110.933 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -148.11 128.71 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 75.02 110.938 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.882 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.45 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.124 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 71.22 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.43 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.52 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 55.45 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.13 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.4 111.111 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.31 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.4 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 74.04 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 74.54 110.881 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 74.21 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.2 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.45 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.35 111.137 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.133 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.21 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 74.22 111.139 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.894 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.877 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.32 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.164 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.132 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 75.33 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.21 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.52 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.32 110.829 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.513 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 61.33 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 64.11 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.54 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.35 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 71.54 111.087 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.23 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.31 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 75.14 111.095 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 73.52 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.2 110.918 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.42 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 55.23 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.11 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.13 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.963 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 73.45 111.114 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.917 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.4 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.21 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.23 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 74.31 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.124 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.15 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.05 110.892 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.03 111.058 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 62.23 111.09 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.21 110.89 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 74.11 111.131 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 62.15 111.086 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.44 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 71.22 111.143 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.31 110.842 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 61.15 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.31 111.091 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.23 110.908 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 75.41 111.161 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.33 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 72.35 111.14 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.01 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 70.24 110.925 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.35 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 74.14 110.915 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 53.22 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.34 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.33 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.34 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.118 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.079 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.3 111.181 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 70.01 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.56 -36.65 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.31 110.855 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.1 140.47 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.858 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 62.0 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.158 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 74.33 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.22 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 75.23 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.33 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.12 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.43 111.153 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 75.3 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 73.5 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 75.21 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.23 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 51.32 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.43 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 74.42 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 62.14 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.936 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 74.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.13 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.52 110.888 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 75.3 111.12 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.43 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.953 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.32 111.169 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.32 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.32 111.138 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.34 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.52 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.32 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.2 112.506 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.02 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.34 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.4 110.891 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.13 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.11 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 74.23 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.24 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.42 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.35 110.907 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.04 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 52.22 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.45 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.954 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.53 111.122 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.91 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.905 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.14 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.34 110.952 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.44 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.52 111.086 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.14 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 74.25 110.917 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.21 111.052 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 72.34 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.865 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 72.23 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.14 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.02 111.125 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.24 111.095 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.2 110.897 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 74.01 111.172 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 72.31 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.41 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.33 111.1 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.13 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.55 111.119 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.23 112.318 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.138 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 72.23 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.841 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.53 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 72.1 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.1 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.14 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.14 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 75.23 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.168 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.138 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.92 -20.69 41.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 71.44 110.879 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.59 68.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.947 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.53 110.876 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.13 112.401 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.92 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.54 111.163 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 74.04 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.04 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.54 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.02 110.937 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 70.24 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.35 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.24 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.35 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 71.02 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 71.05 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.24 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.22 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.14 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.11 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.11 111.134 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.04 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.43 111.143 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.45 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.1 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.167 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.51 111.159 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.4 111.146 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.3 112.492 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 63.2 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.13 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.01 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 63.31 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.3 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 62.1 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.929 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.13 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 63.41 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.21 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.45 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.11 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.15 111.116 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 71.22 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.14 110.922 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.44 111.128 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.33 110.84 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.11 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 71.23 111.137 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.898 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.902 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.23 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.41 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 75.05 110.916 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 74.1 111.096 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.937 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 53.5 111.084 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.893 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.136 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.048 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.31 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.03 111.162 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 74.35 110.833 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 74.44 112.361 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.13 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.101 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 62.03 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 71.22 111.146 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 63.23 112.368 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.107 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 73.43 110.907 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.23 110.89 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.04 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.21 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 75.15 111.107 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.01 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.52 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 72.01 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.24 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.21 111.096 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.51 111.108 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.34 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.31 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.13 -35.89 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.23 110.914 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mt -137.43 74.68 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.916 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 73.25 112.348 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.54 110.912 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.25 111.131 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.14 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.14 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.915 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.42 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.24 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.14 111.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.11 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.04 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.01 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.32 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 64.11 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.21 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.04 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.45 111.155 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.897 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.41 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.34 111.139 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.44 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.32 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.24 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.42 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.01 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 62.45 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 72.23 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 63.21 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.505 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.34 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.31 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.4 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.1 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.076 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 72.31 110.935 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 73.42 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.41 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 75.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.11 110.936 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 74.21 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.33 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.35 110.873 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.23 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.13 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 75.52 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.02 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.33 111.16 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.914 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.44 111.166 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.21 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.01 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.23 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 72.2 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.41 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.096 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 73.13 111.09 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.42 111.132 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.42 110.886 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 74.12 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.41 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.52 111.118 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.22 110.864 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 73.11 111.173 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.11 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 63.32 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 74.33 111.141 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.862 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.01 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 74.41 111.159 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.34 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.43 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 73.04 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.33 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.53 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 70.42 111.096 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.15 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.1 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 64.5 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -77.14 -37.62 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 103' ' ' GLU . 2.3 pt? -178.7 173.04 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 74.43 110.96 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 73.55 110.877 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.44 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.873 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.145 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.1 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.44 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.11 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.11 110.917 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 75.54 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.22 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.21 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.54 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.11 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 74.13 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.35 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 64.53 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.31 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.35 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 71.43 111.132 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.13 110.923 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.03 111.129 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 74.05 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.01 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 71.42 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 72.45 111.132 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.948 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.127 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.41 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 50.21 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 73.13 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.913 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.23 112.482 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.35 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.04 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.33 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 45.13 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 75.43 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.23 111.109 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.3 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.05 111.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 75.11 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 74.11 110.899 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.22 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 41.34 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.32 110.864 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.882 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.02 110.925 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.11 111.143 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.819 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 73.03 110.898 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 71.42 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 73.45 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.02 110.958 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 73.41 111.131 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.118 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 74.5 111.129 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.43 110.898 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 72.43 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.21 111.06 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.86 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.51 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.141 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.059 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 75.52 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.21 110.873 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 74.1 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 72.04 111.095 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.85 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 74.33 111.126 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.51 112.338 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.04 111.175 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.11 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.05 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.04 110.832 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.33 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.3 111.161 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 71.33 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.03 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 61.12 111.121 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.23 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.15 111.084 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.01 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 72.53 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.37 -35.63 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.12 110.894 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.32 51.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.02 110.895 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.886 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 74.22 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.891 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.52 111.084 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 73.53 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.15 110.947 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.03 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 74.21 110.856 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 72.54 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 73.42 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.24 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 74.44 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.21 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.35 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.05 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.43 110.917 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.15 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.14 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.03 112.467 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.15 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.21 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.23 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.14 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.14 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 75.53 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.43 111.095 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 73.14 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.42 111.109 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.34 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 73.44 110.915 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.12 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.14 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.34 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.112 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.894 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.892 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 60.11 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.44 110.933 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.34 111.119 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 75.44 111.105 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.45 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.896 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.886 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.44 111.109 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.52 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.43 110.851 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 73.04 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 74.12 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 70.24 111.116 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 62.45 111.113 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 74.44 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.12 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 63.14 111.116 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 75.11 110.882 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 75.22 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.44 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.24 111.123 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.42 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.44 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.3 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.24 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 75.2 110.871 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.04 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.31 111.193 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.43 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 64.32 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 65.54 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.41 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.31 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.44 111.12 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.35 111.081 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.13 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -77.03 -27.75 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 62.4 110.911 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -173.75 31.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.952 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 74.15 110.898 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.35 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.45 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.162 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 73.13 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.3 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 74.33 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 63.5 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.43 111.121 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.51 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 73.43 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 73.25 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.03 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 64.03 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.12 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 65.21 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.3 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 73.4 110.936 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.53 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.23 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.895 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.52 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.43 111.123 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.871 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.155 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.11 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.15 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 63.04 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.03 110.858 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 72.43 112.494 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 54.24 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 60.31 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.858 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.52 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.53 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.42 111.117 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 71.35 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 63.12 111.068 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.3 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 74.33 110.936 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.53 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 52.55 111.131 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.41 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 70.04 111.13 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.907 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.14 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 70.3 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.42 111.148 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 70.34 111.149 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.52 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 74.23 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.121 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.54 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.93 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 65.45 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.12 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.4 111.15 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.11 111.111 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.51 111.121 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 74.55 110.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 73.33 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.34 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.2 110.801 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.42 111.156 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 72.44 112.345 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.45 111.114 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.51 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.12 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.85 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.53 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 71.1 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 64.41 111.129 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.51 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 75.21 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.14 111.176 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.23 111.095 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.31 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.34 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.44 -33.67 15.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.34 110.868 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.96 177.56 6.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 75.4 110.896 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.888 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.22 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.938 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.113 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 75.42 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.895 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 72.21 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.11 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.1 111.163 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.12 111.09 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.44 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 74.34 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.44 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.13 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.35 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.21 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.894 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.02 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.42 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.02 111.121 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.935 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.43 111.122 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.03 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.24 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.55 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.03 112.451 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 65.21 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.1 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.89 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 74.42 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 73.2 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 64.3 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 71.33 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.32 111.109 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 72.42 110.916 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.34 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.52 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.4 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.03 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.897 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.35 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.42 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.43 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 75.44 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 75.51 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.104 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.34 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.14 111.085 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 64.21 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.42 110.868 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.43 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.12 111.095 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.02 111.12 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.23 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.31 111.114 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.22 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 75.1 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.3 111.082 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.34 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.02 111.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 75.35 112.316 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.24 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.866 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.45 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.872 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.13 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 74.12 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 73.31 111.112 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.52 111.153 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 50.11 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.22 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.1 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.107 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 74.01 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -90.53 -14.03 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 75.42 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -147.91 45.7 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.935 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.885 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.23 112.337 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.416 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.24 111.155 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.34 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 75.52 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.1 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.099 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.11 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.21 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 75.13 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.2 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.55 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.34 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.34 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.32 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.101 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 74.3 110.943 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.34 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.04 111.138 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.925 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.152 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.23 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 73.52 111.121 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 72.13 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 74.32 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 11.0 m-80 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.03 110.846 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 73.13 112.488 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 72.42 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 65.34 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.11 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 54.24 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.44 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 70.25 111.097 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.24 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.32 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 65.43 111.077 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.32 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 74.13 110.906 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.03 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 75.33 111.096 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 72.43 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.903 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.934 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.192 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.54 110.852 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 75.35 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 70.13 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 73.1 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 74.15 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.11 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.152 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 75.25 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 70.5 111.111 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.11 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.914 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.41 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.15 111.165 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 74.42 111.126 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.091 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.52 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.878 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 75.45 111.123 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.44 110.886 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.13 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.44 111.066 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.885 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 71.32 111.115 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.54 112.343 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 72.05 111.107 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.146 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.03 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 62.31 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.54 110.905 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.13 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 75.25 111.117 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.45 111.125 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.53 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.21 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.12 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.23 111.128 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.133 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.53 111.093 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.51 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.01 -36.88 12.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.44 110.891 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.22 107.39 19.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 72.35 110.921 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.878 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 71.45 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.54 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.31 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.43 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 65.4 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.03 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.926 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.03 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.31 110.899 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.125 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 75.53 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.12 111.139 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.21 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 71.45 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 61.25 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 74.23 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 74.11 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.121 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.938 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.167 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.32 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 71.33 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.1 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 73.42 111.108 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 73.33 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 74.43 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.54 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.13 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.11 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.32 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.55 110.871 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 74.22 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.14 111.112 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.04 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.34 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.41 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.55 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 74.44 110.922 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.147 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.03 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.5 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 73.52 110.913 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.907 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 72.43 111.137 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 72.51 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.14 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 65.03 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.4 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.33 110.893 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.51 111.098 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.11 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 71.01 111.126 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.33 110.893 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.965 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.094 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.35 111.12 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.51 110.881 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.41 110.931 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.13 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.143 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.41 111.156 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.43 111.113 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.42 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 74.41 110.88 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.44 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.04 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.54 111.136 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.903 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 75.1 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 75.11 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.52 111.166 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.03 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.03 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 75.22 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.14 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 55.51 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.12 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.33 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 70.24 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.117 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.32 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.14 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 -29.82 47.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.04 110.871 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.75 107.42 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.932 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.4 110.879 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.04 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 74.3 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.55 111.156 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.35 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 74.44 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 74.12 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.54 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.13 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 75.41 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 74.52 110.864 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.128 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.55 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.1 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.1 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 74.04 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.31 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 74.12 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 74.55 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 71.31 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 74.41 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.112 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.912 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.167 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.03 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.33 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 75.34 111.176 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.897 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.138 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.04 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 75.52 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 74.0 110.819 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.44 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.11 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 74.01 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.02 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.904 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 44.11 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 74.24 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 73.12 111.049 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 71.03 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.14 111.108 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 64.31 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 72.31 110.961 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.23 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.43 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.03 110.887 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 65.24 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.152 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.03 110.896 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.871 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.05 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.55 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.41 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.33 111.132 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.131 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.52 110.931 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.14 111.127 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.083 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.841 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.899 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.15 111.117 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.21 111.115 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.44 111.073 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.55 111.12 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.23 110.874 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.35 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.31 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.02 111.108 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.15 110.866 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 75.22 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.11 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.42 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 74.4 111.132 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.52 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.876 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.01 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.04 111.13 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 74.24 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.04 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.155 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 63.22 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.22 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.11 -27.65 28.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.42 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.64 94.3 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 70.32 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.897 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 43.109999999999999 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 111.098 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.019999999999996 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.450000000000003 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' HB3' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 62.200000000000003 110.909 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.140000000000001 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 73.230000000000004 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 62.020000000000003 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 54.509999999999998 111.167 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.049999999999997 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 62.450000000000003 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 70.439999999999998 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.400000000000006 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 64.319999999999993 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.74 HD13 HG13 ' A' ' 64' ' ' VAL . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 65.209999999999994 110.924 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 25.210000000000001 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 HD13 ' A' ' 56' ' ' LEU . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 62.340000000000003 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.842 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.230000000000004 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' OE1' ' A' ' 30' ' ' GLN . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.194 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.617 ' OE1' HG23 ' A' ' 29' ' ' THR . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.948 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.420000000000002 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 34' ' ' GLY . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 111.181 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 33' ' ' THR . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.230000000000004 112.449 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.319999999999993 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.340000000000003 112.544 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 38' ' ' GLY . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.200000000000003 111.075 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 34.420000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 62.340000000000003 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.329999999999998 111.098 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 61.130000000000003 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.97 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.145 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.510000000000005 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.230000000000004 110.912 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 64.510000000000005 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 27' ' ' GLU . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.143 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.519999999999996 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.019999999999996 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 25' ' ' ILE . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 64' ' ' VAL . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 55.5 111.108 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.639 HH22 HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.838 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.425 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 110.866 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 43.340000000000003 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.74 HG13 HD13 ' A' ' 23' ' ' LEU . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 111.145 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 55.310000000000002 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.881 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 110.887 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 71.230000000000004 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 65.209999999999994 110.896 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 111.152 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.126 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.400000000000006 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.549999999999997 111.074 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.019999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 64.329999999999998 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 111.137 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.049999999999997 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.129999999999995 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 97' ' ' ALA . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 111.118 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 58' ' ' ARG . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 55.340000000000003 111.118 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.43 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 65.420000000000002 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.883 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.299999999999997 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 55.340000000000003 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 63.119999999999997 111.111 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 35.439999999999998 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.105 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.97 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 71.420000000000002 111.16 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 44.299999999999997 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 72.109999999999999 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 54.229999999999997 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.573 ' OE1' HG13 ' A' ' 78' ' ' VAL . 6.9 mp0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 72.430000000000007 110.848 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 63.32 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.044 HG22 ' HB2' ' A' ' 75' ' ' ALA . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 65.230000000000004 111.135 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 71.230000000000004 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 64.310000000000002 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.549999999999997 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.239999999999995 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.230000000000004 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 63.32 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.694 ' CG2' HD23 ' A' ' 23' ' ' LEU . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.530000000000001 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.030000000000001 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 55.119999999999997 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 52.100000000000001 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 32.439999999999998 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 71.519999999999996 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.694 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 54.350000000000001 110.903 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.154 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 34.240000000000002 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 8.5 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.936 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.230000000000004 111.131 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 44.340000000000003 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.299999999999997 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 72.430000000000007 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 70.430000000000007 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.239999999999995 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.219999999999999 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.340000000000003 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.76 ' HA ' HG22 ' A' ' 31' ' ' THR . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 40.240000000000002 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.510000000000005 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.109999999999999 111.1 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 44.229999999999997 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.702 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 34.030000000000001 111.111 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 61.119999999999997 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.777 HD21 HD12 ' A' ' 99' ' ' ILE . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.928 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.549999999999997 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.130000000000003 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.319999999999993 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.892 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 110.907 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 87' ' ' VAL . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 111.092 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HG2' HG13 ' A' ' 86' ' ' VAL . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 62.509999999999998 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 40.329999999999998 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 24.210000000000001 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 57' ' ' VAL . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 110.928 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.040000000000006 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.143 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.46 HG22 ' OE1' ' A' ' 66' ' ' GLU . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 111.134 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' OE1' HG22 ' A' ' 65' ' ' THR . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.150000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.340000000000003 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 73.099999999999994 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.030000000000001 110.88 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 41.43 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 58' ' ' ARG . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.098 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 70' ' ' PHE . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.109 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.044 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.399999999999999 111.105 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.150000000000006 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 74' ' ' VAL . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.138 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 72.319999999999993 110.929 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.349999999999994 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.065 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.582 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 110.849 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 54.340000000000003 111.107 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 65.409999999999997 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' ' 58' ' ' ARG . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.092 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 57' ' ' VAL . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.319999999999993 110.848 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 51.020000000000003 111.115 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 52.520000000000003 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.777 HD12 HD21 ' A' ' 50' ' ' LEU . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 111.132 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.582 HG12 ' CB ' ' A' ' 83' ' ' SER . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 111.122 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 78' ' ' VAL . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 63.43 111.16 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.209999999999994 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 110.85 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 74.329999999999998 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 50.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.068 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 111.134 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.310000000000002 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 62.329999999999998 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 63.329999999999998 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.530000000000001 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.129999999999995 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.619 ' CG2' HD23 ' A' ' 67' ' ' LEU . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 53.450000000000003 111.127 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.109999999999999 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' A' ' 21' ' ' THR . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.855 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.319999999999993 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.129999999999995 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 64.540000000000006 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 63.350000000000001 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.43 HG23 ' NH1' ' A' ' 15' ' ' ARG . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 111.151 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.010000000000005 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.936 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 56' ' ' LEU . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.174 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 52' ' ' VAL . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.445 HG21 ' CE2' ' A' ' 70' ' ' PHE . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 111.116 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.896 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 111.164 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 23.109999999999999 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 72.030000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 54.530000000000001 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.040000000000006 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 53.539999999999999 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.099999999999994 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.743 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.84 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.140000000000001 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 64.010000000000005 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.747 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 111.066 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.129999999999995 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 99' ' ' ILE . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.049999999999997 111.091 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 35.119999999999997 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 99' ' ' ILE . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 27' ' ' GLU . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 111.117 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 50.310000000000002 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 62.039999999999999 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.695 HD13 HG13 ' A' ' 25' ' ' ILE . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 110.943 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 87' ' ' VAL . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.064 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 57' ' ' VAL . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 110.897 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.549999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.340000000000003 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.450000000000003 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.5 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 23' ' ' LEU . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 111.119 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 66' ' ' GLU . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.420000000000002 111.141 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.875 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 11' ' ' VAL . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.240000000000002 111.117 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 34.009999999999998 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 70.510000000000005 110.915 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 70' ' ' PHE . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 62.340000000000003 111.117 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 78' ' ' VAL . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.129 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.068 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 64.510000000000005 111.127 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 101' ' ' VAL . 1.4 t60 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.139 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.579 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 63.520000000000003 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 72.019999999999996 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.099999999999994 111.071 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.299999999999997 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.340000000000003 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.109999999999999 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.997 HG21 HD11 ' A' ' 99' ' ' ILE . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 111.156 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 57' ' ' VAL . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.079 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 64.310000000000002 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.923 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.319999999999993 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 90' ' ' ARG . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.400000000000006 111.106 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 94' ' ' VAL . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.135 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.150000000000006 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 86' ' ' VAL . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 62.100000000000001 111.135 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 73.150000000000006 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.422 HG23 ' CE1' ' A' ' 77' ' ' HIS . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 55.109999999999999 111.129 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 62.350000000000001 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.908 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.510000000000005 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.651 HG22 ' CB ' ' A' ' 75' ' ' ALA . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 111.163 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.219999999999999 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 65.319999999999993 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.230000000000004 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.129999999999995 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 54.420000000000002 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 53.409999999999997 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 62.149999999999999 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 34.439999999999998 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.439999999999998 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 71.120000000000005 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.884 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 54' ' ' ASP . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 111.133 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 63.100000000000001 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.230000000000004 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 63.210000000000001 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.530000000000001 111.177 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.585 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.933 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 61.32 111.165 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 62.509999999999998 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.72 HG23 ' OE2' ' A' ' 103' ' ' GLU . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.530000000000001 111.114 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 63.039999999999999 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 61.0 110.843 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 42.539999999999999 110.9 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 50.310000000000002 112.514 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.510000000000005 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.109999999999999 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 62.340000000000003 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.803 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 44.530000000000001 110.88 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.209999999999994 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.040000000000006 111.101 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 53.039999999999999 111.119 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.120000000000005 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.972 HD21 HG21 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.140000000000001 110.911 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 55.039999999999999 111.099 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.340000000000003 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 25' ' ' ILE . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.319999999999993 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 70' ' ' PHE . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 64' ' ' VAL . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.350000000000001 111.131 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.652 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 110.821 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 41.200000000000003 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 60.439999999999998 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 73.120000000000005 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.329999999999998 111.16 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 63.210000000000001 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.848 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.099999999999994 110.922 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.067 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 43.340000000000003 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CD1' HD13 ' A' ' 56' ' ' LEU . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.120000000000005 110.863 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 61.43 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 78' ' ' VAL . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 63.009999999999998 111.121 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.430000000000007 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.439999999999998 110.851 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 111.081 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.299999999999997 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.310000000000002 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' CG ' ' A' ' 58' ' ' ARG . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.349999999999994 111.137 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 53.409999999999997 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.540000000000006 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.863 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.140000000000001 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 54.509999999999998 111.145 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 111.147 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.972 HG21 HD21 ' A' ' 50' ' ' LEU . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.114 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 55.420000000000002 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.439999999999998 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.72 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.030000000000001 110.893 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 44.140000000000001 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 64.209999999999994 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 73.530000000000001 111.13 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.519999999999996 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 50.350000000000001 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 63.219999999999999 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.439999999999998 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 67' ' ' LEU . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 50.539999999999999 111.141 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 65.219999999999999 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 65.340000000000003 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 22' ' ' THR . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.887 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 72.450000000000003 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.009999999999998 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 70.230000000000004 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.148 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.981 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 54' ' ' ASP . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.149 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.898 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 61.530000000000001 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 61.030000000000001 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 61.420000000000002 111.109 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 51.340000000000003 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.430000000000007 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.100000000000001 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 110.882 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 63.109999999999999 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 54.210000000000001 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 53.299999999999997 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.775 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.020000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.519999999999996 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 64.200000000000003 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.530000000000001 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.519999999999996 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 54.409999999999997 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 45.420000000000002 111.058 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HG2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.400000000000006 110.939 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 63.229999999999997 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 27' ' ' GLU . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.420000000000002 111.125 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 30.449999999999999 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.340000000000003 110.844 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.733 HG23 HG13 ' A' ' 87' ' ' VAL . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.019999999999996 111.113 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.861 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.519999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.099999999999994 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.129999999999995 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.140000000000001 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 111.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 61.450000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 11' ' ' VAL . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.906 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 61.509999999999998 111.134 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.875 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 77' ' ' HIS . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.089 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' PHE . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 111.138 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.002 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 111.092 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' HG12 ' A' ' 73' ' ' VAL . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 110.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 74' ' ' VAL . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.340000000000003 110.915 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 43.530000000000001 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.030000000000001 111.136 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 85' ' ' PRO . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 64.120000000000005 111.122 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.129999999999995 112.347 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 57' ' ' VAL . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.530000000000001 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 110.897 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 71.349999999999994 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.409999999999997 111.121 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 54.310000000000002 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.520000000000003 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.240000000000002 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 61.100000000000001 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 51.25 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.863 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.142 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' ' 83' ' ' SER . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.210000000000001 111.065 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 42.109999999999999 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.871 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 71.010000000000005 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.549999999999997 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.133 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 64.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 72.019999999999996 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.420000000000002 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 35.43 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 64.120000000000005 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.687 ' CG2' HD23 ' A' ' 23' ' ' LEU . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.430000000000007 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 HD11 ' A' ' 23' ' ' LEU . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.148 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.109999999999999 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 71.120000000000005 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.399999999999999 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.519999999999996 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.010000000000005 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.229999999999997 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 HG23 HE22 ' A' ' 55' ' ' GLN . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 111.142 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 110.919 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.329999999999998 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.88 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 63.049999999999997 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 51.420000000000002 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.76 ' HG2' HD13 ' A' ' 50' ' ' LEU . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.917 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.771 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.109999999999999 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 53.020000000000003 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.439999999999998 110.859 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.329999999999998 112.482 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.299999999999997 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.420000000000002 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.771 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.871 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 51.200000000000003 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.299999999999997 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.83 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.134 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 43.539999999999999 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 44.539999999999999 111.07 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.219999999999999 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 45' ' ' ALA . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.209999999999994 110.892 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 54.119999999999997 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 27' ' ' GLU . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.310000000000002 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 HG23 ' A' ' 22' ' ' THR . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.949 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 110.96 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 64' ' ' VAL . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 61.43 111.101 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HD3' HG23 ' A' ' 86' ' ' VAL . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.861 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.438 ' H ' HG23 ' A' ' 57' ' ' VAL . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 55.009999999999998 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.319999999999993 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 73.010000000000005 110.914 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.400000000000006 111.106 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 65' ' ' THR . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.895 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 65.349999999999994 111.122 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 44.109999999999999 111.14 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 74' ' ' VAL . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.049999999999997 110.866 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 70.319999999999993 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.118 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.736 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 35.149999999999999 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.409999999999997 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 74' ' ' VAL . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 71.040000000000006 110.868 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.120000000000005 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 54.420000000000002 111.122 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.599 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 110.892 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.099999999999994 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 62.25 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.812 HG23 ' HD3' ' A' ' 58' ' ' ARG . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 62.439999999999998 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.009999999999998 111.117 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 61.539999999999999 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 110.843 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' ARG . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.420000000000002 111.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.409999999999997 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.400000000000006 111.119 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HD21 ' A' ' 50' ' ' LEU . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.520000000000003 111.145 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 83' ' ' SER . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 71.420000000000002 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 52.100000000000001 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 50.020000000000003 110.881 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 64.099999999999994 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 54.210000000000001 111.155 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.420000000000002 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 60.25 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.919 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 7' ' ' LEU . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 64.019999999999996 110.859 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 61.32 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 HD13 ' A' ' 25' ' ' ILE . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 111.125 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.109999999999999 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 44.520000000000003 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 64.099999999999994 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 11' ' ' VAL . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 51.240000000000002 110.873 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.549999999999997 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 56' ' ' LEU . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.115 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' ILE . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.856 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 61.5 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 30' ' ' GLN . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 111.152 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 50' ' ' LEU . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.88 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 45.32 111.155 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.209999999999994 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 22.530000000000001 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.3 m120 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.925 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.140000000000001 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.219999999999999 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 64.25 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.769 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 44.340000000000003 110.858 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.130000000000003 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 71.140000000000001 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 111.127 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 44.32 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 99' ' ' ILE . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 53.409999999999997 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 43.409999999999997 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD11 HD13 ' A' ' 99' ' ' ILE . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.219999999999999 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.450000000000003 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.140000000000001 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 51.229999999999997 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 25' ' ' ILE . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.871 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 64' ' ' VAL . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 52.109999999999999 111.109 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.494 ' CG ' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.852 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.549999999999997 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.140000000000001 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 65.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.310000000000002 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 57' ' ' VAL . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 60.439999999999998 111.112 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 64.010000000000005 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.842 HD13 HD21 ' A' ' 7' ' ' LEU . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 70.230000000000004 110.952 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 51.030000000000001 111.097 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 55.240000000000002 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 60.130000000000003 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 3' ' ' THR . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.089 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.849 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.439999999999998 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 78' ' ' VAL . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 111.124 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.420000000000002 110.879 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 73.530000000000001 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 61.119999999999997 111.074 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 51.200000000000003 110.873 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 83' ' ' SER . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.319999999999993 111.12 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.209999999999994 112.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 99' ' ' ILE . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.131 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 54.200000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.109999999999999 110.838 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 111.065 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 55.119999999999997 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 60.229999999999997 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HD11 ' A' ' 50' ' ' LEU . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.430000000000007 111.182 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.148 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.425 HG12 ' OE1' ' A' ' 103' ' ' GLU . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.107 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 33.130000000000003 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.140000000000001 110.907 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 61.119999999999997 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.9 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.13 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 73.239999999999995 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.129999999999995 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.530000000000001 110.972 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.25 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' O ' HD11 ' A' ' 7' ' ' LEU . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.420000000000002 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.439999999999998 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.420000000000002 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.450000000000003 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.310000000000002 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 66' ' ' GLU . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.873 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 27' ' ' GLU . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 72.239999999999995 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 70.230000000000004 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.92 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 63.109999999999999 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 62.399999999999999 111.126 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 103' ' ' GLU . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 64.120000000000005 111.114 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 54.0 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 63.32 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.319999999999993 112.442 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.140000000000001 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.541 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 110.895 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.239999999999995 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 61.109999999999999 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 52.530000000000001 111.091 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.229999999999997 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.852 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 111.093 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.400000000000006 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.200000000000003 110.908 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 70.239999999999995 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.430000000000007 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 72.239999999999995 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.129999999999995 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 63' ' ' THR . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 111.161 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 70.420000000000002 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 57' ' ' VAL . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.099999999999994 110.864 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 40.039999999999999 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 72.420000000000002 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 61.049999999999997 111.131 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.350000000000001 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 66' ' ' GLU . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 60.340000000000003 111.18 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 110.903 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 7' ' ' LEU . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 40.439999999999998 110.858 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 111.082 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.099999999999994 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 61.450000000000003 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 78' ' ' VAL . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 53.049999999999997 111.126 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 25.539999999999999 111.095 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 61.539999999999999 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 99' ' ' ILE . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.219999999999999 110.904 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.340000000000003 111.147 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 55.039999999999999 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 111.124 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 100' ' ' VAL . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 31.210000000000001 110.846 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 85' ' ' PRO . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 55.350000000000001 111.106 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.400000000000006 112.336 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HZ ' HG21 ' A' ' 99' ' ' ILE . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.885 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 42.109999999999999 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 90' ' ' ARG . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.340000000000003 111.095 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.120000000000005 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.439999999999998 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.409999999999997 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.852 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 70.319999999999993 111.133 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' OG ' ' A' ' 83' ' ' SER . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.120000000000005 111.119 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 103' ' ' GLU . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.121 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.030000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HB3' HG21 ' A' ' 33' ' ' THR . 4.4 mp0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.93 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 41.109999999999999 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 ' HE ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.942 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.74 HG22 ' CB ' ' A' ' 75' ' ' ALA . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 62.539999999999999 111.195 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 54.32 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.209999999999994 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 44.020000000000003 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HD23 ' A' ' 23' ' ' LEU . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.400000000000006 111.114 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.040000000000006 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.230000000000004 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 63.299999999999997 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.210000000000001 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.420000000000002 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 43.140000000000001 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD23 HG21 ' A' ' 11' ' ' VAL . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.200000000000003 110.915 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 54' ' ' ASP . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.895 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.510000000000005 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.932 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 42' ' ' MET . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.147 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.409999999999997 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 111.118 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.219999999999999 112.537 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 74.340000000000003 110.851 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.420000000000002 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.040000000000006 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 71.099999999999994 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.109999999999999 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.876 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 54.219999999999999 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.040000000000006 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 42.130000000000003 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.25 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.099999999999994 111.133 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 55.240000000000002 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 54.210000000000001 110.922 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 27' ' ' GLU . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.340000000000003 111.117 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.219999999999999 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.230000000000004 110.882 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 70' ' ' PHE . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.891 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 63' ' ' THR . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 111.098 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.049999999999997 110.889 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 62.32 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 60.240000000000002 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.416 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 71.239999999999995 110.927 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.659 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 52.310000000000002 111.157 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.409999999999997 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.944 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.118 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.549999999999997 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 74' ' ' VAL . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.854 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.030000000000001 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 52.310000000000002 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 111.113 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 2' ' ' LEU . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.894 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.532 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.849 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 74' ' ' VAL . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 50.409999999999997 111.134 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 64.049999999999997 110.857 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.230000000000004 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 54.350000000000001 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 111.11 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.804 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.009999999999998 110.888 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' CD2' ' A' ' 77' ' ' HIS . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.400000000000006 111.133 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 65.409999999999997 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.140000000000001 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.849 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.319999999999993 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 90' ' ' ARG . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.540000000000006 111.16 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 63.340000000000003 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 54.109999999999999 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.340000000000003 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.967 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 111.132 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 83' ' ' SER . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.107 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.099999999999994 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' OE1' HG13 ' A' ' 78' ' ' VAL . 3.5 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.310000000000002 110.933 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.450000000000003 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 70.239999999999995 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.430000000000007 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 40.020000000000003 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 70.030000000000001 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.682 ' CG2' HD23 ' A' ' 23' ' ' LEU . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 41.32 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 62.420000000000002 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.52 ' HD2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 73.239999999999995 110.881 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 44.399999999999999 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 63.32 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.200000000000003 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.450000000000003 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HD2' ' A' ' 15' ' ' ARG . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.349999999999994 111.137 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.503 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.140000000000001 111.133 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG2' ' A' ' 11' ' ' VAL . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 27' ' ' GLU . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 62.210000000000001 111.139 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 62.119999999999997 110.894 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.877 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.164 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.629 HG23 ' CB ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 55.100000000000001 111.132 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.519999999999996 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' HG11 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 110.829 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 65.030000000000001 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.513 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 42.530000000000001 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 63.229999999999997 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.629 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 51.32 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.310000000000002 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 111.095 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 60.240000000000002 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 99' ' ' ILE . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.200000000000003 110.918 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.420000000000002 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 51.329999999999998 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.109999999999999 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 56' ' ' LEU . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.963 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.707 HG12 ' CG2' ' A' ' 64' ' ' VAL . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.114 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.647 ' HG3' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.917 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.209999999999994 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 65.230000000000004 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 57' ' ' VAL . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.124 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.049999999999997 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 111.058 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 61.219999999999999 111.09 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 74' ' ' VAL . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 110.89 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 71.209999999999994 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 69' ' ' ALA . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.131 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 70' ' ' PHE . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.864 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 53.240000000000002 111.086 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.439999999999998 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.143 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.310000000000002 110.842 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 53.130000000000003 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.091 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.515 ' HB3' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.229999999999997 110.908 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 99' ' ' ILE . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.209999999999994 111.161 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.329999999999998 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 58' ' ' ARG . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 61.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 54.409999999999997 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.925 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.530000000000001 110.915 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 44.5 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.144 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.340000000000003 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 111.118 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 51.119999999999997 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.676 HG22 ' HB1' ' A' ' 48' ' ' ALA . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 111.079 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 83' ' ' SER . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.299999999999997 111.181 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 35.340000000000003 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.515 ' OE2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.310000000000002 110.855 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 50.43 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.888 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.158 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 64.530000000000001 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.219999999999999 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.430000000000007 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.329999999999998 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.120000000000005 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 23' ' ' LEU . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 60.140000000000001 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 61.520000000000003 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 24.34 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 74.420000000000002 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.299999999999997 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 33.240000000000002 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.420000000000002 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.936 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 60.43 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 56' ' ' LEU . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 65.219999999999999 111.142 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.888 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' NE2' ' A' ' 30' ' ' GLN . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 70.430000000000007 111.12 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 28' ' ' VAL . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.953 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.169 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.319999999999993 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 103' ' ' GLU . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 71.450000000000003 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.200000000000003 112.506 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.020000000000003 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.340000000000003 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.774 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 110.891 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.129999999999995 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.109999999999999 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 61.32 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.239999999999995 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.100000000000001 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.209999999999994 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' HG3' ' A' ' 30' ' ' GLN . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 53.119999999999997 110.907 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 40.439999999999998 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.439999999999998 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD12 HH21 ' A' ' 58' ' ' ARG . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 74.019999999999996 110.954 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.744 HG12 ' CG2' ' A' ' 64' ' ' VAL . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 111.122 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.621 HH21 HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.91 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 57' ' ' VAL . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.905 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 53.039999999999999 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.109999999999999 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.532 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.340000000000003 110.952 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.439999999999998 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.744 ' CG2' HG12 ' A' ' 57' ' ' VAL . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 111.086 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 55.43 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 111.052 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 73' ' ' VAL . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.916 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 110.865 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 61.530000000000001 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 70' ' ' PHE . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 53.520000000000003 111.14 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.125 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.240000000000002 111.095 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.897 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.229999999999997 111.172 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 110.892 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.340000000000003 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.409999999999997 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 44.140000000000001 111.1 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 85' ' ' PRO . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.549999999999997 111.119 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.229999999999997 112.318 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG13 ' HG2' ' A' ' 58' ' ' ARG . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.138 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 62.539999999999999 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 62.43 110.841 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.530000000000001 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.130000000000003 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 62.25 111.107 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 63.329999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.140000000000001 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 72.010000000000005 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 61.310000000000002 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.168 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.489 HG12 ' OE1' ' A' ' 103' ' ' GLU . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.138 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.32 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 54.140000000000001 110.879 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.129999999999995 112.401 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 63.5 110.92 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.978 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.540000000000006 111.163 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 53.210000000000001 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.039999999999999 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.150000000000006 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 110.937 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 42.210000000000001 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.349999999999994 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.219999999999999 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 67' ' ' LEU . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 111.131 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 43.509999999999998 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 64.310000000000002 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.140000000000001 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 23' ' ' LEU . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.134 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 22' ' ' THR . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.909 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' ASP . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 111.143 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 63.020000000000003 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 70' ' ' PHE . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.167 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.159 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.400000000000006 111.146 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.299999999999997 112.492 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 61.219999999999999 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 65.319999999999993 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.130000000000003 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.009999999999998 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 41.25 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.299999999999997 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.350000000000001 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.726 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.929 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.129999999999995 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 43.530000000000001 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 40.43 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.450000000000003 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.712 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.149999999999999 111.116 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 60.039999999999999 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 99' ' ' ILE . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.140000000000001 110.922 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.040000000000006 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 52' ' ' VAL . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 111.128 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.329999999999998 110.84 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.200000000000003 111.137 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.534 ' CG ' HG13 ' A' ' 86' ' ' VAL . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.898 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.902 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.230000000000004 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.409999999999997 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 57' ' ' VAL . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 110.916 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 23' ' ' LEU . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 63.219999999999999 111.096 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 11' ' ' VAL . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 63.210000000000001 110.937 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 43.32 111.084 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 29' ' ' THR . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 60.399999999999999 110.893 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.129999999999995 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 78' ' ' VAL . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 52.32 111.136 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.978 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 111.048 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 74' ' ' VAL . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.030000000000001 111.162 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 65.140000000000001 110.833 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 71.239999999999995 112.361 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.130000000000003 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.109999999999999 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 85' ' ' PRO . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 52.409999999999997 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 35.130000000000003 112.368 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG13 ' CG ' ' A' ' 58' ' ' ARG . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 72.109999999999999 111.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 57' ' ' VAL . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.107 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 50' ' ' LEU . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.907 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.89 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.040000000000006 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.140000000000001 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 90' ' ' ARG . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 64.420000000000002 111.107 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.310000000000002 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 32.310000000000002 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.712 HG23 ' CB ' ' A' ' 48' ' ' ALA . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.049999999999997 111.096 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 100' ' ' VAL . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.108 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.310000000000002 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.230000000000004 110.914 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 78' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 62.32 112.348 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 61.520000000000003 110.912 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.989 HG22 ' HB2' ' A' ' 75' ' ' ALA . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.131 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.140000000000001 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 70.530000000000001 110.915 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.420000000000002 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.150000000000006 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.968 HG22 HD23 ' A' ' 67' ' ' LEU . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.010000000000005 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 62.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 72.420000000000002 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.622 ' C ' HD12 ' A' ' 23' ' ' LEU . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.155 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.653 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.897 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.409999999999997 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 56' ' ' LEU . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.340000000000003 111.139 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' HB2' HD13 ' A' ' 50' ' ' LEU . 4.9 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.924 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.420000000000002 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 61.450000000000003 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 64.219999999999999 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 55.130000000000003 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.505 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.310000000000002 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.400000000000006 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 50' ' ' LEU . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.099999999999994 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.076 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 30' ' ' GLN . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 63.109999999999999 110.935 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 72.200000000000003 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.409999999999997 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 62.030000000000001 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 25' ' ' ILE . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.936 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 87' ' ' VAL . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 57' ' ' VAL . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.350000000000001 110.873 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.129999999999995 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 71.549999999999997 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.019999999999996 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.653 ' CG1' HD13 ' A' ' 23' ' ' LEU . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 111.16 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 43.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.968 HD23 HG22 ' A' ' 11' ' ' VAL . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.030000000000001 110.914 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 111.166 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 62.109999999999999 110.925 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.229999999999997 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 63.549999999999997 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 70' ' ' PHE . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 44.119999999999997 111.096 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.989 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 71.040000000000006 111.09 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 64.299999999999997 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.132 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.420000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 73.140000000000001 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.519999999999996 111.118 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.219999999999999 110.864 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 71.409999999999997 111.173 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.141 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.456 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.862 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.549999999999997 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.010000000000005 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 53.299999999999997 111.159 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.530000000000001 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 48' ' ' ALA . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 65.010000000000005 111.096 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 83' ' ' SER . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 72.510000000000005 111.15 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.408 HG21 ' NE2' ' A' ' 30' ' ' GLN . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.1 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 41.549999999999997 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.439999999999998 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.873 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.702 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.145 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.099999999999994 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 34.32 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' HD2' HG23 ' A' ' 25' ' ' ILE . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.109999999999999 110.917 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.210000000000001 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.109999999999999 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 62.240000000000002 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 44.310000000000002 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.310000000000002 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.350000000000001 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 55.420000000000002 111.132 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 23' ' ' LEU . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.508 ' CG1' HD23 ' A' ' 56' ' ' LEU . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.030000000000001 111.129 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.010000000000005 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 63.210000000000001 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.515 HG21 ' CE1' ' A' ' 70' ' ' PHE . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 50.030000000000001 111.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.759 ' CD ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 110.948 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.127 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.409999999999997 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 42.420000000000002 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 54.350000000000001 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 73.010000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.230000000000004 112.482 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.210000000000001 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.039999999999999 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.329999999999998 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.776 ' HA ' HG22 ' A' ' 31' ' ' THR . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 32.409999999999997 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 74.219999999999999 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 111.109 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.450000000000003 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 111.086 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 71.219999999999999 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD12 ' HA ' ' A' ' 45' ' ' ALA . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 52.140000000000001 110.899 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 23.530000000000001 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.319999999999993 110.864 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.049999999999997 110.882 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' CG1' ' A' ' 25' ' ' ILE . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 110.925 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 111.143 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HG3' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.819 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.898 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 44.200000000000003 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 70.099999999999994 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.019999999999996 110.958 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.200000000000003 111.131 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 57' ' ' VAL . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.349999999999994 111.129 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 65' ' ' THR . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.430000000000007 110.898 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 60.25 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 51.329999999999998 111.06 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 29' ' ' THR . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 110.86 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 74' ' ' VAL . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.319999999999993 110.899 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 74' ' ' VAL . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 111.141 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.702 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.059 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.319999999999993 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.873 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 61.350000000000001 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 62.409999999999997 111.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.85 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 83' ' ' SER . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 65.319999999999993 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.338 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 111.175 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.109999999999999 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.049999999999997 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.040000000000006 110.832 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.329999999999998 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 90' ' ' ARG . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.299999999999997 111.161 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 64.200000000000003 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 55.140000000000001 111.121 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.230000000000004 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.725 HG12 HD21 ' A' ' 50' ' ' LEU . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.150000000000006 111.084 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.010000000000005 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 64.299999999999997 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.120000000000005 110.894 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 55.409999999999997 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.689 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 110.891 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.240000000000002 111.084 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 71.099999999999994 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.651 HD12 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 110.947 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.030000000000001 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE2' HD12 ' A' ' 7' ' ' LEU . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 60.039999999999999 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.409999999999997 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.030000000000001 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 61.399999999999999 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 64.010000000000005 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 71.150000000000006 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.400000000000006 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 61.340000000000003 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 50.240000000000002 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 66' ' ' GLU . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 51.130000000000003 110.891 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.049999999999997 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.451 HG23 ' NE2' ' A' ' 30' ' ' GLN . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HG2' HD13 ' A' ' 50' ' ' LEU . 13.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.430000000000007 110.917 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 111.15 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 43.409999999999997 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.140000000000001 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.0 112.467 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.150000000000006 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.799 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.87 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.140000000000001 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 63.5 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 111.095 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 61.210000000000001 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.661 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.420000000000002 111.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.340000000000003 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 63.119999999999997 110.915 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.140000000000001 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.340000000000003 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.310000000000002 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.112 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.695 ' HD2' HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.894 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.621 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.892 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 55.039999999999999 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.439999999999998 110.933 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.340000000000003 111.119 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.450000000000003 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 23' ' ' LEU . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 110.886 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.109 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.519999999999996 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 74' ' ' VAL . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.851 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 52.219999999999999 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.759 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 60.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 25.199999999999999 111.113 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 70.329999999999998 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.130000000000003 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 62.299999999999997 111.116 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 71.510000000000005 110.882 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 73.019999999999996 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 53.329999999999998 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 111.123 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.200000000000003 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG13 ' HD2' ' A' ' 58' ' ' ARG . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.167 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.299999999999997 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.519999999999996 110.871 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.039999999999999 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ARG . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 111.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 52.420000000000002 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 50' ' ' LEU . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.12 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 111.081 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.651 ' HG2' HG13 ' A' ' 78' ' ' VAL . 23.4 mp0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 45.109999999999999 110.911 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.349999999999994 112.369 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.450000000000003 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.162 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 72.409999999999997 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.140000000000001 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 67' ' ' LEU . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.299999999999997 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 24.449999999999999 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE1' HD12 ' A' ' 7' ' ' LEU . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.87 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.477 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.209999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 31.41 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 35.009999999999998 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.120000000000005 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 64.219999999999999 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.299999999999997 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' HB ' ' A' ' 11' ' ' VAL . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.936 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.530000000000001 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.895 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 70' ' ' PHE . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 111.123 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.871 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.409999999999997 111.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.549999999999997 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.149999999999999 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 62.439999999999998 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 1' ' ' PRO . 0.6 OUTLIER 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.030000000000001 110.858 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 14.220000000000001 112.494 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 32.539999999999999 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 43.450000000000003 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.763 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.858 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.109999999999999 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.530000000000001 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 53.100000000000001 111.117 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 43.329999999999998 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.95 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 42.310000000000002 111.068 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.299999999999997 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 48' ' ' ALA . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.936 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 62.450000000000003 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 27' ' ' GLU . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 44.43 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.409999999999997 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 63' ' ' THR . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 64.140000000000001 111.13 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HD2' HG22 ' A' ' 86' ' ' VAL . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.873 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.445 ' H ' HG12 ' A' ' 57' ' ' VAL . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.907 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.420000000000002 111.148 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 57' ' ' VAL . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 111.149 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 7' ' ' LEU . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 72.209999999999994 110.931 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.121 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.93 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 60.329999999999998 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.120000000000005 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.400000000000006 111.15 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.983 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.111 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 70.319999999999993 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 74' ' ' VAL . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.509999999999998 111.121 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.736 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 71.120000000000005 110.871 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 45.020000000000003 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 41.299999999999997 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.210000000000001 111.104 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' O ' HD13 ' A' ' 84' ' ' ILE . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 55.340000000000003 110.801 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 85' ' ' PRO . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.420000000000002 111.156 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 63.43 112.345 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 58' ' ' ARG . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 52.409999999999997 111.114 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 71.099999999999994 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 110.85 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 54.130000000000003 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.530000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 61.210000000000001 111.124 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' VAL . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 51.200000000000003 111.129 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 64.420000000000002 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.129999999999995 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.95 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.140000000000001 111.176 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.229999999999997 111.095 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 51.229999999999997 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.340000000000003 110.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.219999999999999 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.714 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.938 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.815 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.113 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 64.200000000000003 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.481 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.895 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 70.109999999999999 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.62 HG21 HD23 ' A' ' 23' ' ' LEU . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 71.329999999999998 111.163 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 51.340000000000003 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.672 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.120000000000005 111.09 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.439999999999998 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.510000000000005 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.140000000000001 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.129999999999995 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 13' ' ' VAL . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.894 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.349999999999994 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 62.240000000000002 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 30' ' ' GLN . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.019999999999996 111.121 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' HG2' HD13 ' A' ' 50' ' ' LEU . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 52.140000000000001 110.935 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 111.122 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.030000000000001 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.240000000000002 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.549999999999997 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.030000000000001 112.451 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.099999999999994 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 71.340000000000003 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.310000000000002 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.808 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 53.32 110.89 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 72.150000000000006 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 52.140000000000001 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.56 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 33.030000000000001 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 61.520000000000003 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 111.109 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.100000000000001 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 62.32 110.916 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.340000000000003 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.519999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.519999999999996 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.400000000000006 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.897 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 64' ' ' VAL . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.156 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 73.430000000000007 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 57' ' ' VAL . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.340000000000003 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 110.95 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.140000000000001 111.085 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.049999999999997 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.619 ' O ' HG12 ' A' ' 74' ' ' VAL . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.868 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 52.0 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 50.039999999999999 111.095 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.815 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 44.439999999999998 111.12 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 71.230000000000004 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 74' ' ' VAL . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 111.114 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.219999999999999 110.879 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.299999999999997 111.082 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.340000000000003 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 85' ' ' PRO . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.019999999999996 111.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 72.109999999999999 112.316 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CZ ' HD23 ' A' ' 56' ' ' LEU . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.450000000000003 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 110.872 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 33.32 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 55.219999999999999 111.112 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.519999999999996 111.153 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 41.130000000000003 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.58 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.107 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.030000000000001 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 41.43 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.588 ' HG2' HG13 ' A' ' 78' ' ' VAL . 7.1 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 74.019999999999996 110.909 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.58 ' O ' HD22 ' A' ' 2' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.230000000000004 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 50.219999999999999 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 75' ' ' ALA . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 111.155 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.340000000000003 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 73.109999999999999 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 63.350000000000001 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.099 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.109999999999999 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.010000000000005 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 65.010000000000005 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.200000000000003 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.549999999999997 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 64.420000000000002 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.340000000000003 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 11' ' ' VAL . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.120000000000005 110.906 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.689 HG13 HD23 ' A' ' 56' ' ' LEU . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 55.329999999999998 111.101 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 72.120000000000005 110.943 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.876 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.040000000000006 111.138 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 50' ' ' LEU . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.925 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.456 HG23 ' CB ' ' A' ' 45' ' ' ALA . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.152 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 54.420000000000002 111.121 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 64.030000000000001 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 72.230000000000004 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m120 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.030000000000001 110.846 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 103' ' ' GLU . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 64.109999999999999 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 44.420000000000002 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.109999999999999 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 44.32 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.439999999999998 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 44.509999999999998 111.097 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 63.009999999999998 111.077 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.319999999999993 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.055 HD21 HG21 ' A' ' 99' ' ' ILE . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.030000000000001 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 26' ' ' GLN . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.096 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 64.140000000000001 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 62.329999999999998 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' C ' HD22 ' A' ' 56' ' ' LEU . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.903 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 71.439999999999998 110.934 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG23 HG13 ' A' ' 87' ' ' VAL . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.192 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.745 ' HG2' HG13 ' A' ' 86' ' ' VAL . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.540000000000006 110.852 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 61.329999999999998 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 64.239999999999995 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 63.340000000000003 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.040000000000006 111.11 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 64' ' ' VAL . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.152 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.867 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 68' ' ' ALA . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 72.209999999999994 110.891 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 54.200000000000003 111.111 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.109999999999999 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.687 ' O ' HG23 ' A' ' 74' ' ' VAL . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.914 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 61.329999999999998 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 54.140000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.647 HG11 ' HD3' ' A' ' 58' ' ' ARG . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 111.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 70' ' ' PHE . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 111.126 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.091 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 61.219999999999999 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.488 ' NE2' HD11 ' A' ' 99' ' ' ILE . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 35.43 110.878 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 74' ' ' VAL . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 72.049999999999997 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.439999999999998 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HD13 ' A' ' 84' ' ' ILE . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 63.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 83' ' ' SER . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 62.340000000000003 111.115 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.539999999999999 112.343 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.745 HG13 ' HG2' ' A' ' 58' ' ' ARG . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 111.107 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 HG23 ' A' ' 57' ' ' VAL . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 60.539999999999999 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.905 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 64.329999999999998 111.117 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 43.310000000000002 111.125 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 52.530000000000001 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 53.43 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.055 HG21 HD21 ' A' ' 50' ' ' LEU . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.128 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.133 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.593 HG23 HD12 ' A' ' 99' ' ' ILE . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.093 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.510000000000005 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 78' ' ' VAL . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 110.891 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 62.130000000000003 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.675 HG22 ' CB ' ' A' ' 75' ' ' ALA . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.141 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.430000000000007 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 61.140000000000001 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 52.299999999999997 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 67' ' ' LEU . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.310000000000002 110.926 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.030000000000001 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.310000000000002 110.899 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 23' ' ' LEU . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 54.439999999999998 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 23' ' ' LEU . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.450000000000003 111.139 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.209999999999994 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.049999999999997 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 54.219999999999999 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.512 HG23 ' NE2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.121 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.938 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 65.329999999999998 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.941 HG21 HD12 ' A' ' 56' ' ' LEU . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 72.530000000000001 111.167 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.319999999999993 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 50.420000000000002 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 71.109999999999999 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 50.43 111.108 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 71.030000000000001 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.539999999999999 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.129999999999995 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.109999999999999 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.150000000000006 112.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.319999999999993 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 63.539999999999999 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.671 ' HA ' HG22 ' A' ' 31' ' ' THR . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.549999999999997 110.871 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 65.349999999999994 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.140000000000001 111.112 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 65.540000000000006 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.549999999999997 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 45' ' ' ALA . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 65.519999999999996 110.922 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.147 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.030000000000001 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.219999999999999 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 22' ' ' THR . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 110.913 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.941 HD12 HG21 ' A' ' 25' ' ' ILE . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.907 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 87' ' ' VAL . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.25 111.137 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 64.200000000000003 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.350000000000001 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.400000000000006 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.893 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 111.098 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 61.130000000000003 111.126 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 61.340000000000003 110.893 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 7' ' ' LEU . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.030000000000001 110.965 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.094 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.349999999999994 111.12 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE1' HD22 ' A' ' 56' ' ' LEU . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' HG12 ' A' ' 74' ' ' VAL . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.409999999999997 110.931 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 70' ' ' PHE . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.143 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 78' ' ' VAL . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 111.156 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.675 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.113 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.450000000000003 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.439999999999998 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 74' ' ' VAL . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 111.113 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 73.049999999999997 110.88 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 62.5 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.439999999999998 111.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.903 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 53.329999999999998 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 71.209999999999994 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 57' ' ' VAL . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.519999999999996 111.166 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.230000000000004 110.868 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.030000000000001 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 74.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 54.520000000000003 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 54.310000000000002 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 53.43 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 55.399999999999999 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' CB ' ' A' ' 83' ' ' SER . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.117 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.319999999999993 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.140000000000001 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.040000000000006 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.010000000000005 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.729 HG22 ' CB ' ' A' ' 75' ' ' ALA . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 111.156 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.349999999999994 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 64.129999999999995 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 63.420000000000002 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 72.319999999999993 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.129999999999995 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.773 ' HB2' HD11 ' A' ' 25' ' ' ILE . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 64.109999999999999 110.895 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.209999999999994 110.864 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' HD23 ' A' ' 23' ' ' LEU . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 52.149999999999999 111.128 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 60.130000000000003 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.099999999999994 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 71.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.310000000000002 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 71.409999999999997 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 65.25 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 61.409999999999997 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 65.420000000000002 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 111.112 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.912 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 9' ' ' PHE . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 73.200000000000003 111.167 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.030000000000001 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.329999999999998 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 70' ' ' PHE . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 111.176 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.745 ' CD ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 71.400000000000006 110.897 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.783 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.138 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.040000000000006 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 78' ' ' VAL . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 61.200000000000003 110.819 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 71.129999999999995 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.109999999999999 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 60.399999999999999 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.019999999999996 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.783 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 110.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 40.409999999999997 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 111.049 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 61.439999999999998 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 42.210000000000001 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.140000000000001 111.108 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 31.140000000000001 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 99' ' ' ILE . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 63.439999999999998 110.961 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 25' ' ' ILE . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.030000000000001 110.887 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 44.130000000000003 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.645 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.239999999999995 111.152 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.030000000000001 110.896 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.5 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.549999999999997 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.049999999999997 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 57' ' ' VAL . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.329999999999998 111.132 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 23' ' ' LEU . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 65.420000000000002 111.131 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 111.121 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 110.931 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.140000000000001 111.127 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 29' ' ' THR . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.841 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 74' ' ' VAL . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.899 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 70.239999999999995 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 74' ' ' VAL . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 52.210000000000001 111.117 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 78' ' ' VAL . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 111.115 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.729 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 111.073 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 74' ' ' VAL . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 71.239999999999995 111.12 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 110.874 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.240000000000002 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 52.409999999999997 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.019999999999996 111.108 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' HG22 ' A' ' 100' ' ' VAL . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.150000000000006 110.866 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 72.349999999999994 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.109999999999999 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 57' ' ' VAL . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 71.040000000000006 111.132 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.519999999999996 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.510000000000005 110.876 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 64.230000000000004 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.310000000000002 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.040000000000006 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 53.109999999999999 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.040000000000006 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.045 HG21 HD21 ' A' ' 50' ' ' LEU . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 61.039999999999999 111.155 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 83' ' ' SER . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 55.43 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.219999999999999 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 43.109999999999999 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 111.098 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.019999999999996 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.450000000000003 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' HB3' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 62.200000000000003 110.909 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.140000000000001 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 73.230000000000004 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 62.020000000000003 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 54.509999999999998 111.167 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.049999999999997 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 62.450000000000003 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 70.439999999999998 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.400000000000006 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 64.319999999999993 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.74 HD13 HG13 ' A' ' 64' ' ' VAL . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 65.209999999999994 110.924 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 25.210000000000001 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 HD13 ' A' ' 56' ' ' LEU . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 62.340000000000003 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.842 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.230000000000004 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' OE1' ' A' ' 30' ' ' GLN . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.194 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.617 ' OE1' HG23 ' A' ' 29' ' ' THR . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.948 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.420000000000002 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 34' ' ' GLY . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 111.181 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 33' ' ' THR . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.230000000000004 112.449 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.319999999999993 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.340000000000003 112.544 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 38' ' ' GLY . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.200000000000003 111.075 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 34.420000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 62.340000000000003 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.329999999999998 111.098 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 61.130000000000003 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.97 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.145 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.510000000000005 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.230000000000004 110.912 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 64.510000000000005 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 27' ' ' GLU . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.143 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.519999999999996 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.019999999999996 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 25' ' ' ILE . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 64' ' ' VAL . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 55.5 111.108 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.639 HH22 HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.838 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 110.866 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 43.340000000000003 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.74 HG13 HD13 ' A' ' 23' ' ' LEU . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 111.145 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 55.310000000000002 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.881 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 110.887 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 71.230000000000004 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 65.209999999999994 110.896 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 111.152 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.126 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.400000000000006 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.549999999999997 111.074 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.019999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 64.329999999999998 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 111.137 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.049999999999997 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.129999999999995 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 97' ' ' ALA . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 111.118 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 58' ' ' ARG . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 55.340000000000003 111.118 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.43 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 65.420000000000002 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.883 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.299999999999997 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 55.340000000000003 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 63.119999999999997 111.111 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 35.439999999999998 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.105 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.97 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 71.420000000000002 111.16 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 44.299999999999997 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 72.109999999999999 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 54.229999999999997 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.573 ' OE1' HG13 ' A' ' 78' ' ' VAL . 6.9 mp0 -92.46 -27.62 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 72.430000000000007 110.848 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -143.14 95.03 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.200000000000003 110.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 70.400000000000006 110.86 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 63.32 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.044 HG22 ' HB2' ' A' ' 75' ' ' ALA . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 65.230000000000004 111.135 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 71.230000000000004 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 64.310000000000002 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.549999999999997 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.239999999999995 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.230000000000004 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 63.32 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.694 ' CG2' HD23 ' A' ' 23' ' ' LEU . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.530000000000001 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.030000000000001 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 55.119999999999997 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 52.100000000000001 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 32.439999999999998 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 71.519999999999996 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.694 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 54.350000000000001 110.903 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.154 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 34.240000000000002 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 8.5 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.936 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.230000000000004 111.131 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 44.340000000000003 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.299999999999997 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 72.430000000000007 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 70.430000000000007 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.239999999999995 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.219999999999999 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.340000000000003 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.76 ' HA ' HG22 ' A' ' 31' ' ' THR . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 40.240000000000002 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.510000000000005 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.109999999999999 111.1 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 44.229999999999997 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.702 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 34.030000000000001 111.111 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 61.119999999999997 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.777 HD21 HD12 ' A' ' 99' ' ' ILE . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.928 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.549999999999997 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.130000000000003 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.319999999999993 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.892 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 110.907 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 87' ' ' VAL . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 111.092 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HG2' HG13 ' A' ' 86' ' ' VAL . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 62.509999999999998 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 40.329999999999998 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 24.210000000000001 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 57' ' ' VAL . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 110.928 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.040000000000006 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.143 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.46 HG22 ' OE1' ' A' ' 66' ' ' GLU . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 111.134 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' OE1' HG22 ' A' ' 65' ' ' THR . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.150000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.340000000000003 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 73.099999999999994 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.030000000000001 110.88 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 41.43 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 58' ' ' ARG . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.098 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 70' ' ' PHE . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.109 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.044 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.399999999999999 111.105 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.150000000000006 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 74' ' ' VAL . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.138 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 72.319999999999993 110.929 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.349999999999994 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.065 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.582 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 110.849 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 54.340000000000003 111.107 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 65.409999999999997 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' ' 58' ' ' ARG . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.092 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 57' ' ' VAL . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.319999999999993 110.848 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 51.020000000000003 111.115 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 52.520000000000003 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.777 HD12 HD21 ' A' ' 50' ' ' LEU . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 111.132 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.582 HG12 ' CB ' ' A' ' 83' ' ' SER . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 111.122 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 78' ' ' VAL . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 63.43 111.16 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.209999999999994 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -81.41 -36.6 29.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 110.85 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.12 86.21 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 53.039999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 52.5 110.867 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 74.329999999999998 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 50.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.068 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 111.134 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.310000000000002 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 62.329999999999998 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 63.329999999999998 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.530000000000001 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.129999999999995 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.619 ' CG2' HD23 ' A' ' 67' ' ' LEU . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 53.450000000000003 111.127 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.109999999999999 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' A' ' 21' ' ' THR . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.855 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.319999999999993 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.129999999999995 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 64.540000000000006 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 63.350000000000001 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.43 HG23 ' NH1' ' A' ' 15' ' ' ARG . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 111.151 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.010000000000005 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.936 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 56' ' ' LEU . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.174 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 52' ' ' VAL . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.445 HG21 ' CE2' ' A' ' 70' ' ' PHE . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 111.116 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.896 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 111.164 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 23.109999999999999 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 72.030000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 54.530000000000001 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.040000000000006 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 53.539999999999999 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.099999999999994 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.743 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.84 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.140000000000001 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 64.010000000000005 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.747 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 111.066 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.129999999999995 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 99' ' ' ILE . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.049999999999997 111.091 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 35.119999999999997 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 99' ' ' ILE . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 27' ' ' GLU . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 111.117 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 50.310000000000002 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 62.039999999999999 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.695 HD13 HG13 ' A' ' 25' ' ' ILE . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 110.943 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 87' ' ' VAL . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.064 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 57' ' ' VAL . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 110.897 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.549999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.340000000000003 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.450000000000003 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.5 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 23' ' ' LEU . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 111.119 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 66' ' ' GLU . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.420000000000002 111.141 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.875 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 11' ' ' VAL . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.240000000000002 111.117 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 34.009999999999998 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 70.510000000000005 110.915 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 70' ' ' PHE . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 62.340000000000003 111.117 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 78' ' ' VAL . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.129 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.068 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 64.510000000000005 111.127 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 101' ' ' VAL . 1.4 t60 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.139 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.579 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 63.520000000000003 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 72.019999999999996 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.099999999999994 111.071 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.299999999999997 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.340000000000003 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.109999999999999 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.997 HG21 HD11 ' A' ' 99' ' ' ILE . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 111.156 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 57' ' ' VAL . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.079 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 64.310000000000002 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.923 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.319999999999993 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 90' ' ' ARG . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.400000000000006 111.106 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 94' ' ' VAL . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.135 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.150000000000006 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 86' ' ' VAL . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 62.100000000000001 111.135 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 73.150000000000006 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.422 HG23 ' CE1' ' A' ' 77' ' ' HIS . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 55.109999999999999 111.129 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 62.350000000000001 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -92.3 -36.77 13.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.908 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.12 87.19 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.927 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.010000000000005 110.821 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.510000000000005 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.651 HG22 ' CB ' ' A' ' 75' ' ' ALA . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 111.163 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.219999999999999 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 65.319999999999993 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.230000000000004 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.129999999999995 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 54.420000000000002 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 53.409999999999997 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 62.149999999999999 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 34.439999999999998 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.439999999999998 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 71.120000000000005 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.884 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 54' ' ' ASP . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 111.133 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 63.100000000000001 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.230000000000004 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 63.210000000000001 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.530000000000001 111.177 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.585 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.933 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 61.32 111.165 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 62.509999999999998 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.72 HG23 ' OE2' ' A' ' 103' ' ' GLU . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.530000000000001 111.114 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 63.039999999999999 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 61.0 110.843 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 42.539999999999999 110.9 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 50.310000000000002 112.514 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.510000000000005 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.109999999999999 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 62.340000000000003 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.803 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 44.530000000000001 110.88 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.209999999999994 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.040000000000006 111.101 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 53.039999999999999 111.119 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.120000000000005 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.972 HD21 HG21 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.140000000000001 110.911 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 55.039999999999999 111.099 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.340000000000003 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 25' ' ' ILE . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.319999999999993 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 70' ' ' PHE . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 64' ' ' VAL . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.350000000000001 111.131 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.652 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 110.821 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 41.200000000000003 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 60.439999999999998 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 73.120000000000005 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.329999999999998 111.16 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 63.210000000000001 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.848 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.099999999999994 110.922 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.067 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 43.340000000000003 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CD1' HD13 ' A' ' 56' ' ' LEU . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.120000000000005 110.863 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 61.43 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 78' ' ' VAL . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 63.009999999999998 111.121 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.430000000000007 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.439999999999998 110.851 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 111.081 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.299999999999997 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.310000000000002 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' CG ' ' A' ' 58' ' ' ARG . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.349999999999994 111.137 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 53.409999999999997 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.540000000000006 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.863 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.140000000000001 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 54.509999999999998 111.145 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 111.147 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.972 HG21 HD21 ' A' ' 50' ' ' LEU . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.114 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 55.420000000000002 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.439999999999998 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.72 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.7 mm-40 -62.11 -36.48 81.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.030000000000001 110.893 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.645 HD22 ' CA ' ' A' ' 37' ' ' GLY . 1.9 pt? -174.89 170.41 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.896 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 44.140000000000001 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 64.209999999999994 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 73.530000000000001 111.13 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.519999999999996 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 50.350000000000001 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 63.219999999999999 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.439999999999998 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 67' ' ' LEU . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 50.539999999999999 111.141 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 65.219999999999999 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 65.340000000000003 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 22' ' ' THR . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.887 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 72.450000000000003 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.009999999999998 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 70.230000000000004 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.148 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.981 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 54' ' ' ASP . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.149 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.898 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 61.530000000000001 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 61.030000000000001 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 61.420000000000002 111.109 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 51.340000000000003 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.430000000000007 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.100000000000001 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.545 ' O ' HD11 ' A' ' 104' ' ' LEU . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 110.882 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 63.109999999999999 112.488 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 54.210000000000001 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 53.299999999999997 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.775 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.020000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.519999999999996 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 64.200000000000003 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.530000000000001 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.519999999999996 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 54.409999999999997 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 45.420000000000002 111.058 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HG2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.400000000000006 110.939 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 63.229999999999997 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 27' ' ' GLU . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.420000000000002 111.125 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 30.449999999999999 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.340000000000003 110.844 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.733 HG23 HG13 ' A' ' 87' ' ' VAL . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.019999999999996 111.113 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.861 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.519999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.099999999999994 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.129999999999995 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.140000000000001 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 111.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 61.450000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 11' ' ' VAL . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.906 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 61.509999999999998 111.134 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.875 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 77' ' ' HIS . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.089 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' PHE . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 111.138 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.002 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 111.092 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' HG12 ' A' ' 73' ' ' VAL . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 110.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 74' ' ' VAL . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.340000000000003 110.915 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 43.530000000000001 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.030000000000001 111.136 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 85' ' ' PRO . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 64.120000000000005 111.122 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.129999999999995 112.347 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 57' ' ' VAL . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.530000000000001 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 110.897 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 71.349999999999994 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.409999999999997 111.121 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 54.310000000000002 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.520000000000003 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.240000000000002 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 61.100000000000001 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 51.25 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.863 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.142 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' ' 83' ' ' SER . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.210000000000001 111.065 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 42.109999999999999 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -29.43 60.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.655 HD21 ' HA2' ' A' ' 37' ' ' GLY . 1.6 mp -143.58 150.31 38.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.915 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 71.010000000000005 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.549999999999997 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.133 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 64.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 72.019999999999996 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.420000000000002 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 35.43 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 64.120000000000005 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.687 ' CG2' HD23 ' A' ' 23' ' ' LEU . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.430000000000007 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 HD11 ' A' ' 23' ' ' LEU . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.148 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.109999999999999 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 71.120000000000005 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.399999999999999 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.519999999999996 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.010000000000005 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.229999999999997 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 HG23 HE22 ' A' ' 55' ' ' GLN . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 111.142 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 110.919 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.329999999999998 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.88 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 63.049999999999997 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 51.420000000000002 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.76 ' HG2' HD13 ' A' ' 50' ' ' LEU . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.917 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.771 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.109999999999999 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 53.020000000000003 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.439999999999998 110.859 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 104' ' ' LEU . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.329999999999998 112.482 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.299999999999997 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.420000000000002 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.771 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.871 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 51.200000000000003 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.299999999999997 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.83 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.134 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 43.539999999999999 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 44.539999999999999 111.07 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.219999999999999 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 45' ' ' ALA . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.209999999999994 110.892 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 54.119999999999997 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 27' ' ' GLU . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.310000000000002 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 HG23 ' A' ' 22' ' ' THR . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.949 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 110.96 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 64' ' ' VAL . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 61.43 111.101 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HD3' HG23 ' A' ' 86' ' ' VAL . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.861 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.438 ' H ' HG23 ' A' ' 57' ' ' VAL . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 55.009999999999998 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.319999999999993 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 73.010000000000005 110.914 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.400000000000006 111.106 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 65' ' ' THR . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.895 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 65.349999999999994 111.122 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 44.109999999999999 111.14 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 74' ' ' VAL . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.049999999999997 110.866 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 70.319999999999993 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.118 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.736 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 35.149999999999999 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.409999999999997 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 74' ' ' VAL . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 71.040000000000006 110.868 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.120000000000005 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 54.420000000000002 111.122 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.599 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 110.892 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.099999999999994 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 62.25 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.812 HG23 ' HD3' ' A' ' 58' ' ' ARG . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 62.439999999999998 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.009999999999998 111.117 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 61.539999999999999 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 110.843 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' ARG . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.420000000000002 111.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.409999999999997 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.400000000000006 111.119 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HD21 ' A' ' 50' ' ' LEU . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.520000000000003 111.145 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 83' ' ' SER . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 71.420000000000002 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 52.100000000000001 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -81.15 -26.61 35.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 50.020000000000003 110.881 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -128.63 63.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.299999999999997 110.856 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 75.030000000000001 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 64.099999999999994 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 54.210000000000001 111.155 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.420000000000002 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 60.25 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.919 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 7' ' ' LEU . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 64.019999999999996 110.859 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 61.32 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 HD13 ' A' ' 25' ' ' ILE . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 111.125 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.109999999999999 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 44.520000000000003 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 64.099999999999994 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 11' ' ' VAL . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 51.240000000000002 110.873 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.549999999999997 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 56' ' ' LEU . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.115 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' ILE . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.856 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 61.5 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 30' ' ' GLN . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 111.152 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 50' ' ' LEU . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.88 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 45.32 111.155 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.209999999999994 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 22.530000000000001 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.3 m120 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.925 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.140000000000001 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.219999999999999 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 64.25 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.769 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 44.340000000000003 110.858 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.130000000000003 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 71.140000000000001 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 111.127 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 44.32 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 99' ' ' ILE . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 53.409999999999997 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 43.409999999999997 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD11 HD13 ' A' ' 99' ' ' ILE . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.219999999999999 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.450000000000003 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.140000000000001 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 51.229999999999997 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 25' ' ' ILE . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.871 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 64' ' ' VAL . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 52.109999999999999 111.109 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.494 ' CG ' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.852 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.549999999999997 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.140000000000001 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 65.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.310000000000002 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 57' ' ' VAL . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 60.439999999999998 111.112 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 64.010000000000005 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.842 HD13 HD21 ' A' ' 7' ' ' LEU . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 70.230000000000004 110.952 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 51.030000000000001 111.097 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 55.240000000000002 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 60.130000000000003 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 3' ' ' THR . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.089 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.849 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.439999999999998 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 78' ' ' VAL . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 111.124 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.420000000000002 110.879 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 73.530000000000001 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 61.119999999999997 111.074 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 51.200000000000003 110.873 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 83' ' ' SER . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.319999999999993 111.12 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.209999999999994 112.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 99' ' ' ILE . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.131 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 54.200000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.109999999999999 110.838 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 111.065 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 55.119999999999997 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 60.229999999999997 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HD11 ' A' ' 50' ' ' LEU . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.430000000000007 111.182 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.148 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.425 HG12 ' OE1' ' A' ' 103' ' ' GLU . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.107 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 33.130000000000003 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -90.9 -36.26 14.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.140000000000001 110.907 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.93 144.07 30.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.95 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.349999999999994 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 61.119999999999997 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.9 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.13 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 73.239999999999995 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.129999999999995 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.530000000000001 110.972 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.25 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' O ' HD11 ' A' ' 7' ' ' LEU . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.420000000000002 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.439999999999998 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.420000000000002 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.450000000000003 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.310000000000002 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 66' ' ' GLU . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.873 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 27' ' ' GLU . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 72.239999999999995 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 70.230000000000004 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.92 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 63.109999999999999 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 62.399999999999999 111.126 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 103' ' ' GLU . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 64.120000000000005 111.114 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 54.0 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 63.32 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.319999999999993 112.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.140000000000001 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.541 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 110.895 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.239999999999995 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 61.109999999999999 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 52.530000000000001 111.091 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.229999999999997 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.852 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 111.093 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.400000000000006 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.200000000000003 110.908 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 70.239999999999995 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.430000000000007 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 72.239999999999995 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.129999999999995 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 63' ' ' THR . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 111.161 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 70.420000000000002 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 57' ' ' VAL . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.099999999999994 110.864 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 40.039999999999999 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 72.420000000000002 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 61.049999999999997 111.131 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.350000000000001 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 66' ' ' GLU . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 60.340000000000003 111.18 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 110.903 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 7' ' ' LEU . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 40.439999999999998 110.858 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 111.082 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.099999999999994 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 61.450000000000003 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 78' ' ' VAL . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 53.049999999999997 111.126 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 25.539999999999999 111.095 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 61.539999999999999 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 99' ' ' ILE . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.219999999999999 110.904 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.340000000000003 111.147 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 55.039999999999999 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 111.124 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 100' ' ' VAL . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 31.210000000000001 110.846 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 85' ' ' PRO . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 55.350000000000001 111.106 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.400000000000006 112.336 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HZ ' HG21 ' A' ' 99' ' ' ILE . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.885 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 42.109999999999999 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 90' ' ' ARG . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.340000000000003 111.095 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.120000000000005 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.439999999999998 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.409999999999997 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.852 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 70.319999999999993 111.133 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' OG ' ' A' ' 83' ' ' SER . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.120000000000005 111.119 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 103' ' ' GLU . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.121 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.030000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HB3' HG21 ' A' ' 33' ' ' THR . 4.4 mp0 -88.23 -15.01 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.93 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.541 HD21 ' HA2' ' A' ' 37' ' ' GLY . 7.4 mt -142.61 95.41 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 61.409999999999997 110.91 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.889 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 41.109999999999999 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 ' HE ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.942 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.74 HG22 ' CB ' ' A' ' 75' ' ' ALA . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 62.539999999999999 111.195 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 54.32 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.209999999999994 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 44.020000000000003 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HD23 ' A' ' 23' ' ' LEU . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.400000000000006 111.114 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.040000000000006 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.230000000000004 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 63.299999999999997 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.210000000000001 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.420000000000002 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 43.140000000000001 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD23 HG21 ' A' ' 11' ' ' VAL . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.200000000000003 110.915 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 54' ' ' ASP . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.895 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.510000000000005 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.932 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 42' ' ' MET . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.147 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.409999999999997 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 111.118 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.219999999999999 112.537 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 74.340000000000003 110.851 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.420000000000002 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.040000000000006 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 71.099999999999994 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.109999999999999 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.876 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 54.219999999999999 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.040000000000006 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 42.130000000000003 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.25 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.099999999999994 111.133 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 55.240000000000002 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 54.210000000000001 110.922 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 27' ' ' GLU . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.340000000000003 111.117 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.219999999999999 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.230000000000004 110.882 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 70' ' ' PHE . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.891 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 63' ' ' THR . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 111.098 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.049999999999997 110.889 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 62.32 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 60.240000000000002 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.416 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 71.239999999999995 110.927 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.659 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 52.310000000000002 111.157 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.409999999999997 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.944 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.118 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.549999999999997 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 74' ' ' VAL . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.854 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.030000000000001 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 52.310000000000002 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 111.113 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 2' ' ' LEU . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.894 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.532 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.849 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 74' ' ' VAL . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 50.409999999999997 111.134 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 64.049999999999997 110.857 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.230000000000004 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 54.350000000000001 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 111.11 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.804 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.009999999999998 110.888 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' CD2' ' A' ' 77' ' ' HIS . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.400000000000006 111.133 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 65.409999999999997 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.140000000000001 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.849 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.319999999999993 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 90' ' ' ARG . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.540000000000006 111.16 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 63.340000000000003 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 54.109999999999999 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.340000000000003 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.967 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 111.132 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 83' ' ' SER . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.107 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.099999999999994 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' OE1' HG13 ' A' ' 78' ' ' VAL . 3.5 mp0 -91.28 -28.21 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.310000000000002 110.933 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -148.11 128.71 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 75.019999999999996 110.938 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.882 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.450000000000003 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 70.239999999999995 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.430000000000007 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 40.020000000000003 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 70.030000000000001 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.682 ' CG2' HD23 ' A' ' 23' ' ' LEU . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 41.32 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 62.420000000000002 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.52 ' HD2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 73.239999999999995 110.881 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 44.399999999999999 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 63.32 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.200000000000003 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.450000000000003 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HD2' ' A' ' 15' ' ' ARG . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.349999999999994 111.137 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.503 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.140000000000001 111.133 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG2' ' A' ' 11' ' ' VAL . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 27' ' ' GLU . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 62.210000000000001 111.139 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 62.119999999999997 110.894 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.877 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.164 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.629 HG23 ' CB ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 55.100000000000001 111.132 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.519999999999996 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' HG11 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 110.829 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 65.030000000000001 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 104' ' ' LEU . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.513 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 42.530000000000001 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 63.229999999999997 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 51.32 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.310000000000002 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 111.095 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 60.240000000000002 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 99' ' ' ILE . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.200000000000003 110.918 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.420000000000002 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 51.329999999999998 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.109999999999999 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 56' ' ' LEU . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.963 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.707 HG12 ' CG2' ' A' ' 64' ' ' VAL . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.114 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.647 ' HG3' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.917 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.209999999999994 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 65.230000000000004 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 57' ' ' VAL . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.124 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.049999999999997 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 111.058 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 61.219999999999999 111.09 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 74' ' ' VAL . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 110.89 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 71.209999999999994 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 69' ' ' ALA . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.131 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 70' ' ' PHE . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.864 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 53.240000000000002 111.086 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.439999999999998 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.143 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.310000000000002 110.842 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 53.130000000000003 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.091 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.515 ' HB3' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.229999999999997 110.908 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 99' ' ' ILE . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.209999999999994 111.161 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.329999999999998 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 58' ' ' ARG . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 61.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 54.409999999999997 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.925 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.530000000000001 110.915 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 44.5 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.144 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.340000000000003 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 111.118 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 51.119999999999997 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.676 HG22 ' HB1' ' A' ' 48' ' ' ALA . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 111.079 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 83' ' ' SER . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.299999999999997 111.181 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 35.340000000000003 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.515 ' OE2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -93.56 -36.65 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.310000000000002 110.855 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.686 HD12 ' HA2' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -151.1 140.47 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 71.310000000000002 110.911 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.858 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 50.43 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.888 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.158 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 64.530000000000001 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.219999999999999 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.430000000000007 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.329999999999998 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.120000000000005 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 23' ' ' LEU . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 60.140000000000001 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 61.520000000000003 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 24.34 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 74.420000000000002 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.299999999999997 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 33.240000000000002 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.420000000000002 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.936 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 60.43 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 56' ' ' LEU . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 65.219999999999999 111.142 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.888 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' NE2' ' A' ' 30' ' ' GLN . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 70.430000000000007 111.12 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 28' ' ' VAL . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.953 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.169 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.319999999999993 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 103' ' ' GLU . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 71.450000000000003 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.200000000000003 112.506 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.020000000000003 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.340000000000003 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.774 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 110.891 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.129999999999995 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.109999999999999 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 61.32 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.239999999999995 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.100000000000001 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.209999999999994 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' HG3' ' A' ' 30' ' ' GLN . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 53.119999999999997 110.907 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 40.439999999999998 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.439999999999998 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD12 HH21 ' A' ' 58' ' ' ARG . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 74.019999999999996 110.954 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.744 HG12 ' CG2' ' A' ' 64' ' ' VAL . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 111.122 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.621 HH21 HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.91 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 57' ' ' VAL . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.905 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 53.039999999999999 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.109999999999999 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.532 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.340000000000003 110.952 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.439999999999998 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.744 ' CG2' HG12 ' A' ' 57' ' ' VAL . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 111.086 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 55.43 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 111.052 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 73' ' ' VAL . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.916 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 110.865 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 61.530000000000001 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 70' ' ' PHE . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 53.520000000000003 111.14 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.125 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.240000000000002 111.095 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.897 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.229999999999997 111.172 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 110.892 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.340000000000003 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.409999999999997 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 44.140000000000001 111.1 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 85' ' ' PRO . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.549999999999997 111.119 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.229999999999997 112.318 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG13 ' HG2' ' A' ' 58' ' ' ARG . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.138 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 62.539999999999999 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 62.43 110.841 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.530000000000001 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.130000000000003 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 62.25 111.107 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 63.329999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.140000000000001 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 72.010000000000005 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 61.310000000000002 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.168 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.489 HG12 ' OE1' ' A' ' 103' ' ' GLU . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.138 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.32 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.9 mm-40 -80.92 -20.69 41.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 54.140000000000001 110.879 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.5 mm? -120.59 68.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.947 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.530000000000001 110.876 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.129999999999995 112.401 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 63.5 110.92 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.978 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.540000000000006 111.163 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 53.210000000000001 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.039999999999999 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.150000000000006 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 110.937 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 42.210000000000001 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.349999999999994 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.219999999999999 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 67' ' ' LEU . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 111.131 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 43.509999999999998 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 64.310000000000002 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.140000000000001 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 23' ' ' LEU . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.134 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 22' ' ' THR . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.909 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' ASP . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 111.143 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 63.020000000000003 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 70' ' ' PHE . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.167 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.159 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.400000000000006 111.146 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.299999999999997 112.492 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 61.219999999999999 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 65.319999999999993 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.130000000000003 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.009999999999998 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 41.25 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.299999999999997 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.350000000000001 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.726 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.929 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.129999999999995 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 43.530000000000001 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 40.43 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.450000000000003 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.712 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.149999999999999 111.116 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 60.039999999999999 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 99' ' ' ILE . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.140000000000001 110.922 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.040000000000006 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 52' ' ' VAL . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 111.128 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.329999999999998 110.84 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.200000000000003 111.137 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.534 ' CG ' HG13 ' A' ' 86' ' ' VAL . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.898 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.902 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.230000000000004 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.409999999999997 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 57' ' ' VAL . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 110.916 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 23' ' ' LEU . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 63.219999999999999 111.096 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 11' ' ' VAL . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 63.210000000000001 110.937 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 43.32 111.084 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 29' ' ' THR . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 60.399999999999999 110.893 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.129999999999995 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 78' ' ' VAL . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 52.32 111.136 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.978 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 111.048 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 74' ' ' VAL . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.030000000000001 111.162 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 65.140000000000001 110.833 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HB3' HD12 ' A' ' 104' ' ' LEU . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 71.239999999999995 112.361 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.130000000000003 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.109999999999999 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 85' ' ' PRO . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 52.409999999999997 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 35.130000000000003 112.368 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG13 ' CG ' ' A' ' 58' ' ' ARG . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 72.109999999999999 111.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 57' ' ' VAL . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.107 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 50' ' ' LEU . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.907 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.89 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.040000000000006 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.140000000000001 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 90' ' ' ARG . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 64.420000000000002 111.107 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.310000000000002 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 32.310000000000002 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.712 HG23 ' CB ' ' A' ' 48' ' ' ALA . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.049999999999997 111.096 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 100' ' ' VAL . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.108 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.310000000000002 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.13 -35.89 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.230000000000004 110.914 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 80' ' ' PRO . 5.0 mt -137.43 74.68 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.921 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 110.916 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 78' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 62.32 112.348 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 61.520000000000003 110.912 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.989 HG22 ' HB2' ' A' ' 75' ' ' ALA . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.131 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.140000000000001 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 70.530000000000001 110.915 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.420000000000002 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.150000000000006 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.968 HG22 HD23 ' A' ' 67' ' ' LEU . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.010000000000005 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 62.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 72.420000000000002 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.622 ' C ' HD12 ' A' ' 23' ' ' LEU . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.155 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.653 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.897 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.409999999999997 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 56' ' ' LEU . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.340000000000003 111.139 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' HB2' HD13 ' A' ' 50' ' ' LEU . 4.9 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.924 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.420000000000002 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 61.450000000000003 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 64.219999999999999 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.508 ' O ' HD22 ' A' ' 104' ' ' LEU . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 55.130000000000003 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.505 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.310000000000002 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.400000000000006 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 50' ' ' LEU . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.099999999999994 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.076 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 30' ' ' GLN . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 63.109999999999999 110.935 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 72.200000000000003 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.409999999999997 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 62.030000000000001 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 25' ' ' ILE . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.936 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 87' ' ' VAL . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 57' ' ' VAL . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.350000000000001 110.873 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.129999999999995 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 71.549999999999997 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.019999999999996 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.653 ' CG1' HD13 ' A' ' 23' ' ' LEU . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 111.16 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 43.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.968 HD23 HG22 ' A' ' 11' ' ' VAL . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.030000000000001 110.914 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 111.166 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 62.109999999999999 110.925 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.229999999999997 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 63.549999999999997 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 70' ' ' PHE . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 44.119999999999997 111.096 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.989 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 71.040000000000006 111.09 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 64.299999999999997 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.132 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.420000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 73.140000000000001 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.519999999999996 111.118 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.219999999999999 110.864 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 71.409999999999997 111.173 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.141 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.862 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.549999999999997 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.010000000000005 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 53.299999999999997 111.159 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.530000000000001 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 48' ' ' ALA . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 65.010000000000005 111.096 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 83' ' ' SER . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 72.510000000000005 111.15 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.408 HG21 ' NE2' ' A' ' 30' ' ' GLN . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.1 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 41.549999999999997 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -77.14 -37.62 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.587 HD13 ' HA2' ' A' ' 37' ' ' GLY . 2.3 pt? -178.7 173.04 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 110.96 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 73.549999999999997 110.877 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.439999999999998 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.873 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.702 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.145 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.099999999999994 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 34.32 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' HD2' HG23 ' A' ' 25' ' ' ILE . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.109999999999999 110.917 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.210000000000001 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.109999999999999 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 62.240000000000002 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 44.310000000000002 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.310000000000002 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.350000000000001 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 55.420000000000002 111.132 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 23' ' ' LEU . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.508 ' CG1' HD23 ' A' ' 56' ' ' LEU . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.030000000000001 111.129 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.010000000000005 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 63.210000000000001 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.515 HG21 ' CE1' ' A' ' 70' ' ' PHE . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 50.030000000000001 111.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.759 ' CD ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 110.948 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.127 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.409999999999997 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 42.420000000000002 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 54.350000000000001 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HD21 ' A' ' 104' ' ' LEU . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 73.010000000000005 110.913 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.230000000000004 112.482 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.210000000000001 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.039999999999999 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.329999999999998 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.776 ' HA ' HG22 ' A' ' 31' ' ' THR . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 32.409999999999997 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 74.219999999999999 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 111.109 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.450000000000003 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 111.086 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 71.219999999999999 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD12 ' HA ' ' A' ' 45' ' ' ALA . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 52.140000000000001 110.899 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 23.530000000000001 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.319999999999993 110.864 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.049999999999997 110.882 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' CG1' ' A' ' 25' ' ' ILE . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 110.925 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 111.143 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HG3' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.819 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.898 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 44.200000000000003 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 70.099999999999994 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.019999999999996 110.958 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.200000000000003 111.131 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 57' ' ' VAL . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.349999999999994 111.129 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 65' ' ' THR . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.430000000000007 110.898 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 60.25 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 51.329999999999998 111.06 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 29' ' ' THR . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 110.86 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 74' ' ' VAL . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.319999999999993 110.899 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 74' ' ' VAL . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 111.141 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.702 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.059 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.319999999999993 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.873 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 61.350000000000001 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 62.409999999999997 111.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.85 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 83' ' ' SER . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 65.319999999999993 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.338 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 111.175 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.109999999999999 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.049999999999997 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.040000000000006 110.832 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.329999999999998 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 90' ' ' ARG . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.299999999999997 111.161 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 64.200000000000003 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 55.140000000000001 111.121 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.230000000000004 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.725 HG12 HD21 ' A' ' 50' ' ' LEU . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.150000000000006 111.084 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.010000000000005 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 64.299999999999997 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.542 ' HB2' HD22 ' A' ' 104' ' ' LEU . 3.1 mp0 -77.37 -35.63 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.120000000000005 110.894 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.616 HD21 ' HA2' ' A' ' 37' ' ' GLY . 2.1 mm? -115.32 51.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.886 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 55.409999999999997 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.689 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 110.891 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.240000000000002 111.084 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 71.099999999999994 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.651 HD12 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 110.947 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.030000000000001 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE2' HD12 ' A' ' 7' ' ' LEU . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 60.039999999999999 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.409999999999997 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.030000000000001 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 61.399999999999999 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 64.010000000000005 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 71.150000000000006 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.400000000000006 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 61.340000000000003 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 50.240000000000002 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 66' ' ' GLU . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 51.130000000000003 110.891 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.049999999999997 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.451 HG23 ' NE2' ' A' ' 30' ' ' GLN . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HG2' HD13 ' A' ' 50' ' ' LEU . 13.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.430000000000007 110.917 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 111.15 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 43.409999999999997 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.140000000000001 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.0 112.467 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.150000000000006 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.799 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.87 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.140000000000001 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 63.5 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 111.095 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 61.210000000000001 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.661 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.420000000000002 111.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.340000000000003 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 63.119999999999997 110.915 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.140000000000001 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.340000000000003 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.310000000000002 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.112 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.695 ' HD2' HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.894 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.621 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.892 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 55.039999999999999 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.439999999999998 110.933 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.340000000000003 111.119 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.450000000000003 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 23' ' ' LEU . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 110.886 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.109 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.519999999999996 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 74' ' ' VAL . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.851 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 52.219999999999999 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.759 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 60.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 25.199999999999999 111.113 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 70.329999999999998 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.130000000000003 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 62.299999999999997 111.116 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 71.510000000000005 110.882 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 73.019999999999996 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 53.329999999999998 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 111.123 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.200000000000003 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG13 ' HD2' ' A' ' 58' ' ' ARG . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.167 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.299999999999997 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.519999999999996 110.871 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.039999999999999 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ARG . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 111.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 52.420000000000002 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 50' ' ' LEU . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.12 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 111.081 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.651 ' HG2' HG13 ' A' ' 78' ' ' VAL . 23.4 mp0 -77.03 -27.75 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 45.109999999999999 110.911 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 37' ' ' GLY . 2.7 pt? -173.75 31.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.200000000000003 110.952 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.898 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB3' ' ND2' ' A' ' 36' ' ' ASN . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.349999999999994 112.369 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.450000000000003 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.162 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 72.409999999999997 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.140000000000001 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 67' ' ' LEU . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.299999999999997 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 24.449999999999999 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE1' HD12 ' A' ' 7' ' ' LEU . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.87 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.477 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.209999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 31.41 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 35.009999999999998 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.120000000000005 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 64.219999999999999 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.299999999999997 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' HB ' ' A' ' 11' ' ' VAL . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.936 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.530000000000001 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.895 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 70' ' ' PHE . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 111.123 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.871 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.409999999999997 111.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.549999999999997 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.149999999999999 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 62.439999999999998 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 1' ' ' PRO . 0.6 OUTLIER 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.030000000000001 110.858 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 14.220000000000001 112.494 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 32.539999999999999 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 43.450000000000003 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.763 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.858 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.109999999999999 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.530000000000001 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 53.100000000000001 111.117 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 43.329999999999998 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.95 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 42.310000000000002 111.068 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.299999999999997 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 48' ' ' ALA . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.936 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 62.450000000000003 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 27' ' ' GLU . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 44.43 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.409999999999997 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 63' ' ' THR . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 64.140000000000001 111.13 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HD2' HG22 ' A' ' 86' ' ' VAL . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.873 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.445 ' H ' HG12 ' A' ' 57' ' ' VAL . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.907 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.420000000000002 111.148 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 57' ' ' VAL . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 111.149 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 7' ' ' LEU . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 72.209999999999994 110.931 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.121 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.93 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 60.329999999999998 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.120000000000005 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.400000000000006 111.15 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.983 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.111 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 70.319999999999993 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 74' ' ' VAL . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.509999999999998 111.121 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.736 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 71.120000000000005 110.871 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 45.020000000000003 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 41.299999999999997 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.210000000000001 111.104 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' O ' HD13 ' A' ' 84' ' ' ILE . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 55.340000000000003 110.801 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 85' ' ' PRO . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.420000000000002 111.156 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 63.43 112.345 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 58' ' ' ARG . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 52.409999999999997 111.114 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 71.099999999999994 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 110.85 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 54.130000000000003 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.530000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 61.210000000000001 111.124 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' VAL . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 51.200000000000003 111.129 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 64.420000000000002 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.129999999999995 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.95 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.140000000000001 111.176 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.229999999999997 111.095 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 51.229999999999997 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.541 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -91.44 -33.67 15.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.340000000000003 110.868 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.541 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.3 mm? -125.96 177.56 6.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 41.119999999999997 110.896 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.888 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.219999999999999 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.714 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.938 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.815 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.113 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 64.200000000000003 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.895 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 70.109999999999999 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.62 HG21 HD23 ' A' ' 23' ' ' LEU . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 71.329999999999998 111.163 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 51.340000000000003 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.672 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.120000000000005 111.09 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.439999999999998 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.510000000000005 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.140000000000001 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.129999999999995 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 13' ' ' VAL . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.894 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.349999999999994 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 62.240000000000002 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 30' ' ' GLN . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.019999999999996 111.121 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' HG2' HD13 ' A' ' 50' ' ' LEU . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 52.140000000000001 110.935 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 111.122 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.030000000000001 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.240000000000002 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.549999999999997 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.030000000000001 112.451 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.099999999999994 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 71.340000000000003 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.310000000000002 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.808 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 53.32 110.89 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 72.150000000000006 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 52.140000000000001 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.56 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 33.030000000000001 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 61.520000000000003 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 111.109 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.100000000000001 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 62.32 110.916 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.340000000000003 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.519999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.519999999999996 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.400000000000006 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.897 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 64' ' ' VAL . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.156 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 73.430000000000007 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 57' ' ' VAL . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.340000000000003 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 110.95 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.140000000000001 111.085 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.049999999999997 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.619 ' O ' HG12 ' A' ' 74' ' ' VAL . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.868 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 52.0 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 50.039999999999999 111.095 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.815 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 44.439999999999998 111.12 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 71.230000000000004 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 74' ' ' VAL . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 111.114 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.219999999999999 110.879 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.299999999999997 111.082 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.340000000000003 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 85' ' ' PRO . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.019999999999996 111.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 72.109999999999999 112.316 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CZ ' HD23 ' A' ' 56' ' ' LEU . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.450000000000003 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 110.872 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 33.32 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 55.219999999999999 111.112 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.519999999999996 111.153 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 41.130000000000003 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.58 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.107 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.030000000000001 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 41.43 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.588 ' HG2' HG13 ' A' ' 78' ' ' VAL . 7.1 mp0 -90.53 -14.03 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 74.019999999999996 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD21 ' HA2' ' A' ' 37' ' ' GLY . 19.6 mt -147.91 45.7 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 62.350000000000001 110.935 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.885 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.58 ' O ' HD22 ' A' ' 2' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.230000000000004 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 50.219999999999999 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 75' ' ' ALA . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 111.155 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.340000000000003 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 73.109999999999999 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 63.350000000000001 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.099 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.109999999999999 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.010000000000005 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 65.010000000000005 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.200000000000003 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.549999999999997 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 64.420000000000002 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.340000000000003 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 11' ' ' VAL . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.120000000000005 110.906 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.689 HG13 HD23 ' A' ' 56' ' ' LEU . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 55.329999999999998 111.101 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 72.120000000000005 110.943 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.876 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.040000000000006 111.138 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 50' ' ' LEU . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.925 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.456 HG23 ' CB ' ' A' ' 45' ' ' ALA . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.152 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 54.420000000000002 111.121 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 64.030000000000001 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 72.230000000000004 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m120 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.030000000000001 110.846 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 64.109999999999999 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 44.420000000000002 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.109999999999999 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 44.32 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.439999999999998 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 44.509999999999998 111.097 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 63.009999999999998 111.077 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.319999999999993 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.055 HD21 HG21 ' A' ' 99' ' ' ILE . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.030000000000001 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 26' ' ' GLN . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.096 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 64.140000000000001 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 62.329999999999998 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' C ' HD22 ' A' ' 56' ' ' LEU . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.903 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 71.439999999999998 110.934 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG23 HG13 ' A' ' 87' ' ' VAL . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.192 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.745 ' HG2' HG13 ' A' ' 86' ' ' VAL . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.540000000000006 110.852 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 61.329999999999998 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 64.239999999999995 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 63.340000000000003 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.040000000000006 111.11 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 64' ' ' VAL . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.152 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.867 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 68' ' ' ALA . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 72.209999999999994 110.891 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 54.200000000000003 111.111 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.109999999999999 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.687 ' O ' HG23 ' A' ' 74' ' ' VAL . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.914 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 61.329999999999998 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 54.140000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.647 HG11 ' HD3' ' A' ' 58' ' ' ARG . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 111.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 70' ' ' PHE . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 111.126 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.091 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 61.219999999999999 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' NE2' HD11 ' A' ' 99' ' ' ILE . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 35.43 110.878 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 74' ' ' VAL . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 72.049999999999997 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.439999999999998 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HD13 ' A' ' 84' ' ' ILE . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 63.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 83' ' ' SER . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 62.340000000000003 111.115 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.539999999999999 112.343 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.745 HG13 ' HG2' ' A' ' 58' ' ' ARG . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 111.107 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 HG23 ' A' ' 57' ' ' VAL . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 60.539999999999999 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.905 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 64.329999999999998 111.117 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 43.310000000000002 111.125 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 52.530000000000001 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 53.43 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.055 HG21 HD21 ' A' ' 50' ' ' LEU . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.128 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.133 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.593 HG23 HD12 ' A' ' 99' ' ' ILE . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.093 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.510000000000005 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 78' ' ' VAL . 2.1 mm-40 -93.01 -36.88 12.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 110.891 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.623 HD22 ' CA ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -97.22 107.39 19.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 72.349999999999994 110.921 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 62.130000000000003 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.675 HG22 ' CB ' ' A' ' 75' ' ' ALA . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.141 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.430000000000007 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 61.140000000000001 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 52.299999999999997 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 67' ' ' LEU . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.310000000000002 110.926 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.030000000000001 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.310000000000002 110.899 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 23' ' ' LEU . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 54.439999999999998 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 23' ' ' LEU . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.450000000000003 111.139 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.209999999999994 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.049999999999997 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 54.219999999999999 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.512 HG23 ' NE2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.121 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.938 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 65.329999999999998 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.941 HG21 HD12 ' A' ' 56' ' ' LEU . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 72.530000000000001 111.167 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.319999999999993 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 50.420000000000002 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 71.109999999999999 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 50.43 111.108 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 71.030000000000001 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.539999999999999 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.129999999999995 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.109999999999999 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.150000000000006 112.5 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.319999999999993 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 63.539999999999999 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.671 ' HA ' HG22 ' A' ' 31' ' ' THR . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.549999999999997 110.871 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 65.349999999999994 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.140000000000001 111.112 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 65.540000000000006 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.549999999999997 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 45' ' ' ALA . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 65.519999999999996 110.922 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.147 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.030000000000001 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.219999999999999 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 22' ' ' THR . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 110.913 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.941 HD12 HG21 ' A' ' 25' ' ' ILE . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.907 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 87' ' ' VAL . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.25 111.137 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 64.200000000000003 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.350000000000001 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.400000000000006 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.893 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 111.098 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 61.130000000000003 111.126 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 61.340000000000003 110.893 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 7' ' ' LEU . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.030000000000001 110.965 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.094 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.349999999999994 111.12 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE1' HD22 ' A' ' 56' ' ' LEU . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' HG12 ' A' ' 74' ' ' VAL . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.409999999999997 110.931 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 70' ' ' PHE . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.143 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 78' ' ' VAL . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 111.156 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.675 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.113 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.450000000000003 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.439999999999998 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 74' ' ' VAL . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 111.113 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 73.049999999999997 110.88 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 62.5 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.439999999999998 111.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.903 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 53.329999999999998 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 71.209999999999994 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 57' ' ' VAL . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.519999999999996 111.166 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.230000000000004 110.868 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.030000000000001 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 74.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 54.520000000000003 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 54.310000000000002 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 53.43 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 55.399999999999999 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' CB ' ' A' ' 83' ' ' SER . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.117 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.319999999999993 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.140000000000001 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.34 -29.82 47.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.040000000000006 110.871 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.586 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -129.75 107.42 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.932 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 110.879 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.010000000000005 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.729 HG22 ' CB ' ' A' ' 75' ' ' ALA . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 111.156 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.349999999999994 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 64.129999999999995 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 63.420000000000002 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 72.319999999999993 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.129999999999995 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.773 ' HB2' HD11 ' A' ' 25' ' ' ILE . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 64.109999999999999 110.895 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.209999999999994 110.864 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' HD23 ' A' ' 23' ' ' LEU . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 52.149999999999999 111.128 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 60.130000000000003 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.099999999999994 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 71.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.310000000000002 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 71.409999999999997 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 65.25 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 61.409999999999997 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 65.420000000000002 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 111.112 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.912 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 9' ' ' PHE . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 73.200000000000003 111.167 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.030000000000001 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.329999999999998 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 70' ' ' PHE . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 111.176 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.745 ' CD ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 71.400000000000006 110.897 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.783 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.138 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.040000000000006 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 78' ' ' VAL . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 61.200000000000003 110.819 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 71.129999999999995 112.489 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.109999999999999 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 60.399999999999999 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.019999999999996 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.783 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 110.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 40.409999999999997 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 111.049 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 61.439999999999998 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 42.210000000000001 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.140000000000001 111.108 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 31.140000000000001 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 99' ' ' ILE . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 63.439999999999998 110.961 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 25' ' ' ILE . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.030000000000001 110.887 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 44.130000000000003 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.645 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.239999999999995 111.152 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.030000000000001 110.896 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.5 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.549999999999997 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.049999999999997 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 57' ' ' VAL . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.329999999999998 111.132 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 23' ' ' LEU . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 65.420000000000002 111.131 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 111.121 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 110.931 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.140000000000001 111.127 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 29' ' ' THR . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.841 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 74' ' ' VAL . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.899 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 70.239999999999995 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 74' ' ' VAL . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 52.210000000000001 111.117 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 78' ' ' VAL . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 111.115 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 111.073 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 74' ' ' VAL . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 71.239999999999995 111.12 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 110.874 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.240000000000002 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 52.409999999999997 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.019999999999996 111.108 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' HG22 ' A' ' 100' ' ' VAL . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.150000000000006 110.866 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 72.349999999999994 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.109999999999999 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 57' ' ' VAL . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 71.040000000000006 111.132 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.519999999999996 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.510000000000005 110.876 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 64.230000000000004 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.310000000000002 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.040000000000006 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 53.109999999999999 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.040000000000006 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.045 HG21 HD21 ' A' ' 50' ' ' LEU . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 61.039999999999999 111.155 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 83' ' ' SER . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 55.43 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.219999999999999 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -84.11 -27.65 28.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.875 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -129.64 94.3 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 110.887 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.897 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 43.109999999999999 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 111.098 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.019999999999996 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.450000000000003 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' HB3' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 62.200000000000003 110.909 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.140000000000001 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 73.230000000000004 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 62.020000000000003 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 54.509999999999998 111.167 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.049999999999997 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 62.450000000000003 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 70.439999999999998 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.400000000000006 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 64.319999999999993 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.74 HD13 HG13 ' A' ' 64' ' ' VAL . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 65.209999999999994 110.924 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 25.210000000000001 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 HD13 ' A' ' 56' ' ' LEU . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 62.340000000000003 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.842 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.230000000000004 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' OE1' ' A' ' 30' ' ' GLN . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.194 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.617 ' OE1' HG23 ' A' ' 29' ' ' THR . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.948 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.420000000000002 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 34' ' ' GLY . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 111.181 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 33' ' ' THR . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.230000000000004 112.449 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.319999999999993 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.340000000000003 112.544 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 38' ' ' GLY . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.200000000000003 111.075 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 34.420000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 62.340000000000003 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.329999999999998 111.098 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 61.130000000000003 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.97 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.145 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.510000000000005 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.230000000000004 110.912 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 64.510000000000005 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 27' ' ' GLU . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.143 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.519999999999996 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.019999999999996 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 25' ' ' ILE . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 64' ' ' VAL . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 55.5 111.108 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.639 HH22 HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.838 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.425 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 110.866 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 43.340000000000003 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.74 HG13 HD13 ' A' ' 23' ' ' LEU . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 111.145 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 55.310000000000002 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.881 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 110.887 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 71.230000000000004 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 65.209999999999994 110.896 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 111.152 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.126 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.400000000000006 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.549999999999997 111.074 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.019999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 64.329999999999998 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 111.137 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.049999999999997 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.129999999999995 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 97' ' ' ALA . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 111.118 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 58' ' ' ARG . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 55.340000000000003 111.118 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.43 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 65.420000000000002 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.883 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.299999999999997 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 55.340000000000003 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 63.119999999999997 111.111 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 35.439999999999998 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.105 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.97 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 71.420000000000002 111.16 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 44.299999999999997 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 72.109999999999999 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 54.229999999999997 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.573 ' OE1' HG13 ' A' ' 78' ' ' VAL . 6.9 mp0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 72.430000000000007 110.848 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 63.32 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.044 HG22 ' HB2' ' A' ' 75' ' ' ALA . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 65.230000000000004 111.135 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 71.230000000000004 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 64.310000000000002 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.549999999999997 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.239999999999995 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.230000000000004 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 63.32 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.694 ' CG2' HD23 ' A' ' 23' ' ' LEU . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.530000000000001 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.030000000000001 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 55.119999999999997 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 52.100000000000001 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 32.439999999999998 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 71.519999999999996 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.694 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 54.350000000000001 110.903 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.154 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 34.240000000000002 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.7 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.936 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.230000000000004 111.131 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 44.340000000000003 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.299999999999997 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 72.430000000000007 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 70.430000000000007 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.239999999999995 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.219999999999999 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.340000000000003 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.76 ' HA ' HG22 ' A' ' 31' ' ' THR . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 40.240000000000002 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.510000000000005 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.109999999999999 111.1 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 44.229999999999997 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.702 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 34.030000000000001 111.111 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 61.119999999999997 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.777 HD21 HD12 ' A' ' 99' ' ' ILE . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.928 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.549999999999997 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.130000000000003 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.319999999999993 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.892 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 110.907 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 87' ' ' VAL . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 111.092 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HG2' HG13 ' A' ' 86' ' ' VAL . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 62.509999999999998 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 40.329999999999998 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 24.210000000000001 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 57' ' ' VAL . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 110.928 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.040000000000006 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.143 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.46 HG22 ' OE1' ' A' ' 66' ' ' GLU . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 111.134 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' OE1' HG22 ' A' ' 65' ' ' THR . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.150000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.340000000000003 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 73.099999999999994 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.030000000000001 110.88 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 41.43 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 58' ' ' ARG . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.098 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 70' ' ' PHE . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.109 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.044 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.399999999999999 111.105 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.150000000000006 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 74' ' ' VAL . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.138 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 72.319999999999993 110.929 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.349999999999994 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.065 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.582 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 110.849 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 54.340000000000003 111.107 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 65.409999999999997 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' ' 58' ' ' ARG . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.092 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 57' ' ' VAL . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.319999999999993 110.848 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 51.020000000000003 111.115 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 52.520000000000003 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.777 HD12 HD21 ' A' ' 50' ' ' LEU . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 111.132 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.582 HG12 ' CB ' ' A' ' 83' ' ' SER . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 111.122 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 78' ' ' VAL . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 63.43 111.16 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.209999999999994 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 110.85 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 74.329999999999998 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 50.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.068 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 111.134 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.310000000000002 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 62.329999999999998 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 63.329999999999998 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.530000000000001 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.129999999999995 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.619 ' CG2' HD23 ' A' ' 67' ' ' LEU . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 53.450000000000003 111.127 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.109999999999999 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' A' ' 21' ' ' THR . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.855 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.319999999999993 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.129999999999995 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 64.540000000000006 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 63.350000000000001 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.43 HG23 ' NH1' ' A' ' 15' ' ' ARG . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 111.151 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.010000000000005 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.936 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 56' ' ' LEU . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.174 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 52' ' ' VAL . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.445 HG21 ' CE2' ' A' ' 70' ' ' PHE . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 111.116 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.649 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.896 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 111.164 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 23.109999999999999 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 72.030000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 54.530000000000001 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.040000000000006 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 53.539999999999999 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.099999999999994 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.743 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.84 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.140000000000001 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 64.010000000000005 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.747 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 111.066 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.129999999999995 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 99' ' ' ILE . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.049999999999997 111.091 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 35.119999999999997 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 99' ' ' ILE . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 27' ' ' GLU . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 111.117 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 50.310000000000002 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 62.039999999999999 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.695 HD13 HG13 ' A' ' 25' ' ' ILE . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 110.943 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 87' ' ' VAL . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.064 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 57' ' ' VAL . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 110.897 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.549999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.340000000000003 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.450000000000003 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.5 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 23' ' ' LEU . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 111.119 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 66' ' ' GLU . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.420000000000002 111.141 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.875 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 11' ' ' VAL . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.240000000000002 111.117 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 34.009999999999998 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 70.510000000000005 110.915 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 70' ' ' PHE . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 62.340000000000003 111.117 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 78' ' ' VAL . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.129 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.068 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 64.510000000000005 111.127 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.139 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.579 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 63.520000000000003 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 72.019999999999996 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.099999999999994 111.071 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.299999999999997 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.340000000000003 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.109999999999999 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.997 HG21 HD11 ' A' ' 99' ' ' ILE . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 111.156 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 57' ' ' VAL . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.079 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 64.310000000000002 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.923 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.319999999999993 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 90' ' ' ARG . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.400000000000006 111.106 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 94' ' ' VAL . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.135 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.150000000000006 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 86' ' ' VAL . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 62.100000000000001 111.135 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 73.150000000000006 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' OE2' ' A' ' 103' ' ' GLU . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 55.109999999999999 111.129 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 62.350000000000001 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.908 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.510000000000005 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.651 HG22 ' CB ' ' A' ' 75' ' ' ALA . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 111.163 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.219999999999999 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 65.319999999999993 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.230000000000004 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.129999999999995 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 54.420000000000002 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 53.409999999999997 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 62.149999999999999 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 34.439999999999998 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.439999999999998 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 71.120000000000005 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.884 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 54' ' ' ASP . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 111.133 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 63.100000000000001 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.230000000000004 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 63.210000000000001 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.530000000000001 111.177 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.585 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.933 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 61.32 111.165 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 62.509999999999998 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.72 HG23 ' OE2' ' A' ' 103' ' ' GLU . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.530000000000001 111.114 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 63.039999999999999 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 61.0 110.843 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 42.539999999999999 110.9 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 50.310000000000002 112.514 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.510000000000005 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.109999999999999 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 62.340000000000003 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.803 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 44.530000000000001 110.88 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.209999999999994 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.040000000000006 111.101 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 53.039999999999999 111.119 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.120000000000005 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.972 HD21 HG21 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.140000000000001 110.911 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 55.039999999999999 111.099 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.340000000000003 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 25' ' ' ILE . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.319999999999993 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 70' ' ' PHE . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 64' ' ' VAL . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.350000000000001 111.131 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.652 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 110.821 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 41.200000000000003 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 60.439999999999998 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 73.120000000000005 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.329999999999998 111.16 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 63.210000000000001 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.848 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.099999999999994 110.922 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.067 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 43.340000000000003 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CD1' HD13 ' A' ' 56' ' ' LEU . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.120000000000005 110.863 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 61.43 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 78' ' ' VAL . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 63.009999999999998 111.121 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.430000000000007 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.439999999999998 110.851 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 111.081 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.299999999999997 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.310000000000002 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' CG ' ' A' ' 58' ' ' ARG . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.349999999999994 111.137 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 53.409999999999997 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.540000000000006 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.863 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.140000000000001 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 54.509999999999998 111.145 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 111.147 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.972 HG21 HD21 ' A' ' 50' ' ' LEU . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.114 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 55.420000000000002 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.439999999999998 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.72 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.030000000000001 110.893 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 44.140000000000001 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 64.209999999999994 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 73.530000000000001 111.13 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.519999999999996 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 50.350000000000001 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 63.219999999999999 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.439999999999998 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 67' ' ' LEU . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 50.539999999999999 111.141 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 65.219999999999999 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 65.340000000000003 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 22' ' ' THR . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.887 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 72.450000000000003 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.009999999999998 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 70.230000000000004 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.148 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.981 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 54' ' ' ASP . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.149 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.898 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 61.530000000000001 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 61.030000000000001 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 61.420000000000002 111.109 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 51.340000000000003 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.430000000000007 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.100000000000001 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 110.882 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 63.109999999999999 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 54.210000000000001 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 53.299999999999997 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.775 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.020000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.519999999999996 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 64.200000000000003 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.530000000000001 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.519999999999996 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 54.409999999999997 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 45.420000000000002 111.058 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HG2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.400000000000006 110.939 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 63.229999999999997 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 27' ' ' GLU . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.420000000000002 111.125 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 30.449999999999999 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.340000000000003 110.844 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.733 HG23 HG13 ' A' ' 87' ' ' VAL . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.019999999999996 111.113 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.861 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.519999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.099999999999994 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.129999999999995 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.140000000000001 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 111.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 61.450000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 11' ' ' VAL . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.906 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 61.509999999999998 111.134 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.875 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 77' ' ' HIS . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.089 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' PHE . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 111.138 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.002 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 111.092 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' HG12 ' A' ' 73' ' ' VAL . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 110.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 74' ' ' VAL . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.340000000000003 110.915 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 43.530000000000001 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.030000000000001 111.136 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 85' ' ' PRO . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 64.120000000000005 111.122 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.129999999999995 112.347 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 57' ' ' VAL . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.530000000000001 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 110.897 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 71.349999999999994 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.409999999999997 111.121 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 54.310000000000002 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.520000000000003 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.240000000000002 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 61.100000000000001 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 51.25 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.863 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.142 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' ' 83' ' ' SER . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.210000000000001 111.065 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 42.109999999999999 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.871 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 71.010000000000005 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.549999999999997 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.133 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 64.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 72.019999999999996 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.420000000000002 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 35.43 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 64.120000000000005 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.687 ' CG2' HD23 ' A' ' 23' ' ' LEU . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.430000000000007 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 HD11 ' A' ' 23' ' ' LEU . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.148 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.109999999999999 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 71.120000000000005 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.399999999999999 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.519999999999996 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.010000000000005 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.229999999999997 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 HG23 HE22 ' A' ' 55' ' ' GLN . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 111.142 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 110.919 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.329999999999998 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.88 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 63.049999999999997 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 51.420000000000002 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.76 ' HG2' HD13 ' A' ' 50' ' ' LEU . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.917 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.771 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.109999999999999 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 53.020000000000003 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.439999999999998 110.859 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.329999999999998 112.482 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.299999999999997 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.420000000000002 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.771 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.871 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 51.200000000000003 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.299999999999997 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.83 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.134 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 43.539999999999999 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 44.539999999999999 111.07 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.219999999999999 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 45' ' ' ALA . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.209999999999994 110.892 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 54.119999999999997 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 27' ' ' GLU . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.310000000000002 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 HG23 ' A' ' 22' ' ' THR . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.949 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 110.96 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 64' ' ' VAL . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 61.43 111.101 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HD3' HG23 ' A' ' 86' ' ' VAL . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.861 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.438 ' H ' HG23 ' A' ' 57' ' ' VAL . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 55.009999999999998 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.319999999999993 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 73.010000000000005 110.914 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.400000000000006 111.106 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 65' ' ' THR . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.895 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 65.349999999999994 111.122 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 44.109999999999999 111.14 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 74' ' ' VAL . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.049999999999997 110.866 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 70.319999999999993 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.118 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.736 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 35.149999999999999 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.409999999999997 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 74' ' ' VAL . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 71.040000000000006 110.868 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.120000000000005 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 54.420000000000002 111.122 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.599 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 110.892 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.099999999999994 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 62.25 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.812 HG23 ' HD3' ' A' ' 58' ' ' ARG . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 62.439999999999998 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.009999999999998 111.117 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 61.539999999999999 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 110.843 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' ARG . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.420000000000002 111.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.409999999999997 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.400000000000006 111.119 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HD21 ' A' ' 50' ' ' LEU . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.520000000000003 111.145 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 83' ' ' SER . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 71.420000000000002 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 52.100000000000001 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 50.020000000000003 110.881 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 64.099999999999994 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.908 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 54.210000000000001 111.155 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.420000000000002 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 60.25 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.919 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 7' ' ' LEU . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 64.019999999999996 110.859 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 61.32 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 HD13 ' A' ' 25' ' ' ILE . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 111.125 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.109999999999999 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 44.520000000000003 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 64.099999999999994 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 11' ' ' VAL . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 51.240000000000002 110.873 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.549999999999997 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 56' ' ' LEU . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.115 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' ILE . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.856 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 61.5 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 30' ' ' GLN . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 111.152 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 50' ' ' LEU . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.88 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 45.32 111.155 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.209999999999994 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 22.530000000000001 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 16.1 m-80 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.925 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.140000000000001 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.219999999999999 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 64.25 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.769 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 44.340000000000003 110.858 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.130000000000003 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 71.140000000000001 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 111.127 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 44.32 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 99' ' ' ILE . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 53.409999999999997 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 43.409999999999997 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD11 HD13 ' A' ' 99' ' ' ILE . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.219999999999999 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.450000000000003 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.140000000000001 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 51.229999999999997 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 25' ' ' ILE . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.871 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 64' ' ' VAL . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 52.109999999999999 111.109 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.494 ' CG ' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.852 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.549999999999997 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.140000000000001 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 65.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.310000000000002 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 57' ' ' VAL . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 60.439999999999998 111.112 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 64.010000000000005 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.842 HD13 HD21 ' A' ' 7' ' ' LEU . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 70.230000000000004 110.952 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 51.030000000000001 111.097 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 55.240000000000002 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 60.130000000000003 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 3' ' ' THR . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.089 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.849 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.439999999999998 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 78' ' ' VAL . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 111.124 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.420000000000002 110.879 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 73.530000000000001 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 61.119999999999997 111.074 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 51.200000000000003 110.873 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 83' ' ' SER . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.319999999999993 111.12 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.209999999999994 112.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 99' ' ' ILE . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.131 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 54.200000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.109999999999999 110.838 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 111.065 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 55.119999999999997 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 60.229999999999997 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HD11 ' A' ' 50' ' ' LEU . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.430000000000007 111.182 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.148 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.425 HG12 ' OE1' ' A' ' 103' ' ' GLU . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.107 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 33.130000000000003 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.140000000000001 110.907 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 61.119999999999997 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.9 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.13 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 73.239999999999995 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.129999999999995 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.530000000000001 110.972 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.25 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' O ' HD11 ' A' ' 7' ' ' LEU . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.420000000000002 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.439999999999998 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.420000000000002 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.450000000000003 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.310000000000002 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 66' ' ' GLU . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.873 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 27' ' ' GLU . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 72.239999999999995 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 70.230000000000004 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.92 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 63.109999999999999 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 62.399999999999999 111.126 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 103' ' ' GLU . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 64.120000000000005 111.114 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 54.0 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 63.32 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.319999999999993 112.442 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.140000000000001 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.541 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 110.895 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.239999999999995 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 61.109999999999999 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 52.530000000000001 111.091 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.229999999999997 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.852 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 111.093 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.400000000000006 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.200000000000003 110.908 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 70.239999999999995 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.430000000000007 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 72.239999999999995 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.129999999999995 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 63' ' ' THR . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 111.161 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 70.420000000000002 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 57' ' ' VAL . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.099999999999994 110.864 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 40.039999999999999 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 72.420000000000002 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 61.049999999999997 111.131 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.350000000000001 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 66' ' ' GLU . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 60.340000000000003 111.18 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 110.903 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 7' ' ' LEU . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 40.439999999999998 110.858 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 111.082 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.099999999999994 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 61.450000000000003 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 78' ' ' VAL . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 53.049999999999997 111.126 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 25.539999999999999 111.095 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 61.539999999999999 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 99' ' ' ILE . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.219999999999999 110.904 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.340000000000003 111.147 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 55.039999999999999 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 111.124 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 100' ' ' VAL . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 31.210000000000001 110.846 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 85' ' ' PRO . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 55.350000000000001 111.106 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.400000000000006 112.336 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HZ ' HG21 ' A' ' 99' ' ' ILE . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.885 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 42.109999999999999 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 90' ' ' ARG . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.340000000000003 111.095 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.120000000000005 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.439999999999998 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.409999999999997 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.852 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 70.319999999999993 111.133 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' OG ' ' A' ' 83' ' ' SER . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.120000000000005 111.119 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 103' ' ' GLU . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.121 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.030000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HB3' HG21 ' A' ' 33' ' ' THR . 4.4 mp0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.93 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 41.109999999999999 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 ' HE ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.942 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.74 HG22 ' CB ' ' A' ' 75' ' ' ALA . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 62.539999999999999 111.195 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 54.32 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.209999999999994 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 44.020000000000003 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HD23 ' A' ' 23' ' ' LEU . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.400000000000006 111.114 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.040000000000006 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.230000000000004 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 63.299999999999997 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.210000000000001 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.420000000000002 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 43.140000000000001 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD23 HG21 ' A' ' 11' ' ' VAL . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.200000000000003 110.915 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 54' ' ' ASP . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.895 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.510000000000005 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.932 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 42' ' ' MET . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.147 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.409999999999997 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 111.118 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.219999999999999 112.537 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 74.340000000000003 110.851 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.420000000000002 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.040000000000006 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 71.099999999999994 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.109999999999999 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.876 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 54.219999999999999 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.040000000000006 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 42.130000000000003 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.25 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.099999999999994 111.133 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 55.240000000000002 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 54.210000000000001 110.922 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 27' ' ' GLU . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.340000000000003 111.117 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.219999999999999 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.230000000000004 110.882 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 70' ' ' PHE . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.891 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 63' ' ' THR . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 111.098 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.049999999999997 110.889 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 62.32 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 60.240000000000002 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.416 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 71.239999999999995 110.927 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.659 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 52.310000000000002 111.157 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.409999999999997 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.944 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.118 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.549999999999997 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 74' ' ' VAL . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.854 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.030000000000001 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 52.310000000000002 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 111.113 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 2' ' ' LEU . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.894 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.532 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.849 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 74' ' ' VAL . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 50.409999999999997 111.134 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 64.049999999999997 110.857 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.230000000000004 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 54.350000000000001 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 111.11 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.804 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.009999999999998 110.888 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' CD2' ' A' ' 77' ' ' HIS . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.400000000000006 111.133 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 65.409999999999997 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.140000000000001 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.849 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.319999999999993 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 90' ' ' ARG . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.540000000000006 111.16 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 63.340000000000003 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 54.109999999999999 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.340000000000003 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.967 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 111.132 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 83' ' ' SER . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.107 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.099999999999994 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' OE1' HG13 ' A' ' 78' ' ' VAL . 3.5 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.310000000000002 110.933 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.450000000000003 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 70.239999999999995 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.430000000000007 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 40.020000000000003 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 70.030000000000001 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.682 ' CG2' HD23 ' A' ' 23' ' ' LEU . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 41.32 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 62.420000000000002 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.52 ' HD2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 73.239999999999995 110.881 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 44.399999999999999 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 63.32 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.200000000000003 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.450000000000003 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HD2' ' A' ' 15' ' ' ARG . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.349999999999994 111.137 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.503 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.140000000000001 111.133 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG2' ' A' ' 11' ' ' VAL . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 27' ' ' GLU . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 62.210000000000001 111.139 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 62.119999999999997 110.894 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.877 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.164 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.629 HG23 ' CB ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 55.100000000000001 111.132 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.519999999999996 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' HG11 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 110.829 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 65.030000000000001 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.513 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 42.530000000000001 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 63.229999999999997 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.629 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 51.32 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.310000000000002 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 111.095 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 60.240000000000002 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 99' ' ' ILE . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.200000000000003 110.918 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.420000000000002 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 51.329999999999998 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.109999999999999 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 56' ' ' LEU . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.963 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.707 HG12 ' CG2' ' A' ' 64' ' ' VAL . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.114 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.647 ' HG3' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.917 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.209999999999994 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 65.230000000000004 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 57' ' ' VAL . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.124 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.049999999999997 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 111.058 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 61.219999999999999 111.09 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 74' ' ' VAL . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 110.89 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 71.209999999999994 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 69' ' ' ALA . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.131 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 70' ' ' PHE . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.864 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 53.240000000000002 111.086 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.439999999999998 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.143 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.310000000000002 110.842 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 53.130000000000003 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.091 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.515 ' HB3' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.229999999999997 110.908 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 99' ' ' ILE . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.209999999999994 111.161 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.329999999999998 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 58' ' ' ARG . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 61.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 54.409999999999997 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.925 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.530000000000001 110.915 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 44.5 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.144 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.340000000000003 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 111.118 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 51.119999999999997 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.676 HG22 ' HB1' ' A' ' 48' ' ' ALA . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 111.079 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 83' ' ' SER . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.299999999999997 111.181 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 35.340000000000003 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.515 ' OE2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.310000000000002 110.855 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 50.43 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.888 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.158 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 64.530000000000001 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.219999999999999 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.430000000000007 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.329999999999998 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.120000000000005 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 23' ' ' LEU . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 60.140000000000001 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 61.520000000000003 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 24.34 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 74.420000000000002 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.299999999999997 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 33.240000000000002 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.420000000000002 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.936 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 60.43 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 56' ' ' LEU . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 65.219999999999999 111.142 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.888 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' NE2' ' A' ' 30' ' ' GLN . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 70.430000000000007 111.12 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 28' ' ' VAL . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.953 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.169 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.319999999999993 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 103' ' ' GLU . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 71.450000000000003 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.200000000000003 112.506 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.020000000000003 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.340000000000003 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.774 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 110.891 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.129999999999995 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.109999999999999 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 61.32 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.239999999999995 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.100000000000001 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.209999999999994 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' HG3' ' A' ' 30' ' ' GLN . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 53.119999999999997 110.907 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 40.439999999999998 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.439999999999998 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD12 HH21 ' A' ' 58' ' ' ARG . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 74.019999999999996 110.954 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.744 HG12 ' CG2' ' A' ' 64' ' ' VAL . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 111.122 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.621 HH21 HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.91 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 57' ' ' VAL . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.905 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 53.039999999999999 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.109999999999999 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.532 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.340000000000003 110.952 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.439999999999998 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.744 ' CG2' HG12 ' A' ' 57' ' ' VAL . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 111.086 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 55.43 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 111.052 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 73' ' ' VAL . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.916 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 110.865 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 61.530000000000001 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 70' ' ' PHE . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 53.520000000000003 111.14 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.125 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.240000000000002 111.095 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.897 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.229999999999997 111.172 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 110.892 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.340000000000003 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.409999999999997 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 44.140000000000001 111.1 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 85' ' ' PRO . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.549999999999997 111.119 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.229999999999997 112.318 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG13 ' HG2' ' A' ' 58' ' ' ARG . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.138 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 62.539999999999999 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 62.43 110.841 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.530000000000001 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.130000000000003 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 62.25 111.107 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 63.329999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.140000000000001 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 72.010000000000005 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 61.310000000000002 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.168 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.489 HG12 ' OE1' ' A' ' 103' ' ' GLU . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.138 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.32 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 54.140000000000001 110.879 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.129999999999995 112.401 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 63.5 110.92 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.978 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.540000000000006 111.163 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 53.210000000000001 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.039999999999999 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.150000000000006 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 110.937 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 42.210000000000001 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.349999999999994 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.219999999999999 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 67' ' ' LEU . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 111.131 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 43.509999999999998 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 64.310000000000002 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.140000000000001 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 23' ' ' LEU . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.134 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 22' ' ' THR . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.909 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' ASP . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 111.143 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 63.020000000000003 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 70' ' ' PHE . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.167 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.159 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.400000000000006 111.146 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.299999999999997 112.492 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 61.219999999999999 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 65.319999999999993 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.130000000000003 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.009999999999998 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 41.25 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.299999999999997 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.350000000000001 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.726 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.929 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.129999999999995 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 43.530000000000001 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 40.43 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.450000000000003 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.712 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.149999999999999 111.116 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 60.039999999999999 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 99' ' ' ILE . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.140000000000001 110.922 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.040000000000006 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 52' ' ' VAL . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 111.128 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.329999999999998 110.84 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.200000000000003 111.137 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.534 ' CG ' HG13 ' A' ' 86' ' ' VAL . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.898 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.902 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.230000000000004 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.409999999999997 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 57' ' ' VAL . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 110.916 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 23' ' ' LEU . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 63.219999999999999 111.096 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 11' ' ' VAL . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 63.210000000000001 110.937 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 43.32 111.084 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 29' ' ' THR . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 60.399999999999999 110.893 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.129999999999995 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 78' ' ' VAL . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 52.32 111.136 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.978 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 111.048 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 74' ' ' VAL . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.030000000000001 111.162 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 65.140000000000001 110.833 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 71.239999999999995 112.361 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.130000000000003 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.109999999999999 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 85' ' ' PRO . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 52.409999999999997 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 35.130000000000003 112.368 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG13 ' CG ' ' A' ' 58' ' ' ARG . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 72.109999999999999 111.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 57' ' ' VAL . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.107 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 50' ' ' LEU . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.907 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.89 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.040000000000006 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.140000000000001 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 90' ' ' ARG . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 64.420000000000002 111.107 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.310000000000002 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 32.310000000000002 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.712 HG23 ' CB ' ' A' ' 48' ' ' ALA . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.049999999999997 111.096 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 100' ' ' VAL . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.108 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.310000000000002 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.230000000000004 110.914 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 78' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 62.32 112.348 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 61.520000000000003 110.912 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.989 HG22 ' HB2' ' A' ' 75' ' ' ALA . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.131 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.140000000000001 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 70.530000000000001 110.915 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.420000000000002 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.150000000000006 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.968 HG22 HD23 ' A' ' 67' ' ' LEU . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.010000000000005 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 62.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 72.420000000000002 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.622 ' C ' HD12 ' A' ' 23' ' ' LEU . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.155 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.653 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.897 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.409999999999997 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 56' ' ' LEU . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.340000000000003 111.139 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' HB2' HD13 ' A' ' 50' ' ' LEU . 12.3 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.924 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.420000000000002 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 61.450000000000003 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 64.219999999999999 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 55.130000000000003 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.505 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.310000000000002 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.400000000000006 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 50' ' ' LEU . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.099999999999994 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.076 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 30' ' ' GLN . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 63.109999999999999 110.935 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 72.200000000000003 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.409999999999997 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 62.030000000000001 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 25' ' ' ILE . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.936 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 87' ' ' VAL . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 57' ' ' VAL . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.350000000000001 110.873 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.129999999999995 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 71.549999999999997 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.019999999999996 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.653 ' CG1' HD13 ' A' ' 23' ' ' LEU . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 111.16 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 43.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.968 HD23 HG22 ' A' ' 11' ' ' VAL . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.030000000000001 110.914 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 111.166 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 62.109999999999999 110.925 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.229999999999997 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 63.549999999999997 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 70' ' ' PHE . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 44.119999999999997 111.096 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.989 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 71.040000000000006 111.09 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 64.299999999999997 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.132 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.420000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 73.140000000000001 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.519999999999996 111.118 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.219999999999999 110.864 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 71.409999999999997 111.173 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.141 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.456 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.862 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.549999999999997 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.010000000000005 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 53.299999999999997 111.159 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.530000000000001 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 HE22 ' A' ' 30' ' ' GLN . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 65.010000000000005 111.096 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 83' ' ' SER . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 72.510000000000005 111.15 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.1 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 41.549999999999997 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.439999999999998 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.873 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.702 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.145 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.099999999999994 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 34.32 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' HD2' HG23 ' A' ' 25' ' ' ILE . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.109999999999999 110.917 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.210000000000001 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.109999999999999 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 62.240000000000002 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 44.310000000000002 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.310000000000002 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.350000000000001 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 HE22 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 55.420000000000002 111.132 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 23' ' ' LEU . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.508 ' CG1' HD23 ' A' ' 56' ' ' LEU . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.030000000000001 111.129 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.010000000000005 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 63.210000000000001 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.515 HG21 ' CE1' ' A' ' 70' ' ' PHE . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 50.030000000000001 111.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.759 ' CD ' HD13 ' A' ' 50' ' ' LEU . 13.5 mm-40 -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.127 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.409999999999997 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 42.420000000000002 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 54.350000000000001 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 73.010000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.230000000000004 112.482 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.210000000000001 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.039999999999999 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.329999999999998 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.776 ' HA ' HG22 ' A' ' 31' ' ' THR . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 32.409999999999997 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 74.219999999999999 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 111.109 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.450000000000003 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 111.086 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 71.219999999999999 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD12 ' HA ' ' A' ' 45' ' ' ALA . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 52.140000000000001 110.899 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 23.530000000000001 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.319999999999993 110.864 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.506 HE22 HG23 ' A' ' 22' ' ' THR . 31.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.049999999999997 110.882 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' CG1' ' A' ' 25' ' ' ILE . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 110.925 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 111.143 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HG3' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.819 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.898 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 44.200000000000003 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 70.099999999999994 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.019999999999996 110.958 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.200000000000003 111.131 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 57' ' ' VAL . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.349999999999994 111.129 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 65' ' ' THR . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.430000000000007 110.898 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 60.25 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 51.329999999999998 111.06 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 29' ' ' THR . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 110.86 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 74' ' ' VAL . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.319999999999993 110.899 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 74' ' ' VAL . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 111.141 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.702 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.059 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.319999999999993 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.873 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 61.350000000000001 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 62.409999999999997 111.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.85 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 83' ' ' SER . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 65.319999999999993 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.338 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 111.175 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.109999999999999 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.049999999999997 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.040000000000006 110.832 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.329999999999998 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 90' ' ' ARG . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.299999999999997 111.161 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 64.200000000000003 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 55.140000000000001 111.121 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.230000000000004 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.725 HG12 HD21 ' A' ' 50' ' ' LEU . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.150000000000006 111.084 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.010000000000005 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 64.299999999999997 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.120000000000005 110.894 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 55.409999999999997 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.689 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 110.891 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.240000000000002 111.084 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 71.099999999999994 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.651 HD12 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 110.947 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.030000000000001 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE2' HD12 ' A' ' 7' ' ' LEU . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 60.039999999999999 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.409999999999997 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.030000000000001 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 61.399999999999999 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 64.010000000000005 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 71.150000000000006 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.400000000000006 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 61.340000000000003 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 50.240000000000002 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 66' ' ' GLU . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 51.130000000000003 110.891 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.049999999999997 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.642 ' NE2' HD22 ' A' ' 50' ' ' LEU . 2.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.430000000000007 110.917 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 111.15 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 43.409999999999997 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.140000000000001 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.0 112.467 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.150000000000006 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.799 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.87 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.140000000000001 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 63.5 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 111.095 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 61.210000000000001 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.661 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.420000000000002 111.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.340000000000003 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 63.119999999999997 110.915 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.140000000000001 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.340000000000003 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.310000000000002 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.112 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.695 ' HD2' HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.894 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.621 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.892 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 55.039999999999999 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.439999999999998 110.933 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.340000000000003 111.119 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.450000000000003 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 23' ' ' LEU . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 110.886 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.109 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.519999999999996 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 74' ' ' VAL . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.851 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 52.219999999999999 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.759 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 60.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 25.199999999999999 111.113 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 70.329999999999998 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.130000000000003 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 62.299999999999997 111.116 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 71.510000000000005 110.882 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 73.019999999999996 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 53.329999999999998 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 111.123 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.200000000000003 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG13 ' HD2' ' A' ' 58' ' ' ARG . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.167 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.299999999999997 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.519999999999996 110.871 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.039999999999999 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ARG . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 111.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 52.420000000000002 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 50' ' ' LEU . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.12 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 111.081 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.651 ' HG2' HG13 ' A' ' 78' ' ' VAL . 23.4 mp0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 45.109999999999999 110.911 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.349999999999994 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.450000000000003 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.162 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 72.409999999999997 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.140000000000001 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 67' ' ' LEU . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.299999999999997 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 24.449999999999999 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE1' HD12 ' A' ' 7' ' ' LEU . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.87 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.477 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.209999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 31.41 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 35.009999999999998 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.120000000000005 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 64.219999999999999 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.299999999999997 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' HB ' ' A' ' 11' ' ' VAL . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.936 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.530000000000001 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.895 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 70' ' ' PHE . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 111.123 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.871 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.409999999999997 111.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.549999999999997 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.149999999999999 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 62.439999999999998 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.030000000000001 110.858 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 14.220000000000001 112.494 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 32.539999999999999 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 43.450000000000003 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.763 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.858 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.109999999999999 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.530000000000001 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 53.100000000000001 111.117 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 43.329999999999998 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.95 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 42.310000000000002 111.068 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.299999999999997 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 48' ' ' ALA . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.936 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 62.450000000000003 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 27' ' ' GLU . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 44.43 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.409999999999997 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 63' ' ' THR . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 64.140000000000001 111.13 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HD2' HG22 ' A' ' 86' ' ' VAL . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.873 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.445 ' H ' HG12 ' A' ' 57' ' ' VAL . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.907 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.420000000000002 111.148 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 57' ' ' VAL . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 111.149 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 7' ' ' LEU . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 72.209999999999994 110.931 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.121 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.93 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 60.329999999999998 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.120000000000005 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.400000000000006 111.15 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.983 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.111 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 70.319999999999993 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 74' ' ' VAL . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.509999999999998 111.121 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.736 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 71.120000000000005 110.871 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 45.020000000000003 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 41.299999999999997 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.210000000000001 111.104 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' O ' HD13 ' A' ' 84' ' ' ILE . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 55.340000000000003 110.801 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 85' ' ' PRO . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.420000000000002 111.156 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 63.43 112.345 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 58' ' ' ARG . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 52.409999999999997 111.114 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 71.099999999999994 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 110.85 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 54.130000000000003 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.530000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 61.210000000000001 111.124 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' VAL . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 51.200000000000003 111.129 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 64.420000000000002 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.129999999999995 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.95 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.140000000000001 111.176 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.229999999999997 111.095 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 51.229999999999997 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.340000000000003 110.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.219999999999999 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.714 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.938 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.815 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.113 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 64.200000000000003 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.481 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.895 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 70.109999999999999 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.62 HG21 HD23 ' A' ' 23' ' ' LEU . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 71.329999999999998 111.163 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 51.340000000000003 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.672 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.120000000000005 111.09 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.439999999999998 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.510000000000005 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.140000000000001 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.129999999999995 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 13' ' ' VAL . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.894 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.349999999999994 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 62.240000000000002 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 30' ' ' GLN . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.019999999999996 111.121 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' HG2' HD13 ' A' ' 50' ' ' LEU . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 52.140000000000001 110.935 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 111.122 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.030000000000001 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.240000000000002 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.549999999999997 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.030000000000001 112.451 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.099999999999994 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 71.340000000000003 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.310000000000002 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.808 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 53.32 110.89 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 72.150000000000006 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 52.140000000000001 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.56 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 33.030000000000001 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 61.520000000000003 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 111.109 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.100000000000001 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 62.32 110.916 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.340000000000003 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.519999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.519999999999996 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.400000000000006 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.897 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 64' ' ' VAL . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.156 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 73.430000000000007 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 57' ' ' VAL . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.340000000000003 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 110.95 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.140000000000001 111.085 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.049999999999997 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.619 ' O ' HG12 ' A' ' 74' ' ' VAL . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.868 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 52.0 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 50.039999999999999 111.095 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.815 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 44.439999999999998 111.12 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 71.230000000000004 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 74' ' ' VAL . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 111.114 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.219999999999999 110.879 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.299999999999997 111.082 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.340000000000003 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 85' ' ' PRO . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.019999999999996 111.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 72.109999999999999 112.316 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CZ ' HD23 ' A' ' 56' ' ' LEU . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.450000000000003 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 110.872 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 33.32 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 55.219999999999999 111.112 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.519999999999996 111.153 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 41.130000000000003 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.58 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.107 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.030000000000001 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 41.43 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.588 ' HG2' HG13 ' A' ' 78' ' ' VAL . 7.1 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 74.019999999999996 110.909 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.58 ' O ' HD22 ' A' ' 2' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.230000000000004 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 50.219999999999999 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 75' ' ' ALA . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 111.155 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.340000000000003 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 73.109999999999999 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 63.350000000000001 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.099 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.109999999999999 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.010000000000005 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 65.010000000000005 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.200000000000003 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.549999999999997 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 64.420000000000002 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.340000000000003 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 11' ' ' VAL . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.120000000000005 110.906 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.689 HG13 HD23 ' A' ' 56' ' ' LEU . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 55.329999999999998 111.101 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 72.120000000000005 110.943 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.876 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.040000000000006 111.138 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 50' ' ' LEU . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.925 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.456 HG23 ' CB ' ' A' ' 45' ' ' ALA . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.152 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 54.420000000000002 111.121 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 64.030000000000001 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 72.230000000000004 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 11.0 m-80 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.030000000000001 110.846 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 103' ' ' GLU . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 64.109999999999999 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 44.420000000000002 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.109999999999999 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 44.32 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.439999999999998 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 44.509999999999998 111.097 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 63.009999999999998 111.077 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.319999999999993 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.055 HD21 HG21 ' A' ' 99' ' ' ILE . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.030000000000001 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 26' ' ' GLN . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.096 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 64.140000000000001 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 62.329999999999998 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' C ' HD22 ' A' ' 56' ' ' LEU . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.903 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 71.439999999999998 110.934 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.698 HG23 HG13 ' A' ' 87' ' ' VAL . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.192 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.745 ' HG2' HG13 ' A' ' 86' ' ' VAL . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.540000000000006 110.852 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 61.329999999999998 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 64.239999999999995 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 63.340000000000003 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.040000000000006 111.11 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 64' ' ' VAL . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.152 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.867 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 68' ' ' ALA . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 72.209999999999994 110.891 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 54.200000000000003 111.111 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.109999999999999 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.687 ' O ' HG23 ' A' ' 74' ' ' VAL . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.914 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 61.329999999999998 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 54.140000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.647 HG11 ' HD3' ' A' ' 58' ' ' ARG . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 111.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 70' ' ' PHE . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 111.126 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.091 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 61.219999999999999 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.488 ' NE2' HD11 ' A' ' 99' ' ' ILE . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 35.43 110.878 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 74' ' ' VAL . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 72.049999999999997 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.439999999999998 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HD13 ' A' ' 84' ' ' ILE . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 63.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 83' ' ' SER . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 62.340000000000003 111.115 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.539999999999999 112.343 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.745 HG13 ' HG2' ' A' ' 58' ' ' ARG . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 111.107 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 HG23 ' A' ' 57' ' ' VAL . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 60.539999999999999 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.905 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 64.329999999999998 111.117 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 43.310000000000002 111.125 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 52.530000000000001 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 53.43 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.055 HG21 HD21 ' A' ' 50' ' ' LEU . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.128 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.133 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.593 HG23 HD12 ' A' ' 99' ' ' ILE . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.093 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.510000000000005 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 78' ' ' VAL . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 110.891 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 62.130000000000003 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.675 HG22 ' CB ' ' A' ' 75' ' ' ALA . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.141 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.430000000000007 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 61.140000000000001 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 52.299999999999997 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 67' ' ' LEU . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.310000000000002 110.926 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.030000000000001 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.310000000000002 110.899 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 23' ' ' LEU . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 54.439999999999998 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 23' ' ' LEU . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.450000000000003 111.139 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.209999999999994 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.049999999999997 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 54.219999999999999 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.512 HG23 ' NE2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.121 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.938 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 65.329999999999998 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.941 HG21 HD12 ' A' ' 56' ' ' LEU . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 72.530000000000001 111.167 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.319999999999993 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 50.420000000000002 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 71.109999999999999 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 50.43 111.108 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 71.030000000000001 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.539999999999999 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.129999999999995 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.109999999999999 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.150000000000006 112.5 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.319999999999993 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 63.539999999999999 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.671 ' HA ' HG22 ' A' ' 31' ' ' THR . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.549999999999997 110.871 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 65.349999999999994 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.140000000000001 111.112 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 65.540000000000006 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.549999999999997 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 45' ' ' ALA . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 65.519999999999996 110.922 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.147 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.030000000000001 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.219999999999999 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 22' ' ' THR . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 110.913 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.941 HD12 HG21 ' A' ' 25' ' ' ILE . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.907 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 87' ' ' VAL . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.25 111.137 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 64.200000000000003 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.350000000000001 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.400000000000006 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.893 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 111.098 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 61.130000000000003 111.126 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 61.340000000000003 110.893 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 7' ' ' LEU . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.030000000000001 110.965 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.094 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.349999999999994 111.12 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE1' HD22 ' A' ' 56' ' ' LEU . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' HG12 ' A' ' 74' ' ' VAL . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.409999999999997 110.931 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 70' ' ' PHE . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.143 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 78' ' ' VAL . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 111.156 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.675 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.113 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.450000000000003 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.439999999999998 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 74' ' ' VAL . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 111.113 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 73.049999999999997 110.88 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 62.5 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.439999999999998 111.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.903 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 53.329999999999998 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 71.209999999999994 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 57' ' ' VAL . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.519999999999996 111.166 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.230000000000004 110.868 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.030000000000001 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 74.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 54.520000000000003 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 54.310000000000002 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 53.43 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 55.399999999999999 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' CB ' ' A' ' 83' ' ' SER . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.117 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.319999999999993 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.140000000000001 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.040000000000006 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.010000000000005 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.729 HG22 ' CB ' ' A' ' 75' ' ' ALA . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 111.156 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.349999999999994 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 64.129999999999995 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 63.420000000000002 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 72.319999999999993 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.129999999999995 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.773 ' HB2' HD11 ' A' ' 25' ' ' ILE . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 64.109999999999999 110.895 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.209999999999994 110.864 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' HD23 ' A' ' 23' ' ' LEU . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 52.149999999999999 111.128 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 60.130000000000003 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.099999999999994 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 71.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.310000000000002 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 71.409999999999997 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 65.25 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 61.409999999999997 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 65.420000000000002 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 111.112 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.912 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 9' ' ' PHE . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 73.200000000000003 111.167 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.030000000000001 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.329999999999998 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 70' ' ' PHE . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 111.176 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.745 ' CD ' HD13 ' A' ' 50' ' ' LEU . 10.4 mm-40 -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 71.400000000000006 110.897 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.783 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.138 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.040000000000006 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 78' ' ' VAL . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 61.200000000000003 110.819 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 71.129999999999995 112.489 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.109999999999999 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 60.399999999999999 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.019999999999996 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.783 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 110.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 40.409999999999997 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 111.049 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 61.439999999999998 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 42.210000000000001 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.140000000000001 111.108 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 31.140000000000001 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 99' ' ' ILE . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 63.439999999999998 110.961 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 25' ' ' ILE . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.030000000000001 110.887 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 44.130000000000003 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.645 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.239999999999995 111.152 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.030000000000001 110.896 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.5 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.549999999999997 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.049999999999997 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 57' ' ' VAL . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.329999999999998 111.132 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 23' ' ' LEU . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 65.420000000000002 111.131 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 111.121 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 110.931 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.140000000000001 111.127 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 29' ' ' THR . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.841 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 74' ' ' VAL . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.899 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 70.239999999999995 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 74' ' ' VAL . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 52.210000000000001 111.117 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 78' ' ' VAL . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 111.115 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.729 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 111.073 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 74' ' ' VAL . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 71.239999999999995 111.12 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 110.874 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.240000000000002 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 52.409999999999997 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.019999999999996 111.108 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' HG22 ' A' ' 100' ' ' VAL . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.150000000000006 110.866 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 72.349999999999994 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.109999999999999 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 57' ' ' VAL . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 71.040000000000006 111.132 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.519999999999996 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.510000000000005 110.876 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 64.230000000000004 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.310000000000002 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.040000000000006 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 53.109999999999999 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.040000000000006 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.045 HG21 HD21 ' A' ' 50' ' ' LEU . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 61.039999999999999 111.155 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 83' ' ' SER . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 55.43 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.219999999999999 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.859 0.275 . . . . 43.109999999999999 112.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.15 152.73 17.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.925 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.872 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.9 t -130.46 167.46 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 111.098 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.75 160.69 80.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 75.019999999999996 110.836 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.33 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.674 2.249 . . . . 73.450000000000003 112.313 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 132.03 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.929 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' HB3' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -113.11 124.72 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 62.200000000000003 110.909 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.28 44.33 1.32 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.140000000000001 112.503 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -164.5 169.92 16.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 73.230000000000004 110.871 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -114.0 142.5 46.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.01 131.48 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.142 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.36 122.96 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 62.020000000000003 111.096 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -79.93 121.62 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 54.509999999999998 111.167 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.38 -155.95 7.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 112.486 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -132.71 138.26 47.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.348 . . . . 74.049999999999997 110.901 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.97 -176.5 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 62.450000000000003 110.852 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -59.35 -26.03 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.849 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -45.35 10.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.833 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 58.27 1.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.13 11.01 18.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 70.439999999999998 110.844 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.6 m 54.64 86.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 70.400000000000006 111.158 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t -135.15 158.17 45.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 64.319999999999993 111.102 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.74 HD13 HG13 ' A' ' 64' ' ' VAL . 6.1 mp -105.25 130.45 53.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 65.209999999999994 110.924 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 145.93 24.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 25.210000000000001 110.884 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 HD13 ' A' ' 56' ' ' LEU . 28.9 mm -96.09 131.12 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -24.61 13.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 62.340000000000003 110.916 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.03 -171.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.842 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.89 127.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 73.230000000000004 111.096 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' OE1' ' A' ' 30' ' ' GLN . 1.8 t -115.53 -12.62 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.194 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.617 ' OE1' HG23 ' A' ' 29' ' ' THR . 3.7 mp0 -90.02 11.63 20.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.948 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 p -111.63 17.44 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.104 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -121.71 150.0 42.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 74.420000000000002 110.91 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 34' ' ' GLY . 5.0 m -160.4 159.95 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 111.181 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 33' ' ' THR . . . -178.56 -26.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 71.230000000000004 112.449 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.8 p -102.69 126.77 49.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 110.837 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.22 29.68 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.849 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.9 -61.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.736 -0.745 . . . . 73.319999999999993 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . 57.57 83.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 72.340000000000003 112.544 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 38' ' ' GLY . . . 178.4 63.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 70.200000000000003 111.075 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -68.58 111.92 5.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.99 -166.23 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 34.420000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.16 124.06 51.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.78 -70.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 62.340000000000003 112.459 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -28.32 25.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 112.344 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -41.47 96.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.329999999999998 111.098 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.32 -20.22 66.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 61.130000000000003 110.892 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.29 -30.81 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.115 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.97 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.44 -22.4 15.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.145 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.86 15.18 32.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 65.510000000000005 112.521 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.64 112.89 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 74.230000000000004 110.912 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 177.83 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 64.510000000000005 110.833 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 27' ' ' GLU . 27.0 m -73.98 132.98 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.143 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.71 -50.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 72.519999999999996 112.483 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.93 150.82 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 72.019999999999996 110.87 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.96 148.17 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 25' ' ' ILE . 4.9 mp -121.93 126.94 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 64' ' ' VAL . 31.3 m -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 55.5 111.108 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.639 HH22 HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 52.56 30.35 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.838 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' H ' HG23 ' A' ' 57' ' ' VAL . 20.2 m-85 -137.11 147.76 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 110.866 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.94 109.64 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.108 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.63 1.02 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 43.340000000000003 112.469 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.8 m-85 60.51 38.44 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -132.88 151.02 52.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.74 HG13 HD13 ' A' ' 23' ' ' LEU . 9.8 p -148.04 155.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 111.145 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -67.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 55.310000000000002 111.132 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -179.77 -175.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.881 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -53.73 -36.63 62.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 110.887 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.81 92.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 111.129 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.73 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 71.230000000000004 111.082 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 t80 -76.67 -24.26 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 65.209999999999994 110.896 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.87 -42.77 94.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -46.42 59.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 111.197 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.77 -47.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 111.132 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.8 t -58.76 -49.69 81.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 111.152 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.11 -43.67 91.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.126 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -34.14 75.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.400000000000006 110.867 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.73 -27.43 50.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.854 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.3 t -54.77 112.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.549999999999997 111.074 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.04 159.88 31.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 75.019999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 109.81 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 64.329999999999998 112.348 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.06 39.9 19.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.863 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.0 114.67 28.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 111.137 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 p -115.71 128.8 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 63.049999999999997 110.874 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.0 154.92 73.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.663 0.744 . . . . 65.129999999999995 111.113 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.03 22.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.398 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 97' ' ' ALA . 8.7 p -120.41 144.14 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 111.118 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 58' ' ' ARG . 3.5 p -102.58 115.26 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 55.340000000000003 111.118 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -122.84 157.23 32.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 62.43 110.844 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -128.15 148.3 50.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 65.420000000000002 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtt-85 -120.95 82.19 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.883 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.77 38.79 14.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.299999999999997 110.867 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.83 36.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 55.340000000000003 112.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.5 t -96.69 146.11 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 63.119999999999997 111.111 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.9 t -107.61 112.75 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 35.439999999999998 111.15 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.3 tpt -147.42 152.78 38.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.871 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 76.2 p -134.44 131.98 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.854 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -140.86 139.75 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.105 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.4 m -84.11 125.01 31.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.15 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.97 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.91 126.6 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 71.420000000000002 111.16 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.28 112.31 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 44.299999999999997 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.04 127.57 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 72.109999999999999 111.124 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.53 110.45 3.33 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 54.229999999999997 112.488 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.573 ' OE1' HG13 ' A' ' 78' ' ' VAL . 6.9 mp0 -92.46 -27.62 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.909 0.385 . . . . 72.430000000000007 110.848 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -143.14 95.03 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.200000000000003 110.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 70.400000000000006 110.86 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.831 0.263 . . . . 63.32 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.12 154.49 47.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 110.92 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.044 HG22 ' HB2' ' A' ' 75' ' ' ALA . 7.7 t -129.88 167.05 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 65.230000000000004 111.135 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 160.53 25.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 71.230000000000004 110.861 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 76.49 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.242 . . . . 64.310000000000002 112.331 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -124.01 147.53 47.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.889 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.57 122.98 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 65.549999999999997 110.926 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.98 17.59 7.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 73.239999999999995 112.504 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.17 173.25 16.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 75.230000000000004 110.839 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -114.07 146.75 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 63.32 110.868 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.694 ' CG2' HD23 ' A' ' 23' ' ' LEU . 9.0 p -135.26 136.4 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.09 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.29 121.67 35.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.530000000000001 111.113 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 p -81.11 127.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 111.119 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.55 -152.79 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 73.030000000000001 112.487 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -132.76 144.32 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 110.891 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -99.06 -176.16 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 55.119999999999997 110.874 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -64.62 -26.79 68.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.89 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.33 -54.82 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 52.100000000000001 110.864 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.34 54.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.437 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 11.0 18.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 32.439999999999998 110.863 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.7 m 57.95 87.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 71.519999999999996 111.167 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -141.33 157.64 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.138 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.694 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.5 mp -101.01 159.92 14.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 54.350000000000001 110.903 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -122.09 147.88 45.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.856 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 25.7 mm -96.07 133.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.154 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.27 -14.91 14.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 34.240000000000002 110.923 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.67 -169.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.872 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.81 129.73 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 111.122 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 t -119.95 -13.47 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.7 mp0 -86.53 6.06 32.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.936 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.7 p -112.23 17.28 19.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.230000000000004 111.131 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 148.14 45.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.92 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 m -160.7 145.53 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 44.340000000000003 111.16 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -34.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 44.299999999999997 112.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -104.84 136.79 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 72.430000000000007 110.836 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.91 28.85 13.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 70.430000000000007 110.893 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.78 -65.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 72.239999999999995 112.49 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 83.42 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.219999999999999 112.482 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.62 64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 74.340000000000003 111.06 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.44 111.4 4.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.859 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 tp -165.44 -164.41 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.887 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.76 ' HA ' HG22 ' A' ' 31' ' ' THR . 8.2 tmm? -112.27 117.43 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -68.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 40.240000000000002 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -28.82 24.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 64.510000000000005 112.331 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -71.26 -47.71 55.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.109999999999999 111.1 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -23.35 60.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 -35.79 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 44.229999999999997 111.085 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.702 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -87.11 -22.92 25.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 34.030000000000001 111.111 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.53 12.42 28.66 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.687 -0.768 . . . . 61.119999999999997 112.422 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.777 HD21 HD12 ' A' ' 99' ' ' ILE . 4.5 mm? -68.74 111.99 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.928 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.61 156.82 45.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.861 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.21 132.98 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.549999999999997 111.161 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.02 -47.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 43.130000000000003 112.495 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -66.33 154.46 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 70.319999999999993 110.851 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 44.7 mt-30 -102.08 147.04 27.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.892 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -132.84 123.32 25.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 110.907 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 87' ' ' VAL . 2.5 m -119.74 -36.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 111.092 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HG2' HG13 ' A' ' 86' ' ' VAL . 27.4 mtm-85 52.27 30.04 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -140.23 146.85 39.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 62.509999999999998 110.876 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 109.89 6.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 40.329999999999998 111.053 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.8 4.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 24.210000000000001 112.51 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.413 ' HA ' HG21 ' A' ' 57' ' ' VAL . 2.7 m-85 60.82 38.85 17.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 110.928 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.3 151.54 51.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.040000000000006 111.134 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.3 p -148.24 159.83 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.143 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.46 HG22 ' OE1' ' A' ' 66' ' ' GLU . 96.9 m -87.46 -75.73 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 111.134 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' OE1' HG22 ' A' ' 65' ' ' THR . 1.5 pt-20 -174.7 -169.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 70.25 110.843 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.57 -34.34 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 71.150000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.91 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.340000000000003 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.05 -34.23 74.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 73.099999999999994 111.082 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.4 t80 -72.91 -23.43 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 70.030000000000001 110.88 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 -45.09 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -35.12 69.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 41.43 111.121 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 58' ' ' ARG . 95.1 t -68.67 -40.53 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.098 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 70' ' ' PHE . 68.2 t -57.45 -38.12 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.109 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.044 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.16 -43.16 99.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 54.399999999999999 111.105 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -23.54 43.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.6 -53.16 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.150000000000006 110.846 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 74' ' ' VAL . 18.3 m -55.3 113.53 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 111.138 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 6.0 mtt180 -152.86 160.18 31.37 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.692 . . . . 72.319999999999993 110.929 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 94.74 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 64.349999999999994 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 m 55.61 39.44 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.885 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -113.33 125.29 54.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.065 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.582 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -99.04 143.51 29.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 110.849 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -132.59 159.05 74.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.613 0.72 . . . . 54.340000000000003 111.107 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 132.26 22.91 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.6 2.2 . . . . 65.409999999999997 112.375 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' ' 58' ' ' ARG . 21.8 t -141.36 136.68 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.092 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 57' ' ' VAL . 4.6 p -107.45 123.47 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -121.1 157.24 30.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 110.859 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.19 148.29 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.871 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 ttt85 -118.61 81.12 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.319999999999993 110.848 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.76 39.17 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.89 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.26 12.89 34.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.6 t -97.64 146.21 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 51.020000000000003 111.115 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.46 112.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.5 tpp -148.52 146.01 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.892 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.5 p -113.25 133.9 54.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 52.520000000000003 110.828 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.05 34.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 111.116 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.9 m -83.5 126.88 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 111.14 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.777 HD12 HD21 ' A' ' 50' ' ' LEU . 11.3 mm -106.47 124.87 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 111.132 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.582 HG12 ' CB ' ' A' ' 83' ' ' SER . 10.7 m -105.55 111.67 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 111.122 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 78' ' ' VAL . 92.6 t -103.02 129.15 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 63.43 111.16 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.77 110.78 2.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 73.209999999999994 112.506 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -81.41 -36.6 29.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 110.85 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.12 86.21 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 53.039999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 52.5 110.867 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.214 0 CA-C-O 120.804 0.252 . . . . 74.329999999999998 112.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.82 159.1 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 50.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.068 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.4 t -129.82 154.66 47.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 111.134 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -93.74 160.72 32.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.886 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 74.6 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.741 2.294 . . . . 74.310000000000002 112.351 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.66 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 62.329999999999998 110.892 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.77 122.6 46.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 63.329999999999998 110.892 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.4 28.82 4.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.791 -0.719 . . . . 64.530000000000001 112.498 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.32 178.07 8.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.932 0.396 . . . . 72.129999999999995 110.824 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -114.2 141.57 47.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.85 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.619 ' CG2' HD23 ' A' ' 67' ' ' LEU . 4.8 m -134.91 125.36 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 53.450000000000003 111.127 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.44 121.49 35.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 65.109999999999999 111.068 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.15 135.25 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.74 -149.71 6.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 70.5 112.471 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' A' ' 21' ' ' THR . 11.8 mmt180 -132.73 139.18 47.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.855 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -98.94 -176.47 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.913 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -59.42 -26.74 65.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 71.319999999999993 110.85 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 t -87.52 -47.22 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 73.129999999999995 110.828 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.29 59.64 1.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 64.540000000000006 112.44 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.34 11.03 18.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 63.350000000000001 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.43 HG23 ' NH1' ' A' ' 15' ' ' ARG . 1.4 m 58.08 83.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 111.151 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -142.07 157.46 44.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.010000000000005 111.163 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 mp -96.82 159.93 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.936 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.8 t -124.75 143.77 50.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.89 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 56' ' ' LEU . 49.1 mm -96.19 132.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.174 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -12.1 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.876 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 52' ' ' VAL . 1.4 mm-40 -117.31 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.898 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.75 125.01 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.11 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.445 HG21 ' CE2' ' A' ' 70' ' ' PHE . 8.0 t -120.83 -10.17 9.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 111.116 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.649 ' CG ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -83.27 1.45 40.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.896 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.2 p -111.71 17.42 19.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 111.164 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -121.44 147.0 46.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.918 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -156.95 159.84 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 23.109999999999999 111.138 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.69 -29.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 72.030000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -104.9 128.27 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 54.530000000000001 110.854 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.1 m120 59.23 32.2 21.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.931 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.59 -68.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 72.040000000000006 112.524 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.29 79.57 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 53.539999999999999 112.437 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.42 83.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 74.099999999999994 111.073 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.56 111.73 22.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.05 -166.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 110.916 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.743 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -112.99 121.48 44.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.84 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.34 -69.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 65.140000000000001 112.506 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -37.02 9.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.668 2.245 . . . . 64.010000000000005 112.385 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.747 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -66.55 -47.05 74.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 111.066 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -66.22 -24.78 66.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.929 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.73 74.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.129999999999995 111.068 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 99' ' ' ILE . . . -91.88 -22.5 20.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 51.049999999999997 111.091 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.77 15.48 22.34 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.732 . . . . 35.119999999999997 112.504 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 99' ' ' ILE . 10.7 mt -71.99 111.95 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.77 177.99 7.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.899 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 27' ' ' GLU . 18.2 m -58.42 121.46 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 111.117 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.01 -32.33 3.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 50.310000000000002 112.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.32 125.42 27.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.35 . . . . 62.039999999999999 110.842 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -86.99 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.695 HD13 HG13 ' A' ' 25' ' ' ILE . 6.0 mp -115.83 120.77 40.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 110.943 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 87' ' ' VAL . 5.6 p -118.4 -42.46 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 111.064 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 57' ' ' VAL . 0.0 OUTLIER 51.58 30.31 6.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 110.897 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.6 m-85 -139.97 141.37 36.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.549999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 110.38 6.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 111.117 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.4 2.33 5.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 60.340000000000003 112.508 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 60.21 38.27 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 71.450000000000003 110.933 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 t -128.67 130.38 47.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.5 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 23' ' ' LEU . 9.0 p -136.52 155.34 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 111.119 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 66' ' ' GLU . 98.0 m -78.37 -74.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 72.420000000000002 111.141 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 pt-20 -174.43 -169.8 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.875 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 11' ' ' VAL . 3.9 pp -53.59 -34.27 57.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.47 -43.86 84.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 63.240000000000002 111.117 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.67 -34.5 75.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 34.009999999999998 111.078 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.3 t80 -60.81 -28.66 68.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 70.510000000000005 110.915 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.58 -36.0 82.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.913 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -46.55 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.15 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 70' ' ' PHE . 23.1 m -69.66 -40.14 79.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 62.340000000000003 111.117 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 78' ' ' VAL . 18.9 t -58.93 -37.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.129 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.068 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -62.24 -43.84 97.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 64.510000000000005 111.127 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -80.37 -19.47 46.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.69 -53.39 6.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.1 m -51.11 113.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.139 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.579 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 21.5 mtm180 -151.96 161.27 29.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.622 0.725 . . . . 63.520000000000003 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 102.96 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 72.019999999999996 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 p 50.93 40.01 24.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.909 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.97 124.76 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 75.099999999999994 111.071 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -108.26 143.52 36.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.299999999999997 110.875 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.91 73.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.583 0.706 . . . . 75.340000000000003 111.183 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 118.27 5.58 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.706 2.27 . . . . 71.109999999999999 112.376 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.997 HG21 HD11 ' A' ' 99' ' ' ILE . 89.3 t -118.16 144.79 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 111.156 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 57' ' ' VAL . 2.4 p -107.88 125.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.079 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 160.95 29.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 64.310000000000002 110.892 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.95 139.91 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.879 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -119.18 90.62 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.923 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.01 38.48 14.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.05 -15.39 58.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.68 -0.771 . . . . 74.319999999999993 112.474 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 90' ' ' ARG . 86.9 t -66.21 145.6 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.400000000000006 111.106 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 94' ' ' VAL . 4.3 p -112.94 113.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.135 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.4 tpt -145.8 154.27 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -130.54 129.79 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.72 31.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 72.150000000000006 111.063 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -83.87 125.57 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.13 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 86' ' ' VAL . 13.2 pt -115.03 126.31 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 62.100000000000001 111.135 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 100' ' ' VAL . 4.0 p -100.14 114.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.473 . . . . 73.150000000000006 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' OE2' ' A' ' 103' ' ' GLU . 45.9 t -102.7 134.01 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 55.109999999999999 111.129 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -108.38 110.65 3.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 62.350000000000001 112.525 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -92.3 -36.77 13.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.908 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.12 87.19 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.927 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.010000000000005 110.821 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.793 0.247 . . . . 73.510000000000005 112.357 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -173.45 153.72 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 110.908 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.651 HG22 ' CB ' ' A' ' 75' ' ' ALA . 5.9 t -128.58 167.17 17.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 111.163 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.65 160.13 48.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.618 0.723 . . . . 64.219999999999999 110.873 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 78.22 1.02 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 65.319999999999993 112.332 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.71 126.55 46.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.93 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.0 123.01 48.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.11 34.27 3.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 64.230000000000004 112.474 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -152.27 166.55 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 74.129999999999995 110.878 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -114.8 147.76 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.838 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.09 128.54 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.65 44.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 111.094 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.71 129.67 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.448 . . . . 54.420000000000002 111.103 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.43 -157.41 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 53.409999999999997 112.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.86 143.54 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.346 . . . . 62.149999999999999 110.81 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -98.99 -176.49 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 110.849 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.6 m -72.04 -26.78 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 34.439999999999998 110.861 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.7 p -72.79 -63.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.409999999999997 110.867 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.83 46.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 42.439999999999998 112.488 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.33 -9.93 13.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 71.120000000000005 110.86 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 98.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.149 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -139.57 157.73 45.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.4 mp -98.66 143.28 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.884 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 t -108.71 144.27 36.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.827 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 54' ' ' ASP . 1.5 tp -88.12 133.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 111.133 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -108.77 -19.16 13.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 63.100000000000001 110.949 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -168.98 1.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.230000000000004 110.871 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.65 127.5 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 63.210000000000001 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.4 t -120.74 -4.19 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.530000000000001 111.177 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.585 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.7 mp0 -89.87 11.53 20.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.933 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.88 17.18 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 61.32 111.165 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -122.05 147.01 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 62.509999999999998 110.921 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.72 HG23 ' OE2' ' A' ' 103' ' ' GLU . 6.9 m -153.27 156.24 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 74.530000000000001 111.114 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -162.28 -34.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 63.039999999999999 112.477 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.72 151.38 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 61.0 110.843 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.46 30.01 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 42.539999999999999 110.9 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . 173.56 -70.22 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 50.310000000000002 112.514 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 79.18 79.07 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.765 . . . . 74.510000000000005 112.478 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.34 92.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 73.109999999999999 111.091 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.18 117.28 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 62.340000000000003 110.831 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.87 -167.89 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.922 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.803 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -112.96 118.04 33.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 44.530000000000001 110.88 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.64 -69.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -16.04 37.11 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 75.209999999999994 112.314 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.26 -47.47 79.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.040000000000006 111.101 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -76.22 -9.93 59.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.853 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 111.122 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -98.28 -22.71 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 53.039999999999999 111.119 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 16.02 20.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 65.120000000000005 112.468 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.972 HD21 HG21 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -67.92 112.13 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.140000000000001 110.911 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 161.04 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.868 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -57.39 121.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 55.039999999999999 111.099 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.43 -16.09 5.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 60.340000000000003 112.458 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 25' ' ' ILE . 91.2 m-20 -96.57 124.6 40.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 75.319999999999993 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.53 110.32 13.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.918 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 70' ' ' PHE . 1.4 pp -92.62 114.01 26.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 64' ' ' VAL . 15.8 m -116.08 -40.84 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 63.350000000000001 111.131 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.652 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.63 29.96 6.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 110.821 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -135.22 147.97 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 110.873 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.59 109.51 5.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 41.200000000000003 111.129 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.86 0.39 4.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 60.439999999999998 112.514 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.79 38.61 17.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 73.120000000000005 110.889 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.098 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.7 p -148.35 158.66 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 65.329999999999998 111.16 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -71.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 63.210000000000001 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 pt-20 -175.02 -171.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 110.848 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.5 pp -54.97 -35.47 64.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.099999999999994 110.922 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -41.84 81.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.067 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.86 -34.66 78.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 43.340000000000003 111.061 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CD1' HD13 ' A' ' 56' ' ' LEU . 57.3 t80 -69.73 -31.08 68.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 65.120000000000005 110.863 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -68.28 -34.47 76.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 110.907 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -46.65 61.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.04 -40.49 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 61.43 111.126 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 78' ' ' VAL . 41.0 t -65.32 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 63.009999999999998 111.121 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.46 -44.99 85.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -79.97 -24.35 40.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.430000000000007 110.92 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -78.15 -26.58 47.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.865 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.8 t -51.45 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.49 158.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.593 0.711 . . . . 73.439999999999998 110.851 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 106.49 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 112.317 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 t 59.94 39.95 19.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.858 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -86.23 112.04 20.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 111.081 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.29 132.77 52.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 75.299999999999997 110.826 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 pt -143.13 156.3 61.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 111.131 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 122.04 8.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 74.310000000000002 112.374 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' CG ' ' A' ' 58' ' ' ARG . 94.5 t -123.29 144.22 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 72.349999999999994 111.137 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.61 127.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 53.409999999999997 111.094 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -128.62 155.02 45.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.540000000000006 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.39 147.48 51.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 110.848 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.8 mtm180 -124.32 91.41 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.863 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.67 38.74 15.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.928 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -14.43 58.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 73.140000000000001 112.468 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -66.35 145.02 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 54.509999999999998 111.145 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.82 113.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 111.147 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -147.82 145.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.861 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.97 130.95 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.84 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.93 34.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.091 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -83.55 128.5 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.136 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.972 HG21 HD21 ' A' ' 50' ' ' LEU . 22.7 mm -114.75 125.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.114 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -116.02 112.03 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 53.43 111.134 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.76 126.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 55.420000000000002 111.17 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.2 110.96 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.706 -0.759 . . . . 70.439999999999998 112.501 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.72 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.7 mm-40 -62.11 -36.48 81.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 73.030000000000001 110.893 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.645 HD22 ' CA ' ' A' ' 37' ' ' GLY . 1.9 pt? -174.89 170.41 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.896 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.218 0 CA-C-O 120.832 0.263 . . . . 44.140000000000001 112.353 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.26 46.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 64.209999999999994 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.1 t -130.68 167.29 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 73.530000000000001 111.13 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.08 160.66 75.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.599 0.714 . . . . 73.519999999999996 110.893 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 77.08 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 50.350000000000001 112.341 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.91 142.41 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.925 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.66 123.02 48.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 63.219999999999999 110.909 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.18 23.07 6.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 75.0 112.468 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.66 172.18 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 65.439999999999998 110.886 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.0 145.48 41.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.856 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 67' ' ' LEU . 10.8 p -135.09 135.65 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.49 121.73 36.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.106 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -85.14 129.6 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 50.539999999999999 111.141 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.24 7.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 65.219999999999999 112.468 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.9 143.67 49.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 65.340000000000003 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 22' ' ' THR . 1.4 p-10 -99.19 -176.51 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.887 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -71.47 -26.77 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 110.84 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -54.45 6.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 72.450000000000003 110.87 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.78 48.37 0.96 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 44.009999999999998 112.505 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.22 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 70.230000000000004 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m 56.09 93.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.156 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -136.77 157.26 47.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.148 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.4 mp -106.63 139.29 41.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.981 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.24 149.77 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.93 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 54' ' ' ASP . 6.5 tp -96.13 133.44 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.149 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -18.15 13.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.921 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.3 tt0 -118.28 -175.38 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.898 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.68 125.65 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 61.530000000000001 111.144 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -120.78 -0.29 10.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 61.030000000000001 111.166 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' HD22 ' A' ' 50' ' ' LEU . 2.8 mp0 -85.34 4.32 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.8 OUTLIER -111.55 17.47 19.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 61.420000000000002 111.109 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.45 146.61 46.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 110.919 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -143.89 153.0 41.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 51.340000000000003 111.168 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.22 -34.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 70.430000000000007 112.509 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.39 138.44 41.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 60.100000000000001 110.874 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.545 ' O ' HD11 ' A' ' 104' ' ' LEU . 0.5 OUTLIER 60.8 34.31 19.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 110.882 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.71 -68.99 0.1 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 63.109999999999999 112.488 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.72 73.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 54.210000000000001 112.543 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.86 96.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 53.299999999999997 111.066 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.69 131.28 42.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.912 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.05 -168.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.896 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.775 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.7 tmm? -113.72 121.82 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 62.020000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.07 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.775 -0.726 . . . . 75.519999999999996 112.52 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -23.07 31.0 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 64.200000000000003 112.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.26 -47.34 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.442 . . . . 64.530000000000001 111.12 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.56 -18.82 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 73.519999999999996 110.878 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.42 87.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 54.409999999999997 111.093 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.69 -22.6 15.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 45.420000000000002 111.058 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.77 15.73 25.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 112.491 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HG2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -68.11 112.25 4.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.400000000000006 110.939 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 173.39 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 63.229999999999997 110.843 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 27' ' ' GLU . 27.3 m -67.81 128.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 65.420000000000002 111.125 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.8 -15.95 5.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 30.449999999999999 112.475 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.32 120.43 38.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.733 0.301 . . . . 64.340000000000003 110.844 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.67 110.18 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.947 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -87.63 109.25 19.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 110.975 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.733 HG23 HG13 ' A' ' 87' ' ' VAL . 3.5 m -113.62 -41.5 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.019999999999996 111.113 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.7 OUTLIER 51.64 30.18 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.861 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -137.24 146.53 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 75.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.82 110.04 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.519999999999996 111.119 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.54 0.52 4.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.732 . . . . 71.099999999999994 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 60.99 38.77 17.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.4 . . . . 74.129999999999995 110.951 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 t -134.48 153.72 51.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.140000000000001 111.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.4 p -148.41 158.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 111.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.87 -65.73 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 111.137 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -179.47 -176.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 61.450000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 11' ' ' VAL . 3.3 pp -56.26 -35.33 67.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.906 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.23 -43.93 96.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 61.509999999999998 111.134 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.57 75.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 111.055 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t80 -78.23 -25.1 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.875 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.81 -39.7 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.872 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -37.99 71.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 111.122 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 77' ' ' HIS . 85.2 t -70.48 -43.32 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.089 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' PHE . 74.8 t -58.61 -43.75 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 75.430000000000007 111.138 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.002 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.7 -30.87 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 111.092 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -80.6 -31.58 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' HG12 ' A' ' 73' ' ' VAL . 3.8 m-70 -79.46 -47.51 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 110.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 74' ' ' VAL . 16.8 m -48.19 114.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CB ' ' HB3' ' A' ' 82' ' ' ALA . 4.3 mtp85 -148.97 161.16 33.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 75.340000000000003 110.915 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 110.56 2.58 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.331 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.65 40.01 29.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 43.530000000000001 110.889 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 79' ' ' ARG . . . -112.98 112.09 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 71.030000000000001 111.136 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.6 p -86.01 143.33 28.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 85' ' ' PRO . 55.7 mt -148.74 133.21 8.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.602 0.715 . . . . 64.120000000000005 111.122 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.3 Cg_endo -69.72 132.69 23.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 74.129999999999995 112.347 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.22 147.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 111.163 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.733 HG13 HG23 ' A' ' 57' ' ' VAL . 2.8 p -107.5 122.45 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -124.51 157.6 34.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 74.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.71 147.4 50.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.530000000000001 110.863 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -134.23 100.49 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 110.897 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.2 30.61 19.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.879 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.75 -10.83 59.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 71.349999999999994 112.452 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.9 t -66.37 144.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 72.409999999999997 111.121 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -109.8 113.24 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 54.310000000000002 111.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.0 tpp -141.49 154.67 45.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.520000000000003 110.909 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -140.59 130.31 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 63.240000000000002 110.863 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.82 139.51 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 61.100000000000001 111.146 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -84.12 121.74 27.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 51.25 111.098 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.863 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.74 126.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.142 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.638 HG22 ' HB3' ' A' ' 83' ' ' SER . 22.0 t -84.77 123.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 63.210000000000001 111.065 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.95 136.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.08 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.09 110.76 1.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 42.109999999999999 112.524 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -29.43 60.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.655 HD21 ' HA2' ' A' ' 37' ' ' GLY . 1.6 mp -143.58 150.31 38.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.915 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.835 0.265 . . . . 71.010000000000005 112.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -173.36 153.98 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.549999999999997 110.902 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.736 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.5 t -130.0 167.07 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.133 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 155.18 81.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.592 0.711 . . . . 64.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 77.93 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 72.019999999999996 112.348 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 131.57 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.47 123.06 48.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.420000000000002 110.901 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.2 32.73 4.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.743 . . . . 35.43 112.531 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -147.46 170.28 17.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 64.120000000000005 110.885 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.07 145.31 41.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.843 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.687 ' CG2' HD23 ' A' ' 23' ' ' LEU . 13.0 p -134.91 133.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 111.114 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.48 121.9 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 75.430000000000007 111.1 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 HD11 ' A' ' 23' ' ' LEU . 14.0 p -80.91 131.76 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.148 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.05 -157.0 7.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 74.109999999999999 112.504 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -132.68 141.65 48.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 71.120000000000005 110.903 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -98.92 -176.55 3.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 60.399999999999999 110.91 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -26.69 60.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.866 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -64.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.812 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.87 46.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 65.519999999999996 112.445 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.26 -9.38 13.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 72.010000000000005 110.915 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.73 98.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 63.229999999999997 111.135 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 HG23 HE22 ' A' ' 55' ' ' GLN . 0.9 OUTLIER -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 111.142 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 11' ' ' VAL . 7.6 mp -100.23 150.67 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 110.919 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.61 152.05 33.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.855 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 pt -96.49 134.36 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.329999999999998 111.112 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.49 -25.25 17.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -128.64 -169.81 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.88 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 131.73 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 63.049999999999997 111.119 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -120.92 3.24 10.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 51.420000000000002 111.151 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.76 ' HG2' HD13 ' A' ' 50' ' ' LEU . 7.4 mp0 -89.34 10.45 22.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.917 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.771 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -112.04 17.72 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.65 146.92 46.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 110.916 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -151.53 154.28 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.139 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.31 -36.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 63.109999999999999 112.455 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 p -105.56 149.76 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 53.020000000000003 110.85 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.52 30.07 14.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 71.439999999999998 110.859 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 104' ' ' LEU . . . 173.39 -69.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 65.329999999999998 112.482 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.39 78.26 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 74.299999999999997 112.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.68 92.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 54.420000000000002 111.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.9 118.45 23.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.894 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.64 -166.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.771 ' HA ' HG22 ' A' ' 31' ' ' THR . 11.0 tmm? -113.09 119.86 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.871 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.28 -69.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 51.200000000000003 112.487 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -20.85 34.42 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.299999999999997 112.33 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.83 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -77.25 -47.53 19.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.134 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.27 -20.89 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.851 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -32.64 63.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 43.539999999999999 111.054 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.672 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -92.87 -22.85 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 44.539999999999999 111.07 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.14 16.22 30.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.219999999999999 112.47 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 45' ' ' ALA . 6.2 mt -67.66 112.24 4.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.329 . . . . 73.209999999999994 110.892 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -142.49 170.95 14.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 54.119999999999997 110.857 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.605 HG12 ' HA ' ' A' ' 27' ' ' GLU . 15.6 m -55.57 133.02 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.24 4.04 41.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 54.310000000000002 112.478 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 113.91 27.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.522 HE22 HG23 ' A' ' 22' ' ' THR . 52.5 mt-30 -77.59 134.17 38.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.949 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -127.05 116.02 20.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 110.96 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 64' ' ' VAL . 28.7 m -118.4 -35.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 61.43 111.101 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HD3' HG23 ' A' ' 86' ' ' VAL . 4.0 tpp180 51.73 29.81 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.861 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.438 ' H ' HG23 ' A' ' 57' ' ' VAL . 75.1 t80 -135.9 148.66 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.25 110.874 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.67 107.71 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 55.009999999999998 111.103 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.6 -0.9 4.29 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 71.319999999999993 112.518 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HA ' HG21 ' A' ' 57' ' ' VAL . 3.2 m-85 60.39 39.09 19.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 73.010000000000005 110.914 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -134.41 149.69 50.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 111.175 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 57' ' ' VAL . 7.5 p -148.48 159.36 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 62.5 111.084 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.5 m -76.7 -73.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 75.400000000000006 111.106 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 65' ' ' THR . 1.6 pt-20 -171.65 -169.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.895 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.16 -36.19 60.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -58.41 -38.94 78.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 65.349999999999994 111.122 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -68.4 -34.52 76.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 44.109999999999999 111.14 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 74' ' ' VAL . 71.5 t80 -71.62 -32.63 68.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 75.049999999999997 110.866 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.835 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -38.59 68.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.107 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.62 -49.79 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 70.319999999999993 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.4 p -63.2 -39.72 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.118 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.736 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -60.21 -43.53 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 35.149999999999999 111.083 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -27.31 43.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.914 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -77.01 -27.69 54.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.409999999999997 110.853 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 74' ' ' VAL . 18.8 t -51.57 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -153.95 155.34 31.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.602 0.715 . . . . 71.040000000000006 110.868 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 120.97 7.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 62.0 112.332 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 p 52.43 39.51 27.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.120000000000005 110.87 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -100.96 108.06 19.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 54.420000000000002 111.122 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.599 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.9 OUTLIER -115.46 136.68 52.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 110.892 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.4 pt -151.57 155.19 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.648 0.737 . . . . 72.099999999999994 111.148 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 149.09 66.6 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 62.25 112.347 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.812 HG23 ' HD3' ' A' ' 58' ' ' ARG . 7.4 p -141.36 149.01 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 62.439999999999998 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 58' ' ' ARG . 2.7 p -96.43 112.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.009999999999998 111.117 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.93 157.9 26.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 61.539999999999999 110.847 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.37 140.98 46.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 mtm-85 -120.41 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 110.843 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.44 38.48 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.31 -15.48 57.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.505 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 90' ' ' ARG . 93.3 t -66.57 145.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 74.420000000000002 111.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.83 112.85 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 71.409999999999997 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.6 tpp -155.3 145.87 22.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 110.854 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.1 p -117.48 137.46 52.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.82 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.35 140.19 33.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.400000000000006 111.119 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -84.0 129.48 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.16 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HD21 ' A' ' 50' ' ' LEU . 3.7 mp -115.05 126.33 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 51.520000000000003 111.145 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 83' ' ' SER . 16.1 m -95.29 116.35 36.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 71.420000000000002 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.06 134.79 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.25 111.096 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.77 110.58 1.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 52.100000000000001 112.478 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -81.15 -26.61 35.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 50.020000000000003 110.881 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -128.63 63.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.299999999999997 110.856 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 75.030000000000001 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.168 0 CA-C-O 120.838 0.266 . . . . 64.099999999999994 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -161.8 153.9 19.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 110.908 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.6 t -129.84 154.51 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 54.210000000000001 111.155 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -89.14 160.5 42.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.882 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 78.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.420000000000002 112.313 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.24 130.8 53.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 60.25 110.877 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 67' ' ' LEU . 2.9 mm? -114.63 122.73 47.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.919 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.1 26.18 5.35 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.475 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' A' ' 7' ' ' LEU . 15.6 p90 -152.52 168.78 24.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 64.019999999999996 110.859 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -114.0 148.42 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 61.32 110.886 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 HD13 ' A' ' 25' ' ' ILE . 5.4 m -135.14 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 111.125 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.61 121.41 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.085 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.32 125.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 111.129 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.47 -150.19 5.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 73.109999999999999 112.497 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -132.79 142.87 49.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.08 -176.41 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 110.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -60.39 -26.75 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 110.843 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -65.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 110.888 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.92 58.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.736 . . . . 44.520000000000003 112.461 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -113.2 11.09 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.921 0.391 . . . . 64.099999999999994 110.921 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m 56.21 78.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 111.165 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -131.85 158.14 42.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.18 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB ' ' A' ' 11' ' ' VAL . 10.6 mp -101.45 149.85 23.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 51.240000000000002 110.873 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.64 133.69 55.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 75.549999999999997 110.82 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 56' ' ' LEU . 26.3 mm -88.74 131.33 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 74.099999999999994 111.115 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -23.66 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' ILE . 28.1 mm-40 -115.44 -169.02 1.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.856 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.39 132.63 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 61.5 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 30' ' ' GLN . 4.1 t -119.86 -11.85 9.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 111.152 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 50' ' ' LEU . 3.5 mp0 -85.06 4.01 36.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.88 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -111.73 17.99 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 45.32 111.155 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.36 146.8 46.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 110.87 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -160.8 160.5 31.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.156 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.29 -26.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 71.209999999999994 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -104.25 131.13 51.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 22.530000000000001 110.825 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 16.1 m-80 51.68 29.59 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.925 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.15 -67.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 63.140000000000001 112.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.44 80.36 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 72.219999999999999 112.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.65 74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 64.25 111.11 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.06 111.78 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.827 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.54 -168.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.769 ' HA ' HG22 ' A' ' 31' ' ' THR . 5.0 ttm -113.59 122.53 47.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 44.340000000000003 110.858 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.81 -76.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 42.130000000000003 112.447 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.43 30.83 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 71.140000000000001 112.329 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.46 -34.89 41.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 111.127 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -66.14 -20.25 66.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.35 59.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 44.32 111.076 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 99' ' ' ILE . . . -88.41 -22.87 23.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 53.409999999999997 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.62 15.51 37.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 43.409999999999997 112.476 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD11 HD13 ' A' ' 99' ' ' ILE . 1.3 mt -68.26 111.86 4.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.219999999999999 110.901 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.77 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.92 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -55.48 130.7 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 111.164 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.56 -38.91 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 71.450000000000003 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.32 150.18 49.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.736 0.303 . . . . 63.140000000000001 110.866 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -104.1 143.25 33.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 51.229999999999997 110.909 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 25' ' ' ILE . 5.5 mp -128.5 120.25 26.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.871 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 64' ' ' VAL . 14.9 m -118.37 -37.49 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 52.109999999999999 111.109 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.494 ' CG ' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.85 30.15 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.852 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -136.3 147.3 47.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.885 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.19 109.45 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 73.549999999999997 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.71 0.86 5.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 74.140000000000001 112.51 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.5 38.64 18.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.941 0.4 . . . . 65.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -133.03 149.05 52.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 52.310000000000002 111.131 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 57' ' ' VAL . 9.9 p -148.35 155.34 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 60.439999999999998 111.112 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -70.69 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 64.010000000000005 111.157 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -174.73 -169.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.893 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.842 HD13 HD21 ' A' ' 7' ' ' LEU . 4.2 pp -53.56 -37.16 62.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 70.230000000000004 110.952 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.39 -39.69 76.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 51.030000000000001 111.097 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.98 75.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.146 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -79.8 -14.54 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -45.39 91.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -73.29 -34.32 65.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 55.240000000000002 111.151 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.26 -48.93 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 60.130000000000003 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 3' ' ' THR . 12.0 p -66.05 -34.86 73.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.089 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.849 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -65.89 -41.85 91.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 70.439999999999998 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.95 -25.88 31.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.865 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -77.93 -48.05 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 110.86 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 78' ' ' VAL . 6.3 p -45.93 105.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 111.124 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.62 160.19 31.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 75.420000000000002 110.879 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 114.99 3.89 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.262 . . . . 73.530000000000001 112.304 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 53.05 39.9 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.32 110.858 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -104.78 120.43 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 61.119999999999997 111.074 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -108.13 131.59 54.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 51.200000000000003 110.873 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 83' ' ' SER . 49.0 mm -130.89 133.15 24.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.745 . . . . 73.319999999999993 111.12 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.77 110.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 73.209999999999994 112.358 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 99' ' ' ILE . 6.2 m -109.03 148.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.131 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.2 t -104.69 127.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 54.200000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -123.9 161.94 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.874 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.85 147.88 50.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.867 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 tmm_? -120.22 79.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.109999999999999 110.838 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.43 39.21 15.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.908 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.58 13.0 33.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 70.0 t -97.35 145.59 8.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 111.065 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.64 112.83 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 55.119999999999997 111.143 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 10.7 tpp -145.33 158.31 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.3 p -140.65 130.18 24.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.5 110.818 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 139.58 32.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 60.229999999999997 111.102 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.7 m -84.2 128.7 34.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.168 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HD11 ' A' ' 50' ' ' LEU . 14.6 mt -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 73.430000000000007 111.182 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -110.67 111.98 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.148 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.425 HG12 ' OE1' ' A' ' 103' ' ' GLU . 21.2 t -102.71 140.02 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.107 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.01 110.72 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 33.130000000000003 112.504 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -90.9 -36.26 14.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 62.140000000000001 110.907 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.93 144.07 30.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.95 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 71.349999999999994 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.829 0.262 . . . . 61.119999999999997 112.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -167.01 153.54 8.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.9 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.5 t -130.34 154.61 47.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.13 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -74.18 160.47 81.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.596 0.712 . . . . 73.239999999999995 110.875 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.02 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 73.129999999999995 112.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.17 127.74 51.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.943 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 18.0 tp -114.53 122.84 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 72.530000000000001 110.972 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.35 22.44 5.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.25 112.503 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' O ' HD11 ' A' ' 7' ' ' LEU . 4.2 p90 -155.8 165.02 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.24 152.43 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.853 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.11 135.41 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 54.420000000000002 111.117 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.84 121.65 41.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.219999999999999 111.08 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -80.21 127.82 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 61.439999999999998 111.084 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 -154.54 6.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.778 -0.725 . . . . 73.420000000000002 112.5 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -133.22 137.94 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.85 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -99.05 -176.03 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 t -59.22 -26.72 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.851 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -87.53 -41.92 13.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.882 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.11 53.93 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 72.450000000000003 112.504 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.6 m -113.67 10.0 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 74.310000000000002 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 m 59.61 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.119 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -130.47 173.73 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.119 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 66' ' ' GLU . 4.2 mp -129.62 121.06 26.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.873 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.5 144.51 27.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 110.819 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 27' ' ' GLU . 23.2 mm -92.55 132.95 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 72.239999999999995 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -106.29 -22.62 12.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 70.230000000000004 110.938 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -118.27 -169.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.92 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.36 122.49 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.171 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -118.4 -14.2 9.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 63.109999999999999 111.121 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.4 -10.6 59.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.4 p -96.96 16.57 19.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 62.399999999999999 111.126 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -122.34 149.71 43.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.924 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 103' ' ' GLU . 8.7 m -160.49 154.68 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 64.120000000000005 111.114 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -163.75 -36.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 54.0 112.439 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.13 148.66 27.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 63.32 110.824 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.46 29.16 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 110.876 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 174.14 -67.65 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.726 -0.749 . . . . 74.319999999999993 112.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.52 82.29 0.53 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 64.140000000000001 112.525 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.85 90.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 74.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.05 112.01 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.876 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.05 -164.08 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.894 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.541 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -112.49 112.13 23.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 110.895 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.21 -69.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 72.239999999999995 112.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -20.58 34.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.683 2.255 . . . . 61.109999999999999 112.345 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.89 -47.3 15.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 52.530000000000001 111.091 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -66.21 -23.06 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.854 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.12 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 54.229999999999997 111.124 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.852 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -99.6 -22.62 15.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 111.093 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.76 15.8 44.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 74.400000000000006 112.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -68.23 111.73 4.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.759 0.314 . . . . 61.200000000000003 110.908 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.92 178.09 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 70.239999999999995 110.866 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.56 129.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.430000000000007 111.109 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.28 -58.04 0.67 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 72.239999999999995 112.454 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -66.26 142.58 57.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.763 0.316 . . . . 71.129999999999995 110.882 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -99.72 139.38 35.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.917 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.14 121.8 45.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 110.912 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 63' ' ' THR . 3.8 p -119.79 -42.18 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 111.161 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.9 30.0 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 70.420000000000002 110.905 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 57' ' ' VAL . 80.2 t80 -141.96 147.37 36.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.099999999999994 110.864 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 104.83 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 111.125 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.74 -8.65 3.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 40.039999999999999 112.512 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 59.9 38.29 21.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 72.420000000000002 110.92 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.2 t -111.33 136.34 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 61.049999999999997 111.131 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.41 154.8 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.350000000000001 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 66' ' ' GLU . 86.7 m -99.02 -71.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 60.340000000000003 111.18 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.1 pt-20 -175.28 -172.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 110.903 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 7' ' ' LEU . 2.4 pp -54.79 -26.64 35.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 40.439999999999998 110.858 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.58 -43.74 84.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 111.065 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -65.78 -34.65 78.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 111.082 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -68.96 -33.99 74.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.879 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.32 -34.05 73.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 75.099999999999994 110.907 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -41.84 63.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.097 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 82.3 t -70.54 -48.12 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 61.450000000000003 111.11 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 78' ' ' VAL . 10.7 p -58.08 -34.39 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 53.049999999999997 111.126 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -60.86 -44.76 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 25.539999999999999 111.095 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -84.13 -20.78 31.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 61.539999999999999 110.855 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 99' ' ' ILE . 3.5 t60 -77.57 -48.43 16.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.219999999999999 110.904 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.5 m -47.52 109.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 74.340000000000003 111.147 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -155.03 160.72 30.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.704 2.269 . . . . 55.039999999999999 112.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 60.31 40.28 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.841 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.73 97.6 11.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 111.124 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 100' ' ' VAL . 31.5 m -90.42 114.1 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 31.210000000000001 110.846 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 85' ' ' PRO . 69.0 mt -134.64 133.3 21.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 55.350000000000001 111.106 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.0 Cg_endo -69.75 122.14 8.83 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.252 . . . . 75.400000000000006 112.336 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.7 t -114.84 145.09 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.156 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.1 t -89.79 125.0 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.134 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HZ ' HG21 ' A' ' 99' ' ' ILE . 91.1 m-85 -116.85 152.32 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.29 138.65 45.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.5 110.885 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 mtm180 -125.44 99.35 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.885 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 30.55 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.902 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.71 -10.4 59.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 42.109999999999999 112.47 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 90' ' ' ARG . 74.9 t -66.43 141.13 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 72.340000000000003 111.095 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.6 t -103.15 113.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 65.120000000000005 111.124 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -144.24 158.65 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.439999999999998 110.9 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 p -128.49 130.4 47.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.856 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.5 139.14 33.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 54.409999999999997 111.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -85.71 126.63 34.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.147 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.852 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.1 pp -114.84 126.13 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 70.319999999999993 111.133 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' OG ' ' A' ' 83' ' ' SER . 25.3 t -101.67 112.29 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.120000000000005 111.119 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.456 HG12 ' OE2' ' A' ' 103' ' ' GLU . 62.1 t -102.27 103.25 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.121 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.36 110.39 2.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 64.030000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HB3' HG21 ' A' ' 33' ' ' THR . 4.4 mp0 -88.23 -15.01 37.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.93 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.541 HD21 ' HA2' ' A' ' 37' ' ' GLY . 7.4 mt -142.61 95.41 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 61.409999999999997 110.91 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.889 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.817 0.257 . . . . 41.109999999999999 112.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 ' HE ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -179.36 154.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.942 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.74 HG22 ' CB ' ' A' ' 75' ' ' ALA . 6.9 t -129.69 167.09 18.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 62.539999999999999 111.195 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -81.89 160.5 63.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.89 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 54.32 112.36 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 133.83 53.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.209999999999994 110.88 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.54 128.74 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.95 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -126.9 32.08 3.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 44.020000000000003 112.513 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -158.84 169.51 24.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 110.855 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -114.05 151.21 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.828 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HD23 ' A' ' 23' ' ' LEU . 13.6 p -135.02 140.24 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.400000000000006 111.114 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.28 121.65 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 64.040000000000006 111.144 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.48 133.56 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.230000000000004 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.24 -155.77 8.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 63.299999999999997 112.469 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -132.76 145.38 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 62.210000000000001 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.07 -176.25 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 110.803 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -67.09 -26.75 66.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.876 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -61.73 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.22 54.03 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 72.420000000000002 112.492 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.19 11.05 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 43.140000000000001 110.905 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 m 51.57 87.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 111.146 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.6 157.12 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.21 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD23 HG21 ' A' ' 11' ' ' VAL . 8.3 mp -102.49 160.0 14.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 74.200000000000003 110.915 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -120.58 150.68 40.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.847 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 54' ' ' ASP . 10.4 tt -96.07 134.24 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -22.31 11.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.913 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -115.93 -168.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.895 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -114.41 124.39 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.510000000000005 111.125 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 t -119.1 -11.5 9.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.173 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.01 4.46 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.932 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 42' ' ' MET . 4.5 p -111.73 18.67 18.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.147 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -120.7 146.13 46.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 74.409999999999997 110.936 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -161.36 160.02 29.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 111.118 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.18 -32.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.219999999999999 112.537 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -105.37 135.81 46.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 74.340000000000003 110.851 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 50.58 29.43 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.420000000000002 110.9 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.42 -58.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 53.5 112.479 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.01 84.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 73.040000000000006 112.491 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.98 58.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 71.099999999999994 111.088 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -68.49 111.49 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.109999999999999 110.847 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -178.97 -166.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.916 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.6 mtt -113.31 113.06 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.876 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.22 -69.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 54.219999999999999 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -16.84 37.75 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.692 2.262 . . . . 70.040000000000006 112.339 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.51 -43.51 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 42.130000000000003 111.108 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.13 -17.61 64.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.25 110.857 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.45 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 111.082 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -95.41 -22.67 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 64.099999999999994 111.133 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.8 15.56 33.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 55.240000000000002 112.52 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -68.37 111.29 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.783 0.325 . . . . 54.210000000000001 110.922 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -143.15 178.25 7.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.889 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 27' ' ' GLU . 20.1 m -69.99 133.42 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.340000000000003 111.117 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.7 -17.86 8.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 51.219999999999999 112.479 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 25' ' ' ILE . 37.5 m-20 -95.89 122.65 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.776 0.322 . . . . 75.230000000000004 110.882 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.22 110.37 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.9 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 70' ' ' PHE . 4.4 mm? -76.06 111.06 11.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.891 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 63' ' ' THR . 96.7 t -110.81 -58.55 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 111.098 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 51.86 29.24 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.1 m-85 -142.87 144.55 32.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.049999999999997 110.889 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.37 107.37 4.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 62.32 111.079 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.58 -4.86 3.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 60.240000000000002 112.49 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.416 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.3 m-85 60.83 38.52 17.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.981 0.419 . . . . 71.239999999999995 110.927 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.659 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -122.15 157.0 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 52.310000000000002 111.157 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.5 t -142.47 155.04 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.13 -68.75 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.409999999999997 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.25 -178.03 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.902 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.4 pp -53.59 -29.77 39.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.944 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.545 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.1 -35.93 81.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.118 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.03 75.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.549999999999997 111.09 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 74' ' ' VAL . 70.1 t80 -82.44 -28.68 31.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.854 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -73.46 -40.38 64.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 110.889 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -66.1 -41.24 90.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.147 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.4 m -70.32 -40.09 77.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.030000000000001 111.138 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 78' ' ' VAL . 25.8 t -65.96 -41.13 89.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 52.310000000000002 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -56.68 -44.14 81.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 111.113 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 2' ' ' LEU . 1.2 mpt_? -79.25 -25.8 42.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.894 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.532 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.8 m80 -77.48 -27.63 52.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.849 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 74' ' ' VAL . 46.3 t -53.89 105.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 50.409999999999997 111.134 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -153.81 157.16 32.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.73 . . . . 64.049999999999997 110.857 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 110.43 2.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 64.230000000000004 112.364 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m 59.99 39.7 19.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 54.350000000000001 110.88 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.63 114.32 26.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 74.040000000000006 111.11 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.804 ' HB3' HG22 ' A' ' 100' ' ' VAL . 1.3 m -101.88 138.94 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 61.009999999999998 110.888 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' CD2' ' A' ' 77' ' ' HIS . 2.7 tp -151.54 131.64 7.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.654 0.74 . . . . 75.400000000000006 111.133 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 111.29 2.77 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.671 2.248 . . . . 65.409999999999997 112.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 t -102.46 148.77 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.141 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.3 t -102.53 130.29 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 111.135 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -123.34 151.51 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 71.140000000000001 110.873 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.97 147.48 50.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.831 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.6 mtt180 -138.86 98.93 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.849 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.81 30.48 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.901 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.21 -10.8 60.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 72.319999999999993 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 90' ' ' ARG . 69.6 t -66.27 143.58 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 73.540000000000006 111.16 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.83 113.04 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.164 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -138.89 159.01 43.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 63.340000000000003 110.866 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.7 p -139.96 130.06 25.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 54.109999999999999 110.832 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.18 139.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 75.340000000000003 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 m -84.5 124.54 31.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.119 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.967 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.5 pp -114.72 126.06 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 111.132 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 83' ' ' SER . 25.4 t -107.79 114.22 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.107 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.3 t -102.32 126.91 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 110.71 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 64.099999999999994 112.518 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' OE1' HG13 ' A' ' 78' ' ' VAL . 3.5 mp0 -91.28 -28.21 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 72.310000000000002 110.933 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -148.11 128.71 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 75.019999999999996 110.938 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.882 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 72.450000000000003 112.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.56 154.18 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.917 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 75' ' ' ALA . 3.7 t -129.62 167.33 18.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -92.98 160.41 33.77 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.587 0.708 . . . . 70.239999999999995 110.863 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 77.33 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 73.430000000000007 112.386 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.92 146.85 48.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.9 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.58 129.11 56.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.949 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.04 33.0 3.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.765 -0.731 . . . . 40.020000000000003 112.467 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -174.4 168.45 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 110.898 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -114.08 148.57 36.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 70.030000000000001 110.859 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.682 ' CG2' HD23 ' A' ' 23' ' ' LEU . 7.5 p -135.01 127.57 48.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 41.32 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 121.73 40.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.046 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.13 128.04 38.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.124 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.22 -159.6 9.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.723 . . . . 62.420000000000002 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.52 ' HD2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -133.03 137.17 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 73.239999999999995 110.881 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -99.02 178.17 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.861 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -55.23 -26.94 42.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 44.399999999999999 110.829 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -74.34 -42.53 59.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 63.32 110.901 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.31 43.49 5.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.74 . . . . 70.200000000000003 112.451 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.1 m -113.84 11.28 17.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.865 0.364 . . . . 72.450000000000003 110.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HD2' ' A' ' 15' ' ' ARG . 2.2 m 53.29 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 71.349999999999994 111.137 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.503 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.3 p -115.07 170.94 7.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.140000000000001 111.133 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG2' ' A' ' 11' ' ' VAL . 9.7 mp -122.53 122.28 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.886 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.09 139.2 30.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 27' ' ' GLU . 24.5 mm -95.19 130.85 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 62.210000000000001 111.139 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.77 -29.02 14.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 62.119999999999997 110.894 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -111.55 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.877 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.65 135.21 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 111.087 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 70' ' ' PHE . 3.7 t -111.49 -21.92 11.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.164 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -7.64 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.629 HG23 ' CB ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -99.3 17.76 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 55.100000000000001 111.132 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.54 145.42 47.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.949 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.66 162.74 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.182 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.32 -26.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.519999999999996 112.506 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' HG11 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -108.58 123.28 48.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 110.829 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m120 50.31 40.16 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 65.030000000000001 110.88 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.686 ' HA2' HD12 ' A' ' 104' ' ' LEU . . . -154.89 -75.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.513 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.54 -82.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 42.530000000000001 112.531 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.2 167.88 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.764 0.316 . . . . 63.229999999999997 111.114 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.46 131.61 45.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -169.9 1.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.906 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.55 129.91 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.924 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.0 -69.97 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 74.25 112.455 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -26.25 27.94 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.345 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.29 -46.77 82.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 51.32 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.55 -16.2 56.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 110.883 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 63.310000000000002 111.065 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -97.17 -22.36 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 111.095 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.24 15.22 14.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 60.240000000000002 112.478 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 99' ' ' ILE . 3.8 mm? -68.73 112.34 5.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 73.200000000000003 110.918 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 163.96 31.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.846 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.52 131.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 75.420000000000002 111.154 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.1 -44.4 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 51.329999999999998 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 75.109999999999999 110.893 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 110.902 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 56' ' ' LEU . 1.1 tt -119.27 117.1 27.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.963 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.707 HG12 ' CG2' ' A' ' 64' ' ' VAL . 13.2 m -117.96 -42.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.114 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.647 ' HG3' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 51.47 30.13 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.917 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -141.9 146.19 35.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.39 105.01 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.156 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.66 -1.46 4.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.209999999999994 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 60.03 38.69 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 110.971 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -118.54 148.59 42.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 65.230000000000004 111.137 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.707 ' CG2' HG12 ' A' ' 57' ' ' VAL . 15.0 t -145.01 154.83 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.124 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -68.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.102 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -179.94 -178.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 68' ' ' ALA . 4.1 pp -54.57 -27.02 35.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.049999999999997 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.68 -40.22 88.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 111.058 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -67.72 -34.54 77.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 61.219999999999999 111.09 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 74' ' ' VAL . 59.5 t80 -79.94 -31.77 40.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 110.89 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.86 -44.9 93.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 71.209999999999994 110.858 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -35.39 78.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 111.103 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 69' ' ' ALA . 99.1 t -69.86 -40.81 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.131 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 70' ' ' PHE . 78.5 t -58.07 -37.17 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.864 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.51 -43.93 97.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 53.240000000000002 111.086 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -79.38 -25.19 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.439999999999998 110.863 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -77.73 -38.26 47.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.809 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.3 t -54.1 106.3 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.143 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 2.5 mtt180 -155.31 155.76 30.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.611 0.72 . . . . 75.310000000000002 110.842 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 110.02 2.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.705 2.27 . . . . 53.130000000000003 112.372 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m 60.68 39.72 17.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.847 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -94.17 115.91 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.091 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.515 ' HB3' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -105.18 121.41 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.229999999999997 110.908 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 99' ' ' ILE . 2.2 pp -129.37 145.01 55.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.209999999999994 111.161 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.82 58.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.739 2.292 . . . . 64.329999999999998 112.304 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 58' ' ' ARG . 1.7 p -141.36 149.24 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 61.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.46 125.95 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 54.409999999999997 111.093 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 21.1 m-85 -113.24 157.95 21.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.925 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -136.94 147.4 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.83 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 mtp180 -134.79 86.46 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.530000000000001 110.915 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.13 38.83 13.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.853 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.71 -9.74 57.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 44.5 112.491 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.3 t -70.22 143.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 74.340000000000003 111.144 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.33 117.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.08 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.3 mtm -141.89 164.36 30.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.85 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.5 p -140.93 130.07 23.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 51.340000000000003 110.848 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 86' ' ' VAL . . . -142.1 141.3 32.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 111.118 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 m -83.34 128.68 34.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 51.119999999999997 111.173 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.676 HG22 ' HB1' ' A' ' 48' ' ' ALA . 13.7 pt -110.09 126.8 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 111.079 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 83' ' ' SER . 3.2 m -112.44 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.299999999999997 111.181 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.98 125.49 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.143 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.27 109.24 3.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 35.340000000000003 112.514 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.515 ' OE2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -93.56 -36.65 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 72.310000000000002 110.855 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.686 HD12 ' HA2' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -151.1 140.47 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 71.310000000000002 110.911 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.858 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.811 0.254 . . . . 50.43 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tp -149.06 153.02 37.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.905 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.888 HG22 ' HB2' ' A' ' 75' ' ' ALA . 13.0 t -130.67 167.21 19.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.158 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -94.23 160.42 32.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.73 . . . . 64.530000000000001 110.887 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 76.22 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.692 2.261 . . . . 73.219999999999999 112.325 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -124.12 126.79 46.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.906 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 122.98 48.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.430000000000007 110.908 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.18 30.8 4.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 62.329999999999998 112.443 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -147.22 173.32 12.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 74.120000000000005 110.893 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -113.98 138.72 49.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.905 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 23' ' ' LEU . 10.6 p -135.12 135.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.153 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.58 121.89 36.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 60.140000000000001 111.101 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.73 135.91 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 61.520000000000003 111.109 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.58 -158.44 12.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.717 -0.754 . . . . 24.34 112.472 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.18 141.0 51.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 74.420000000000002 110.85 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -98.93 -178.46 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.87 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -26.66 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 73.299999999999997 110.849 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.9 t -79.76 -69.14 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.893 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 46.62 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 33.240000000000002 112.498 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.59 11.11 26.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.883 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 m 51.81 85.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 111.118 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.78 157.38 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.420000000000002 111.168 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' CG2' ' A' ' 11' ' ' VAL . 8.1 mp -101.89 155.58 18.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.936 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 t -118.95 140.7 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 60.43 110.857 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.611 HG13 HD21 ' A' ' 56' ' ' LEU . 17.2 mm -95.89 133.12 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 65.219999999999999 111.142 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -96.61 -24.72 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 110.876 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -119.31 -169.13 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.888 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' NE2' ' A' ' 30' ' ' GLN . 5.0 m -118.74 127.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 70.430000000000007 111.12 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 t -118.53 2.81 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 111.212 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' HG12 ' A' ' 28' ' ' VAL . 5.7 pm0 -87.0 6.12 33.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.953 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.6 16.81 20.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.169 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.01 146.87 46.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.319999999999993 110.937 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 103' ' ' GLU . 14.5 m -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 73.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -36.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -106.16 144.08 33.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 110.889 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.86 29.73 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 71.450000000000003 110.893 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.43 -67.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.200000000000003 112.506 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.98 81.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 53.020000000000003 112.479 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.6 90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 73.340000000000003 111.082 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.62 115.56 23.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.853 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.69 -165.83 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.924 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.774 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.1 mpp? -112.85 121.87 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 110.891 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.17 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 74.129999999999995 112.513 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -10.52 28.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 65.109999999999999 112.379 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.89 -47.57 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 61.32 111.115 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.57 -23.83 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.239999999999995 110.858 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.16 61.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.100000000000001 111.105 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.74 -22.88 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.088 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.21 16.16 41.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.721 . . . . 74.209999999999994 112.482 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' HG3' ' A' ' 30' ' ' GLN . 6.2 mt -68.33 112.82 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 53.119999999999997 110.907 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 156.98 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.881 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -56.48 132.87 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 74.040000000000006 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.52 -33.42 3.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 40.439999999999998 112.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.07 154.42 20.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.307 . . . . 73.439999999999998 110.889 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.47 147.58 26.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.903 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD12 HH21 ' A' ' 58' ' ' ARG . 0.0 OUTLIER -128.89 124.95 36.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 74.019999999999996 110.954 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.744 HG12 ' CG2' ' A' ' 64' ' ' VAL . 27.4 m -115.22 -36.62 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 111.122 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.621 HH21 HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER 51.31 27.77 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.91 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 57' ' ' VAL . 86.7 t80 -144.19 148.54 35.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.905 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.18 104.71 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 53.039999999999999 111.133 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -6.94 2.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 72.109999999999999 112.449 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.532 ' HA ' HG21 ' A' ' 57' ' ' VAL . 4.1 m-85 61.0 39.38 16.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 75.340000000000003 110.952 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -124.49 156.94 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 75.439999999999998 111.106 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.744 ' CG2' HG12 ' A' ' 57' ' ' VAL . 14.3 t -138.28 155.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 111.086 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 111.191 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -179.81 176.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.853 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.1 pp -54.4 -26.57 31.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 55.43 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -64.86 -43.71 92.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 111.052 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.6 77.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 111.057 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 73' ' ' VAL . 17.6 t80 -61.21 -21.81 64.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.916 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -72.59 -33.35 66.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 110.865 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -42.74 59.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 61.530000000000001 111.15 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 70' ' ' PHE . 27.4 m -70.74 -43.04 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 53.520000000000003 111.14 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.3 p -64.71 -34.76 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.125 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.42 -43.74 98.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 62.240000000000002 111.095 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -82.53 -21.69 35.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -77.83 -50.15 12.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.897 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.9 m -47.33 104.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.229999999999997 111.172 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.05 160.05 31.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 110.892 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 103.28 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.340000000000003 112.364 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 40.16 18.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 55.409999999999997 110.862 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.94 102.9 12.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 44.140000000000001 111.1 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -88.88 106.15 18.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 110.898 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 85' ' ' PRO . 3.3 mt -128.46 133.24 24.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 63.549999999999997 111.119 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.9 Cg_endo -69.82 124.72 11.33 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 63.229999999999997 112.318 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG13 ' HG2' ' A' ' 58' ' ' ARG . 83.9 t -113.17 145.06 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.138 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.63 122.52 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 111.127 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.73 154.64 29.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 110.883 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.98 147.88 52.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 62.539999999999999 110.9 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.93 82.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 62.43 110.841 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 61.24 38.39 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.530000000000001 110.817 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.54 12.76 37.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.769 -0.729 . . . . 63.130000000000003 112.521 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 90' ' ' ARG . 62.6 t -94.99 143.2 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.387 . . . . 62.25 111.107 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.54 112.84 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 63.329999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 ttp -143.33 148.38 36.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.902 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 p -119.99 130.21 54.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.140000000000001 110.885 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.66 139.18 32.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 72.010000000000005 111.098 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -85.6 124.35 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 71.0 111.127 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 59.0 mt -114.73 125.66 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 61.310000000000002 111.131 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -107.74 111.93 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.168 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.489 HG12 ' OE1' ' A' ' 103' ' ' GLU . 93.3 t -102.97 114.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.138 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.27 110.79 2.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.32 112.512 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 33' ' ' THR . 1.9 mm-40 -80.92 -20.69 41.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 54.140000000000001 110.879 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.5 mm? -120.59 68.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.947 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.530000000000001 110.876 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.788 0.245 . . . . 73.129999999999995 112.401 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -158.14 167.61 29.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 63.5 110.92 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.978 HG22 ' HB2' ' A' ' 75' ' ' ALA . 10.2 t -129.87 167.79 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 64.540000000000006 111.163 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -49.61 157.44 0.98 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 53.210000000000001 110.844 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -48.82 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 51.039999999999999 112.338 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.63 152.76 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.451 . . . . 64.150000000000006 110.926 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.623 ' CD2' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -92.84 141.78 28.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 110.937 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.01 44.27 1.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.74 . . . . 42.210000000000001 112.505 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -156.77 159.91 38.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 71.349999999999994 110.912 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -113.9 148.6 36.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 64.219999999999999 110.893 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 67' ' ' LEU . 15.1 m -135.45 131.23 51.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 111.131 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.14 121.48 45.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 111.072 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.45 124.77 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 111.124 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.95 -158.13 8.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 43.509999999999998 112.503 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -132.99 128.18 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 64.310000000000002 110.856 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -85.03 178.87 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.813 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 m -55.24 -26.76 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.866 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 t -76.01 -42.14 48.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.25 110.829 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.33 43.84 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.479 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.57 11.0 18.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.935 0.398 . . . . 74.140000000000001 110.917 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m 58.1 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 111.153 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 23' ' ' LEU . 7.3 p -125.51 170.28 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.134 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 22' ' ' THR . 10.8 mp -125.54 124.68 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.909 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -91.22 144.9 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' ASP . 12.1 tt -96.14 134.75 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 111.143 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -109.2 -15.06 14.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.888 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.81 -167.01 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 120.92 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 63.020000000000003 111.14 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 70' ' ' PHE . 2.0 t -115.0 -11.73 12.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.167 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.94 8.86 24.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 64.25 110.92 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 42' ' ' MET . 2.1 p -111.83 17.95 19.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.159 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -121.5 147.98 45.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.931 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 34' ' ' GLY . 3.8 m -160.57 159.87 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 65.400000000000006 111.146 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 33' ' ' THR . . . -175.22 -31.27 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 74.299999999999997 112.492 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.28 129.82 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 61.219999999999999 110.826 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 52.92 28.68 6.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 65.319999999999993 110.902 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 -56.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.734 . . . . 62.130000000000003 112.522 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.62 83.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 54.009999999999998 112.496 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.94 60.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 41.25 111.109 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.35 111.29 4.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 75.299999999999997 110.895 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -165.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.350000000000001 110.925 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.726 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.9 OUTLIER -112.5 117.8 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.929 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.37 -69.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 65.129999999999995 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -25.01 28.8 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.685 2.256 . . . . 43.530000000000001 112.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.64 -47.43 19.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 40.43 111.051 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.44 -26.63 63.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.450000000000003 110.855 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.83 -35.04 64.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.712 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -79.82 -22.55 42.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 52.149999999999999 111.116 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.0 15.48 19.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 60.039999999999999 112.484 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 99' ' ' ILE . 4.0 mt -83.42 111.25 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 74.140000000000001 110.922 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.17 161.87 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 71.040000000000006 110.869 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 52' ' ' VAL . 16.8 m -55.76 118.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 111.128 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.22 -14.77 8.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 m-20 -93.25 143.98 25.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 74.329999999999998 110.84 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -93.62 141.22 28.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.911 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 117.28 17.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.942 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.2 p -120.0 -37.08 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 61.200000000000003 111.137 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.534 ' CG ' HG13 ' A' ' 86' ' ' VAL . 2.4 tmm_? 51.23 30.17 5.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.898 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.632 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.4 m-85 -141.99 147.67 37.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.902 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.06 104.86 5.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.230000000000004 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.76 -5.1 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 74.409999999999997 112.469 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' HA ' HG11 ' A' ' 57' ' ' VAL . 3.3 m-85 58.69 38.82 24.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 74.209999999999994 110.916 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 t -113.37 127.17 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.25 111.165 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 23' ' ' LEU . 15.6 t -122.91 154.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 63.219999999999999 111.096 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -69.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 111.1 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -179.69 175.26 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.893 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 11' ' ' VAL . 3.2 pp -55.07 -26.39 37.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 63.210000000000001 110.937 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.8 -43.81 82.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 43.32 111.084 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.62 76.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 111.098 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 29' ' ' THR . 89.8 t80 -68.85 -33.3 73.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 60.399999999999999 110.893 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.51 81.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.856 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -35.41 65.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 111.126 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.92 -49.3 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 74.129999999999995 111.147 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 78' ' ' VAL . 12.2 p -57.95 -35.82 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 52.32 111.136 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.978 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.33 -44.52 97.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 111.048 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.06 -21.86 36.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.841 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -77.26 -52.61 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 110.855 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 74' ' ' VAL . 15.8 m -49.28 113.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.030000000000001 111.162 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -152.46 160.42 31.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.65 0.738 . . . . 65.140000000000001 110.833 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HB3' HD12 ' A' ' 104' ' ' LEU . 53.7 Cg_endo -69.71 108.44 2.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 71.239999999999995 112.361 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.07 39.95 19.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 60.130000000000003 110.86 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.5 109.14 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 74.109999999999999 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.0 124.46 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.88 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 85' ' ' PRO . 5.2 mp -135.72 132.97 19.79 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 52.409999999999997 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 84' ' ' ILE . 54.5 Cg_endo -69.72 122.4 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 35.130000000000003 112.368 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG13 ' CG ' ' A' ' 58' ' ' ARG . 96.1 t -118.93 144.75 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 72.109999999999999 111.174 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 57' ' ' VAL . 4.0 p -95.55 126.87 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.107 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 50' ' ' LEU . 3.3 m-85 -117.14 159.57 22.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.907 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.66 147.94 52.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 110.827 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -125.23 82.83 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.89 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.56 38.55 15.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 73.040000000000006 110.846 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.17 7.81 48.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.736 . . . . 73.140000000000001 112.489 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 90' ' ' ARG . 64.8 t -89.81 143.98 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 64.420000000000002 111.107 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.25 112.78 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 62.310000000000002 111.137 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.59 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.852 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.6 p -127.28 130.35 49.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.811 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.63 139.61 33.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 32.310000000000002 111.106 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.1 m -83.95 129.91 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 111.188 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.712 HG23 ' CB ' ' A' ' 48' ' ' ALA . 35.1 mt -110.28 125.95 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.049999999999997 111.096 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 100' ' ' VAL . 8.9 m -106.97 112.13 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.108 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.9 125.88 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.083 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.08 109.48 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 55.310000000000002 112.475 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.13 -35.89 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 74.230000000000004 110.914 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 80' ' ' PRO . 5.0 mt -137.43 74.68 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.921 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 110.916 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 78' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.798 0.249 . . . . 62.32 112.348 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -154.5 167.4 30.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 61.520000000000003 110.912 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.989 HG22 ' HB2' ' A' ' 75' ' ' ALA . 8.8 t -126.76 167.3 15.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.131 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -50.67 159.1 0.96 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.74 . . . . 72.140000000000001 110.849 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.64 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.140000000000001 112.374 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -103.9 152.78 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.902 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -86.37 141.94 28.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 70.530000000000001 110.915 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.43 44.37 1.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 53.420000000000002 112.471 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -158.54 158.52 34.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.886 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -114.03 145.37 41.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.150000000000006 110.844 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.968 HG22 HD23 ' A' ' 67' ' ' LEU . 25.4 m -135.36 133.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.82 121.38 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 111.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.8 135.23 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 111.142 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.95 -153.66 6.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 74.010000000000005 112.456 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.12 130.25 39.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 110.871 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.05 -175.34 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 62.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 t -68.75 -26.8 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.906 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 t -80.7 -46.02 16.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 70.209999999999994 110.864 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.12 43.77 3.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.517 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.63 11.03 18.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 72.420000000000002 110.869 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.9 m 57.86 95.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.118 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.622 ' C ' HD12 ' A' ' 23' ' ' LEU . 11.3 p -112.76 165.39 12.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.155 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.653 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.0 mp -131.8 121.88 24.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.897 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 135.08 33.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 55.409999999999997 110.89 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 56' ' ' LEU . 5.2 mm -96.29 133.34 37.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.340000000000003 111.139 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.3 -27.25 18.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.918 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 -168.55 1.92 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.919 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.39 135.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 111.096 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -118.6 -2.86 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 111.156 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' HB2' HD13 ' A' ' 50' ' ' LEU . 12.3 mt-30 -90.42 11.85 20.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.924 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.62 16.68 20.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.133 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -122.58 156.67 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.420000000000002 110.911 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 160.82 31.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 111.137 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.54 -33.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 61.450000000000003 112.526 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.01 124.38 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.384 . . . . 64.219999999999999 110.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.508 ' O ' HD22 ' A' ' 104' ' ' LEU . 1.5 t-20 61.67 39.13 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 55.130000000000003 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 174.18 -73.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.505 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.01 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 64.5 112.503 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.59 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.133 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 111.55 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.869 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.3 -165.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.906 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.05 119.02 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.896 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.9 -68.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 63.310000000000002 112.498 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -8.13 22.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.697 2.264 . . . . 74.400000000000006 112.343 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 50' ' ' LEU . . . -65.7 -47.83 74.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.25 111.061 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.55 -18.23 62.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.869 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 -37.26 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.099999999999994 111.09 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -94.53 -22.74 18.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.076 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.37 10.46 60.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.5 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 30' ' ' GLN . 1.2 pp -68.48 111.93 4.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 63.109999999999999 110.935 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.86 159.25 42.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.873 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 m -55.75 132.75 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 72.200000000000003 111.15 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.84 -49.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 72.409999999999997 112.481 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.41 145.75 55.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.883 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -97.66 110.27 22.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 62.030000000000001 110.922 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 25' ' ' ILE . 2.9 pp -80.96 119.11 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.936 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 87' ' ' VAL . 38.9 t -109.09 -58.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.151 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 59.26 29.96 19.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.828 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 57' ' ' VAL . 34.2 m-85 -138.87 147.46 42.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 63.350000000000001 110.873 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.47 108.26 6.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.129 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.07 3.15 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 64.129999999999995 112.461 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 60.09 38.27 20.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 71.549999999999997 110.904 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 t -130.13 129.7 43.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.019999999999996 111.137 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.653 ' CG1' HD13 ' A' ' 23' ' ' LEU . 4.7 p -119.47 155.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 111.16 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -73.4 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.163 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -179.27 -176.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 43.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.968 HD23 HG22 ' A' ' 11' ' ' VAL . 4.0 pp -64.31 -28.75 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 70.030000000000001 110.914 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -66.67 -43.93 83.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 111.166 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.67 75.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.053 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.669 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.6 t80 -70.34 -26.11 63.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 62.109999999999999 110.925 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -43.86 92.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.229999999999997 110.935 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -35.2 70.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 63.549999999999997 111.199 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.84 -41.65 79.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 111.125 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 70' ' ' PHE . 75.4 t -58.65 -37.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 44.119999999999997 111.096 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.989 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.77 -43.93 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 71.040000000000006 111.09 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.57 -20.99 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 64.299999999999997 110.858 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -78.18 -51.7 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.858 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 74' ' ' VAL . 12.3 m -47.34 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.132 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -147.07 160.63 39.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.691 . . . . 74.420000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 104.79 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.655 2.237 . . . . 73.140000000000001 112.361 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m 60.0 40.52 18.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 110.881 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.6 117.65 26.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 71.519999999999996 111.118 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -113.48 125.8 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 73.219999999999999 110.864 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -144.21 152.4 54.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.607 0.718 . . . . 71.409999999999997 111.173 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 140.9 43.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.369 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.32 148.69 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.15 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 p -107.9 131.85 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.141 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.88 149.36 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.915 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.68 147.55 52.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 61.43 110.886 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -132.1 88.81 2.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.862 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.48 38.72 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.549999999999997 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.34 -13.34 58.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 65.010000000000005 112.464 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 90' ' ' ARG . 76.8 t -66.42 143.0 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 53.299999999999997 111.159 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.48 113.06 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.5 tpp -143.96 155.78 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.862 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.5 p -119.39 130.48 55.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 110.873 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.53 139.58 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 111.15 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 133.93 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 75.530000000000001 111.122 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 HE22 ' A' ' 30' ' ' GLN . 18.2 mm -114.78 118.15 57.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 65.010000000000005 111.096 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 83' ' ' SER . 21.7 t -118.24 111.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 72.510000000000005 111.15 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.55 153.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.1 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.99 110.48 1.1 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 41.549999999999997 112.501 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -77.14 -37.62 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 72.25 110.856 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.587 HD13 ' HA2' ' A' ' 37' ' ' GLY . 2.3 pt? -178.7 173.04 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 110.96 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 73.549999999999997 110.877 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.813 0.255 . . . . 71.439999999999998 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -167.5 154.0 8.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.873 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.702 HG22 ' CB ' ' A' ' 75' ' ' ALA . 7.6 t -129.67 167.07 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.145 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.55 155.25 62.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.599 0.714 . . . . 73.099999999999994 110.895 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 78.29 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.334 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.73 132.24 53.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 110.899 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.62 135.58 53.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.902 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.2 18.6 5.82 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.751 . . . . 34.32 112.479 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' HD2' HG23 ' A' ' 25' ' ' ILE . 5.7 p90 -149.9 172.32 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.109999999999999 110.917 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.22 24.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -135.07 140.16 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.86 121.69 36.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 45.210000000000001 111.094 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -80.19 134.91 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.21 -159.44 11.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 70.109999999999999 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -129.75 145.37 51.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 62.240000000000002 110.877 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.06 -175.07 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.824 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 t -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.804 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -85.35 -49.42 8.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.889 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.18 58.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.692 -0.766 . . . . 44.310000000000002 112.492 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -113.27 -6.65 13.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.86 0.362 . . . . 62.310000000000002 110.901 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.58 90.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 53.350000000000001 111.162 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 HE22 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -142.1 150.92 41.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 55.420000000000002 111.132 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 23' ' ' LEU . 6.4 mp -94.32 159.89 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 148.95 42.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.858 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.508 ' CG1' HD23 ' A' ' 56' ' ' LEU . 3.8 mp -93.68 131.61 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 74.030000000000001 111.129 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -106.24 -21.68 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.904 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -169.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 71.010000000000005 110.879 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.27 120.25 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 63.210000000000001 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.515 HG21 ' CE1' ' A' ' 70' ' ' PHE . 4.3 t -120.93 -9.51 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 50.030000000000001 111.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.759 ' CD ' HD13 ' A' ' 50' ' ' LEU . 13.5 mm-40 -81.83 0.81 37.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.1 p -111.71 18.6 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.127 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -121.24 147.14 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -152.5 155.73 38.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 71.409999999999997 111.142 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.99 -35.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 42.420000000000002 112.508 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.62 150.72 25.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 54.350000000000001 110.863 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HD21 ' A' ' 104' ' ' LEU . 0.7 OUTLIER 52.95 31.96 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 73.010000000000005 110.913 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 172.93 -69.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 74.230000000000004 112.482 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.82 78.4 0.73 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 44.210000000000001 112.499 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.94 92.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 55.039999999999999 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.77 116.23 22.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.845 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.93 -168.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 73.329999999999998 110.93 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.776 ' HA ' HG22 ' A' ' 31' ' ' THR . 43.2 ttm -113.49 123.8 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.839 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.2 -70.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 32.409999999999997 112.522 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -35.36 12.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.718 2.279 . . . . 74.219999999999999 112.306 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 111.109 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.32 -26.05 67.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.450000000000003 110.88 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.78 -38.41 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.126 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB1' HG13 ' A' ' 99' ' ' ILE . . . -83.58 -22.6 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 111.086 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.41 15.78 49.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 71.219999999999999 112.526 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD12 ' HA ' ' A' ' 45' ' ' ALA . 3.5 mt -68.32 110.97 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 52.140000000000001 110.899 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 177.94 8.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.896 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.12 132.63 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 111.136 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.13 -54.72 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 23.530000000000001 112.466 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.4 m-20 -66.15 154.76 38.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.775 0.321 . . . . 73.319999999999993 110.864 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.506 HE22 HG23 ' A' ' 22' ' ' THR . 31.5 mt-30 -105.94 131.15 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.049999999999997 110.882 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' CG1' ' A' ' 25' ' ' ILE . 3.3 pp -92.06 126.52 37.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 110.925 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.1 t -120.28 -57.18 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 111.143 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HG3' HG13 ' A' ' 86' ' ' VAL . 0.3 OUTLIER 51.8 28.92 5.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.819 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 26.3 m-85 -143.06 147.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.898 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.84 104.89 4.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 44.200000000000003 111.096 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.35 -6.33 3.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 70.099999999999994 112.482 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' HA ' HG11 ' A' ' 57' ' ' VAL . 2.7 m-85 60.35 38.73 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.944 0.402 . . . . 71.019999999999996 110.958 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -118.99 156.86 28.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.200000000000003 111.131 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 57' ' ' VAL . 14.3 t -144.72 154.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 66' ' ' GLU . 96.8 m -102.08 -73.93 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.349999999999994 111.129 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 65' ' ' THR . 3.6 pt-20 -166.24 -171.67 2.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 75.430000000000007 110.898 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -30.39 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.906 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.79 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 60.25 111.117 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' A' ' 65' ' ' THR . . . -60.38 -33.35 72.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 51.329999999999998 111.06 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.515 ' CE1' HG21 ' A' ' 29' ' ' THR . 40.0 t80 -81.99 -29.28 32.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 110.86 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 74' ' ' VAL . 36.3 t-20 -74.21 -34.57 63.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.319999999999993 110.899 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -73.59 -39.72 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 111.153 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 74' ' ' VAL . 27.6 m -71.48 -41.94 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 111.141 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.8 p -67.96 -36.29 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 72.25 111.159 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.702 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.97 -43.36 86.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.059 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.74 -26.84 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.319999999999993 110.863 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -77.68 -27.54 50.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 74' ' ' VAL . 40.3 t -52.77 101.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.87 159.08 32.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.873 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.273 . . . . 61.350000000000001 112.354 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 t 60.21 39.68 18.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.91 102.85 15.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 62.409999999999997 111.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -91.92 120.97 33.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.85 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 83' ' ' SER . 43.4 mm -136.26 133.09 19.27 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 65.319999999999993 111.126 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.8 Cg_endo -69.81 120.59 7.34 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.338 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 99' ' ' ILE . 21.4 t -114.18 148.83 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 111.175 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.03 127.91 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 73.109999999999999 111.133 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -118.71 153.34 34.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.907 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.84 147.54 51.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 64.049999999999997 110.813 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 mtm180 -131.93 89.65 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 73.040000000000006 110.832 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 61.13 38.61 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.854 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.33 58.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 72.329999999999998 112.507 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 90' ' ' ARG . 58.1 t -66.38 142.2 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 72.299999999999997 111.161 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.11 113.29 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.0 tpp -143.44 158.63 43.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 64.200000000000003 110.854 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.7 p -131.49 130.42 42.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 99' ' ' ILE . . . -141.61 139.28 33.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 55.140000000000001 111.121 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -84.42 124.1 30.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 75.230000000000004 111.152 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.725 HG12 HD21 ' A' ' 50' ' ' LEU . 5.2 mp -114.96 125.94 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 72.150000000000006 111.084 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.7 p -108.69 114.57 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.0 111.128 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -102.56 113.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.010000000000005 111.1 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.5 110.48 2.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 64.299999999999997 112.486 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.542 ' HB2' HD22 ' A' ' 104' ' ' LEU . 3.1 mp0 -77.37 -35.63 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 73.120000000000005 110.894 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.616 HD21 ' HA2' ' A' ' 37' ' ' GLY . 2.1 mm? -115.32 51.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 110.895 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.886 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.815 0.256 . . . . 55.409999999999997 112.353 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.689 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -153.89 167.5 29.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 110.891 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.9 t -122.18 167.63 12.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.240000000000002 111.084 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -50.99 157.62 1.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 75.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -44.85 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 71.099999999999994 112.351 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -85.59 152.76 22.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.92 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.651 HD12 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -85.61 141.81 29.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 110.947 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -112.16 39.57 2.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.030000000000001 112.458 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CE2' HD12 ' A' ' 7' ' ' LEU . 23.5 p90 -174.49 164.6 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 60.039999999999999 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -121.64 151.94 39.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.409999999999997 110.854 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.9 145.86 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.030000000000001 111.123 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.98 124.48 44.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.85 127.02 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 61.399999999999999 111.132 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.29 -154.66 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 64.010000000000005 112.47 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 143.37 49.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 71.150000000000006 110.874 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.52 -176.63 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.400000000000006 110.864 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -56.35 -25.62 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 110.859 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -89.14 -54.29 4.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 61.340000000000003 110.846 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.7 61.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 50.240000000000002 112.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 m -113.15 11.12 18.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.884 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m 56.18 84.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.5 111.144 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.27 156.57 45.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 111.157 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 66' ' ' GLU . 5.9 mp -99.85 140.09 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 51.130000000000003 110.891 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -98.0 147.9 24.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 tp -88.91 134.83 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 111.156 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -24.58 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.924 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -126.71 -168.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.049999999999997 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.19 135.98 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 7.6 t -120.43 -9.54 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 65.25 111.117 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.642 ' NE2' HD22 ' A' ' 50' ' ' LEU . 2.2 mp0 -91.08 13.72 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 72.430000000000007 110.917 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.2 p -111.92 16.8 20.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 111.15 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -122.11 145.85 47.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 110.948 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 m -161.82 145.89 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 54.32 111.163 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -158.75 -36.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 43.409999999999997 112.457 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.67 143.2 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.140000000000001 110.876 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.3 29.93 18.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.863 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . 173.36 -67.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 73.0 112.467 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 76.17 85.61 0.38 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 73.150000000000006 112.557 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.33 78.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 74.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -81.74 112.24 18.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.862 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.95 -166.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.927 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.799 ' HA ' HG22 ' A' ' 31' ' ' THR . 1.8 ttm -113.26 127.55 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.87 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.05 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 74.140000000000001 112.505 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -22.0 32.74 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.269 . . . . 63.5 112.349 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -64.23 -47.47 79.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 111.095 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -10.93 59.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 110.886 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.36 -36.24 83.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 61.210000000000001 111.051 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.661 ' CB ' HG23 ' A' ' 99' ' ' ILE . . . -96.52 -22.57 17.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 75.420000000000002 111.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.26 13.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 71.340000000000003 112.487 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -67.79 112.13 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 63.119999999999997 110.915 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 157.43 44.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.885 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.6 m -55.44 132.73 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 111.165 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.79 5.44 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 75.140000000000001 112.521 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -96.13 121.97 38.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 73.340000000000003 110.869 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -73.05 118.66 16.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 75.310000000000002 110.939 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.06 109.15 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.887 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 59' ' ' PHE . 86.3 t -103.04 -56.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.112 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.695 ' HD2' HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 52.63 28.61 6.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.894 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.621 ' H ' HG12 ' A' ' 57' ' ' VAL . 24.5 m-85 -143.3 145.33 32.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.892 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.35 105.41 4.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.22 -4.26 3.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.677 -0.773 . . . . 55.039999999999999 112.507 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.4 m-85 60.79 38.51 18.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 62.439999999999998 110.933 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 t -121.29 153.51 37.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 64.340000000000003 111.119 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 57' ' ' VAL . 10.9 t -143.54 155.17 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -99.83 -64.66 1.02 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 65.450000000000003 111.179 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 23' ' ' LEU . 8.7 pt-20 -178.27 -176.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.3 pp -53.71 -31.68 49.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 110.886 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.31 -40.27 96.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.109 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.6 78.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.519999999999996 111.078 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 74' ' ' VAL . 46.9 t80 -77.97 -34.05 51.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 110.851 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.02 -35.02 74.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.935 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.98 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 52.219999999999999 111.162 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.73 -50.22 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 111.115 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.759 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -59.37 -39.27 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 60.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -58.95 -43.75 91.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 25.199999999999999 111.113 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.42 -26.42 41.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 70.329999999999998 110.911 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -77.12 -27.54 54.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.130000000000003 110.83 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 74' ' ' VAL . 31.1 t -52.56 101.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 62.299999999999997 111.116 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 5.1 mtt180 -153.25 158.8 32.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.64 0.733 . . . . 71.510000000000005 110.882 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 73.019999999999996 112.346 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 60.04 39.63 19.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 53.329999999999998 110.899 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -87.53 105.04 17.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 55.32 111.046 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.55 114.69 29.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.876 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.2 pp -129.16 158.81 71.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 111.123 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.44 45.24 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.689 2.259 . . . . 73.200000000000003 112.358 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG13 ' HD2' ' A' ' 58' ' ' ARG . 63.7 t -141.49 145.23 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.167 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.3 t -109.32 120.14 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 111.097 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -119.46 156.16 30.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 72.299999999999997 110.901 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.6 p -123.42 148.61 45.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -121.19 77.75 1.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.519999999999996 110.871 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.03 39.7 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.914 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.22 31.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 60.039999999999999 112.464 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ARG . 97.8 t -99.78 146.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 111.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.79 112.44 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 111.121 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.4 tpp -146.35 146.09 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 110.855 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.6 p -116.01 130.17 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 52.420000000000002 110.823 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.55 140.11 33.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.099 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.57 125.5 31.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.172 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 50' ' ' LEU . 28.1 mm -114.98 125.93 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 111.12 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.2 p -112.47 111.78 37.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 111.081 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.0 125.66 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 111.103 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.22 110.41 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.651 ' HG2' HG13 ' A' ' 78' ' ' VAL . 23.4 mp0 -77.03 -27.75 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 45.109999999999999 110.911 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 37' ' ' GLY . 2.7 pt? -173.75 31.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.200000000000003 110.952 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.898 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.802 0.251 . . . . 74.349999999999994 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 pp -161.18 154.0 20.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 70.450000000000003 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -129.9 167.13 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.162 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -94.11 155.35 40.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.726 . . . . 72.409999999999997 110.856 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 79.24 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.664 2.243 . . . . 63.140000000000001 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.71 129.45 51.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 110.937 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 67' ' ' LEU . 12.6 tp -114.65 122.97 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.299999999999997 110.887 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.42 20.29 7.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.747 . . . . 24.449999999999999 112.488 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE1' HD12 ' A' ' 7' ' ' LEU . 9.6 p90 -146.48 173.09 12.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.87 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -114.05 154.62 27.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.881 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.477 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -135.08 131.11 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.209999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.73 121.65 43.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.164 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 p -84.68 130.07 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.12 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.48 -159.5 13.19 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 31.41 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.83 142.73 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.844 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.06 -176.28 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.856 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -26.76 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 35.009999999999998 110.879 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -48.96 9.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 110.865 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 57.76 1.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.458 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 m -113.22 10.93 18.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.373 . . . . 74.120000000000005 110.887 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m 51.34 87.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 64.219999999999999 111.162 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.05 157.64 44.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 74.299999999999997 111.119 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' HB ' ' A' ' 11' ' ' VAL . 6.6 mp -102.82 159.97 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.936 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -122.34 134.95 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.888 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.3 mt -83.75 133.37 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 71.530000000000001 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -108.43 -8.77 15.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.942 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -122.51 -168.24 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.895 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 t -118.42 123.3 71.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 111.107 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 70' ' ' PHE . 7.3 t -120.83 -10.08 9.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 111.123 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.37 3.36 36.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.871 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.3 p -111.91 16.73 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.409999999999997 111.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.34 147.28 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.549999999999997 110.919 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 m -157.12 150.68 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 111.155 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 38' ' ' GLY . . . -159.05 -35.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 55.149999999999999 112.453 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -105.31 149.52 25.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 62.439999999999998 110.84 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 55.03 29.56 12.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 75.030000000000001 110.858 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.47 -70.64 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.743 -0.742 . . . . 14.220000000000001 112.494 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HA2' ' A' ' 34' ' ' GLY . . . 77.06 84.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 32.539999999999999 112.498 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 179.99 79.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 43.450000000000003 111.109 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.09 115.35 15.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.855 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -164.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.948 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.763 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.4 mtm -112.47 119.87 39.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.858 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.18 -69.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 73.109999999999999 112.507 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -21.07 33.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 70.530000000000001 112.338 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' GLN . . . -75.3 -47.6 27.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 53.100000000000001 111.117 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.78 -26.37 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.888 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.97 -28.48 61.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 43.329999999999998 111.107 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.95 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -96.54 -23.01 16.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 42.310000000000002 111.068 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.13 16.05 31.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 72.299999999999997 112.54 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 48' ' ' ALA . 4.6 mm? -68.0 111.66 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.936 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.97 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 62.450000000000003 110.848 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 27' ' ' GLU . 33.7 m -55.66 130.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 44.43 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.49 -41.0 2.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 75.409999999999997 112.5 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.4 146.96 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 65.25 110.827 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -94.0 128.8 40.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.924 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.57 116.09 31.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 63' ' ' THR . 98.9 t -109.84 -56.36 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 64.140000000000001 111.13 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HD2' HG22 ' A' ' 86' ' ' VAL . 2.4 mtm180 59.53 29.01 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.873 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.445 ' H ' HG12 ' A' ' 57' ' ' VAL . 60.7 t80 -142.63 147.51 35.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.907 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.21 105.2 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.073 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.49 -3.45 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 60.47 38.34 19.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 74.25 110.916 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.9 t -120.12 151.0 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 72.420000000000002 111.148 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 57' ' ' VAL . 11.9 t -144.28 155.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 111.149 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -69.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.118 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.69 -177.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.901 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD22 HD22 ' A' ' 7' ' ' LEU . 3.2 pp -54.73 -26.51 34.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 72.209999999999994 110.931 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -63.22 -43.75 97.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.121 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.61 77.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 111.118 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' VAL . 27.2 t80 -65.27 -34.43 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.93 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.2 -36.95 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 60.329999999999998 110.934 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -41.57 72.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.146 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.32 -43.45 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 64.120000000000005 111.137 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 78' ' ' VAL . 69.6 t -58.54 -43.82 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.400000000000006 111.15 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.983 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -56.89 -41.89 78.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.111 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -78.5 -28.39 46.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 70.319999999999993 110.829 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -77.05 -27.57 54.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.833 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 74' ' ' VAL . 47.8 t -63.88 97.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.509999999999998 111.121 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.736 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.93 157.29 31.92 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 71.120000000000005 110.871 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 107.48 1.87 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.244 . . . . 45.020000000000003 112.361 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 m 59.8 39.94 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 41.299999999999997 110.837 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -88.29 105.62 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 61.210000000000001 111.104 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' O ' HD13 ' A' ' 84' ' ' ILE . 3.0 m -91.91 113.51 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 55.340000000000003 110.801 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 85' ' ' PRO . 49.7 mm -126.23 133.06 24.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 73.420000000000002 111.156 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.5 Cg_endo -69.81 113.73 3.48 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.707 2.271 . . . . 63.43 112.345 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 58' ' ' ARG . 64.3 t -110.0 141.49 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 52.409999999999997 111.114 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.1 t -96.63 129.29 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 111.117 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -115.43 157.8 23.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.863 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.91 147.54 46.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 71.099999999999994 110.874 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -134.33 87.41 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 110.85 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.71 38.81 14.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 54.130000000000003 110.893 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.66 -13.88 57.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 74.530000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.2 t -66.45 143.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 61.210000000000001 111.124 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' VAL . 5.4 p -109.82 119.03 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 51.200000000000003 111.129 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.2 mtp -143.86 164.08 31.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 64.420000000000002 110.917 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 p -141.15 128.68 21.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.09 139.79 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 75.129999999999995 111.138 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -83.97 125.07 31.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.142 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.95 HG22 ' HB1' ' A' ' 48' ' ' ALA . 2.2 pp -110.57 127.2 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.140000000000001 111.176 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.3 p -105.11 112.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 53.229999999999997 111.095 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -93.58 123.64 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 51.229999999999997 111.155 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.0 110.67 3.32 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 74.340000000000003 112.466 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.541 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -91.44 -33.67 15.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 74.340000000000003 110.868 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.541 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.3 mm? -125.96 177.56 6.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 41.119999999999997 110.896 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.888 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.792 0.247 . . . . 73.219999999999999 112.381 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.714 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -155.44 168.04 28.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.938 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.815 HG22 ' HB2' ' A' ' 75' ' ' ALA . 9.2 t -126.89 167.62 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.113 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -48.38 153.9 1.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.601 0.715 . . . . 64.200000000000003 110.863 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.01 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 65.25 112.297 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.99 152.41 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.948 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -113.63 141.93 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.895 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.08 44.3 1.54 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 70.109999999999999 112.509 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -149.33 151.29 33.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.109999999999999 110.859 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 153.8 28.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.884 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.62 HG21 HD23 ' A' ' 23' ' ' LEU . 10.6 p -134.94 144.51 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 71.329999999999998 111.163 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.25 121.59 36.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 51.340000000000003 111.069 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.672 HG23 HD11 ' A' ' 23' ' ' LEU . 7.2 p -86.48 135.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.120000000000005 111.09 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.67 -148.37 5.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 51.439999999999998 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -132.66 142.3 49.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 110.87 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -98.9 -178.57 4.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.852 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.69 -26.9 68.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 110.861 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 t -78.89 -69.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 73.510000000000005 110.852 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.84 47.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 64.140000000000001 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.29 11.22 18.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 75.129999999999995 110.877 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 56.43 87.93 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.115 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -135.89 157.76 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.174 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.672 HD11 HG23 ' A' ' 13' ' ' VAL . 7.6 mp -104.73 159.93 15.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.894 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.3 143.93 47.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.837 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 tp -92.51 134.74 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.13 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.64 -20.25 13.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.349999999999994 110.946 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -128.32 -169.45 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.854 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.62 133.83 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 62.240000000000002 111.107 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 30' ' ' GLN . 8.9 t -120.92 3.95 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 70.019999999999996 111.121 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' HG2' HD13 ' A' ' 50' ' ' LEU . 3.4 mp0 -85.57 6.55 26.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 52.140000000000001 110.935 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -105.34 17.32 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 111.122 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -122.36 150.67 42.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.915 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -160.41 152.11 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 72.030000000000001 111.132 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.99 -37.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 45.240000000000002 112.494 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.6 143.41 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 73.549999999999997 110.846 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 51.17 29.13 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.872 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -173.63 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.72 -0.752 . . . . 74.030000000000001 112.451 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.41 80.09 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.437 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.32 74.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 74.099999999999994 111.075 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -71.34 111.9 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 71.340000000000003 110.852 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.0 -165.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.310000000000002 110.934 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.808 ' HA ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -112.29 111.67 22.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 53.32 110.89 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.3 -68.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 72.150000000000006 112.497 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -13.09 34.25 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 52.140000000000001 112.388 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.56 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -79.17 -38.25 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 33.030000000000001 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.7 -15.33 42.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 110.881 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.46 91.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 61.520000000000003 111.149 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.19 -22.47 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 111.109 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.75 15.71 26.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 63.100000000000001 112.5 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -68.17 111.9 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.817 0.342 . . . . 62.32 110.916 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 178.01 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 74.340000000000003 110.894 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 m -71.66 132.19 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 65.519999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.37 -16.53 17.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 70.519999999999996 112.441 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.53 126.59 38.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.743 0.306 . . . . 75.400000000000006 110.833 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -77.37 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.901 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -113.09 110.55 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.897 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 64' ' ' VAL . 16.9 m -115.92 -40.52 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.156 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.47 29.51 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.885 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -138.07 147.8 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.904 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.64 109.37 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.095 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.25 -1.86 4.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.509 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 60.87 38.91 17.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.944 0.402 . . . . 73.430000000000007 110.927 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -133.29 152.19 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 57' ' ' VAL . 4.5 p -148.41 161.28 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.6 m -83.1 -75.46 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.340000000000003 111.116 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.13 -170.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.889 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.0 pp -54.19 -35.36 62.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 110.95 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.77 -43.75 85.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 72.140000000000001 111.085 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.67 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.049999999999997 111.115 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.619 ' O ' HG12 ' A' ' 74' ' ' VAL . 36.2 t80 -68.44 -33.12 73.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.868 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.09 -35.75 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.86 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.38 -38.9 65.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.184 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.79 -50.28 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 52.0 111.127 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.2 p -58.82 -39.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 50.039999999999999 111.095 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.815 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -59.81 -43.17 94.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 44.439999999999998 111.12 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -26.95 45.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 110.88 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -29.23 55.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 71.230000000000004 110.896 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 74' ' ' VAL . 30.1 t -57.73 98.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 111.114 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -154.92 160.43 30.92 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 74.219999999999999 110.879 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 107.89 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.342 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.28 39.45 18.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.867 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -91.93 98.77 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 62.299999999999997 111.082 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 m -93.57 133.85 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 62.340000000000003 110.885 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 85' ' ' PRO . 56.5 mt -148.23 133.21 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 74.019999999999996 111.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.75 118.68 5.83 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 72.109999999999999 112.316 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.1 t -111.97 148.88 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.152 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.28 121.87 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 111.094 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CZ ' HD23 ' A' ' 56' ' ' LEU . 30.9 m-85 -116.43 151.5 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 147.75 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 72.450000000000003 110.874 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.6 mtm180 -128.91 88.63 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 110.872 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.37 39.45 15.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.835 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.78 57.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 33.32 112.505 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 90' ' ' ARG . 78.1 t -66.37 143.35 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.38 . . . . 55.219999999999999 111.112 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -111.9 113.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 71.519999999999996 111.153 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.0 tpp -147.25 145.8 29.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.88 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.7 p -109.42 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.872 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.43 138.99 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 41.130000000000003 111.099 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 m -93.56 129.25 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 111.174 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.58 HG22 ' HB1' ' A' ' 48' ' ' ALA . 1.3 pp -114.79 123.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.107 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.71 114.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 111.127 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.81 102.42 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.030000000000001 111.144 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.92 110.19 3.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 41.43 112.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.588 ' HG2' HG13 ' A' ' 78' ' ' VAL . 7.1 mp0 -90.53 -14.03 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 74.019999999999996 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD21 ' HA2' ' A' ' 37' ' ' GLY . 19.6 mt -147.91 45.7 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 62.350000000000001 110.935 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.885 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.58 ' O ' HD22 ' A' ' 2' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.804 0.252 . . . . 74.230000000000004 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -147.46 159.77 43.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 50.219999999999999 110.876 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 75' ' ' ALA . 6.1 t -129.81 167.09 18.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 111.155 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 160.36 28.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 70.340000000000003 110.854 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 76.33 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.703 2.269 . . . . 73.109999999999999 112.317 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -123.98 134.79 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 110.926 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.62 122.87 47.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.906 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 25.77 5.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 63.350000000000001 112.45 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.68 166.11 32.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -114.02 152.45 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.879 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 23' ' ' LEU . 6.2 m -134.92 122.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.099 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.61 121.79 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 70.109999999999999 111.064 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -80.23 122.55 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.010000000000005 111.098 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.78 -156.62 7.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.85 138.09 46.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 65.010000000000005 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -99.09 -176.49 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.872 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -63.6 -26.72 68.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 61.200000000000003 110.859 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -47.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.549999999999997 110.821 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.32 54.89 1.9 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 64.420000000000002 112.462 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.26 11.05 18.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 65.340000000000003 110.889 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.1 m 56.29 92.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.198 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -140.59 157.58 45.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 111.123 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 11' ' ' VAL . 9.7 mp -104.66 156.7 17.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 74.120000000000005 110.906 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.17 151.0 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.887 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.689 HG13 HD23 ' A' ' 56' ' ' LEU . 13.8 mm -96.17 133.26 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 55.329999999999998 111.101 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-30 -105.17 -17.75 14.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 72.120000000000005 110.943 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -126.66 -169.0 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.876 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -112.05 133.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 111.092 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 70' ' ' PHE . 15.2 t -116.12 -22.96 8.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.040000000000006 111.138 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 50' ' ' LEU . 31.8 mm-40 -74.45 -6.53 48.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.925 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.456 HG23 ' CB ' ' A' ' 45' ' ' ALA . 1.4 p -95.46 18.47 12.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.152 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -121.0 144.86 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.916 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -162.56 163.43 27.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 54.420000000000002 111.121 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.7 -26.86 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 64.030000000000001 112.464 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -112.28 127.19 55.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 72.230000000000004 110.877 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 2' ' ' LEU . 11.0 m-80 50.93 39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 71.030000000000001 110.846 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' CA ' HD22 ' A' ' 104' ' ' LEU . . . -156.93 -74.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.62 -81.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 64.109999999999999 112.465 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.67 166.83 7.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 44.420000000000002 111.093 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.1 138.72 55.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.845 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.3 -168.74 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 64.109999999999999 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.09 111.6 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 110.869 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.87 -69.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 44.32 112.485 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -30.71 21.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.622 2.215 . . . . 73.439999999999998 112.36 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 31' ' ' THR . . . -64.25 -25.94 68.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 44.509999999999998 111.097 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -94.9 -9.73 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.885 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.32 93.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.134 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -100.36 -22.83 14.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 63.009999999999998 111.077 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 15.96 45.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.724 . . . . 74.319999999999993 112.455 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.055 HD21 HG21 ' A' ' 99' ' ' ILE . 5.6 mt -75.89 110.81 10.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.33 178.01 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 72.030000000000001 110.837 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 26' ' ' GLN . 2.3 p -56.74 133.08 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.096 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.11 -58.22 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 64.140000000000001 112.484 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -79.28 144.28 34.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 62.329999999999998 110.834 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' C ' HD22 ' A' ' 56' ' ' LEU . 32.5 mt-30 -87.88 142.71 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.903 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 25' ' ' ILE . 3.3 mm? -118.0 120.09 36.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 71.439999999999998 110.934 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.698 HG23 HG13 ' A' ' 87' ' ' VAL . 2.4 m -119.8 -37.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.192 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.745 ' HG2' HG13 ' A' ' 86' ' ' VAL . 2.2 mtt85 51.5 30.01 5.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.540000000000006 110.852 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -139.35 146.96 40.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.884 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.52 5.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 61.329999999999998 111.121 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.33 0.65 4.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 64.239999999999995 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 60.67 38.68 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.985 0.421 . . . . 63.340000000000003 110.906 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -132.72 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 111.198 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 57' ' ' VAL . 6.9 p -148.43 159.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.040000000000006 111.11 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 64' ' ' VAL . 92.7 m -80.84 -75.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.152 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -174.88 -169.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.867 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 68' ' ' ALA . 2.7 pp -54.2 -34.57 60.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.497 . . . . 72.209999999999994 110.891 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.48 -39.54 76.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 54.200000000000003 111.111 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -34.37 75.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.109999999999999 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.687 ' O ' HG23 ' A' ' 74' ' ' VAL . 24.1 t80 -68.95 -27.01 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.914 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -42.51 91.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 61.329999999999998 110.857 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.41 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 54.140000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.647 HG11 ' HD3' ' A' ' 58' ' ' ARG . 99.6 t -70.46 -41.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 111.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 70' ' ' PHE . 71.8 t -57.96 -37.31 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 111.126 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 3' ' ' THR . . . -61.32 -43.5 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.091 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -79.31 -25.9 42.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 61.219999999999999 110.849 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' NE2' HD11 ' A' ' 99' ' ' ILE . 1.1 t-80 -77.84 -36.38 50.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 35.43 110.878 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 74' ' ' VAL . 37.7 t -59.37 96.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 72.049999999999997 111.123 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 4.2 mtt180 -154.93 158.16 32.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 74.439999999999998 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 103.68 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.678 2.252 . . . . 73.0 112.367 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 40.7 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.833 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -83.89 102.71 12.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HD13 ' A' ' 84' ' ' ILE . 42.6 m -89.85 120.91 31.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 63.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 83' ' ' SER . 41.6 mm -140.17 133.31 15.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.685 0.755 . . . . 62.340000000000003 111.115 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 84' ' ' ILE . 53.4 Cg_endo -69.82 120.11 6.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 61.539999999999999 112.343 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.745 HG13 ' HG2' ' A' ' 58' ' ' ARG . 95.4 t -109.4 144.51 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 111.107 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 HG23 ' A' ' 57' ' ' VAL . 4.1 p -99.12 119.64 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.75 156.0 31.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.866 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.08 139.79 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 60.539999999999999 110.869 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.2 ttt-85 -124.21 100.43 6.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.905 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.64 31.42 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.8 -12.42 59.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.484 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.9 t -66.29 145.64 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 64.329999999999998 111.117 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 94' ' ' VAL . 3.4 p -112.57 113.48 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 43.310000000000002 111.125 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.9 tpp -144.64 145.88 31.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 52.530000000000001 110.861 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.3 p -119.51 131.14 55.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 110.878 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 139.75 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 53.43 111.101 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -83.73 123.49 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 111.171 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.055 HG21 HD21 ' A' ' 50' ' ' LEU . 2.0 pp -114.8 126.09 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.128 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.6 p -98.18 111.91 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.133 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.593 HG23 HD12 ' A' ' 99' ' ' ILE . 71.8 t -103.12 111.27 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.093 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.92 109.59 3.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 73.510000000000005 112.534 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 78' ' ' VAL . 2.1 mm-40 -93.01 -36.88 12.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 110.891 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.623 HD22 ' CA ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -97.22 107.39 19.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 72.349999999999994 110.921 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.847 0.27 . . . . 62.130000000000003 112.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -163.07 153.18 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.915 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.675 HG22 ' CB ' ' A' ' 75' ' ' ALA . 8.2 t -130.23 167.23 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.141 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 161.05 62.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.586 0.708 . . . . 72.430000000000007 110.909 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 84.61 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 61.140000000000001 112.382 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.77 149.58 45.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 52.299999999999997 110.899 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 67' ' ' LEU . 8.6 mp -114.57 140.81 48.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.310000000000002 110.926 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.63 18.99 4.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 74.030000000000001 112.473 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HE1' HG22 ' A' ' 25' ' ' ILE . 1.2 p90 -169.16 178.56 4.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 71.310000000000002 110.899 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -113.56 156.12 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 23' ' ' LEU . 20.3 m -135.01 136.75 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.21 121.18 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 54.439999999999998 111.113 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 23' ' ' LEU . 14.8 p -83.59 132.6 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.450000000000003 111.139 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.36 -155.69 8.12 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.758 -0.734 . . . . 70.209999999999994 112.476 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -132.83 140.17 47.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.834 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -98.95 -176.18 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.855 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -72.7 -26.54 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 74.049999999999997 110.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -71.99 -62.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.859 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.78 45.56 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 54.219999999999999 112.515 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.22 -15.24 12.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.871 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m 64.79 96.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.176 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.512 HG23 ' NE2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -142.12 156.74 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.121 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 66' ' ' GLU . 10.5 mp -94.72 159.51 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.938 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.6 151.9 39.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 65.329999999999998 110.85 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.941 HG21 HD12 ' A' ' 56' ' ' LEU . 12.0 pt -96.25 133.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 72.530000000000001 111.167 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.78 -23.76 14.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.37 -169.85 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.882 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.1 131.62 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 71.319999999999993 111.115 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -120.25 -11.09 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 50.420000000000002 111.175 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.52 13.34 16.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 71.109999999999999 110.889 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 42' ' ' MET . 0.9 OUTLIER -111.71 17.97 19.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 50.43 111.108 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -121.15 146.74 46.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 71.030000000000001 110.946 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -153.11 157.39 40.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.165 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.73 -34.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 53.539999999999999 112.509 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.49 150.85 24.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 74.129999999999995 110.821 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.81 32.34 9.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 65.109999999999999 110.898 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.34 -70.14 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 73.150000000000006 112.5 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.29 81.72 0.66 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 44.32 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.09 89.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.319999999999993 111.111 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.17 111.85 20.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.815 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.27 -167.51 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 63.539999999999999 110.955 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.671 ' HA ' HG22 ' A' ' 31' ' ' THR . 4.5 mtm -113.69 119.32 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.549999999999997 110.871 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.66 -76.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.482 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.59 23.99 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.678 2.252 . . . . 65.349999999999994 112.369 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -73.72 -47.56 38.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 64.140000000000001 111.112 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -66.05 -16.27 63.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 65.540000000000006 110.941 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.31 -23.72 61.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 111.148 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.68 -22.51 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 111.111 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.22 47.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 54.549999999999997 112.518 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' A' ' 45' ' ' ALA . 1.9 pp -70.4 123.72 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 65.519999999999996 110.922 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -142.92 156.83 44.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.1 m -55.64 121.14 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.147 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.04 2.7 10.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.030000000000001 112.502 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.01 115.24 30.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 73.219999999999999 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 22' ' ' THR . 5.9 mt-30 -69.41 110.07 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 110.913 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.941 HD12 HG21 ' A' ' 25' ' ' ILE . 5.7 mt -81.5 111.15 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.907 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 87' ' ' VAL . 39.3 t -104.58 -55.15 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.25 111.137 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.96 28.64 5.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 64.200000000000003 110.822 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -142.6 145.89 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.856 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.42 109.05 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.350000000000001 111.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.08 1.09 5.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 74.400000000000006 112.44 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 4.9 m-85 60.56 38.47 18.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.893 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 2.7 t -131.72 147.98 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 111.098 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.14 155.48 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.143 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -83.98 -74.8 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 61.130000000000003 111.126 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -163.15 -168.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 61.340000000000003 110.893 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 7' ' ' LEU . 3.4 pp -53.16 -34.79 58.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.030000000000001 110.965 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.6 -41.17 80.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.094 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -63.9 -33.96 76.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 70.349999999999994 111.12 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE1' HD22 ' A' ' 56' ' ' LEU . 41.3 t80 -82.72 -26.24 32.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' HG12 ' A' ' 74' ' ' VAL . 9.0 t-20 -74.58 -34.47 62.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 75.409999999999997 110.931 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 t -73.43 -39.4 65.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 111.174 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 70' ' ' PHE . 28.1 m -71.41 -41.97 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.143 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 78' ' ' VAL . 11.9 p -67.83 -36.26 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 111.156 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.675 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.58 -43.84 84.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.113 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.28 -26.58 42.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 71.450000000000003 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -77.56 -25.88 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.439999999999998 110.849 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 74' ' ' VAL . 39.3 t -49.23 100.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 111.113 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.97 158.19 31.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.593 0.711 . . . . 73.049999999999997 110.88 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 113.17 3.29 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.358 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.6 m 59.99 40.27 19.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 62.5 110.853 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -89.88 121.92 32.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.439999999999998 111.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -114.64 134.66 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.903 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.43 152.85 36.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 53.329999999999998 111.114 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 140.87 43.89 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.655 2.236 . . . . 71.209999999999994 112.366 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.45 133.84 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.123 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 57' ' ' VAL . 6.7 p -98.58 124.43 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 65.519999999999996 111.166 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.26 150.48 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.839 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 147.57 51.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.869 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.2 mtt180 -137.95 98.33 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.230000000000004 110.868 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.02 30.77 19.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.883 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.7 -11.2 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 61.030000000000001 112.498 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 90' ' ' ARG . 73.6 t -66.3 144.44 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 74.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.06 113.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.094 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.8 tpt -140.87 158.11 44.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 54.520000000000003 110.902 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.99 130.37 46.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 54.310000000000002 110.801 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.71 139.58 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 72.409999999999997 111.102 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -83.99 133.1 34.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 53.43 111.136 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.63 124.87 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 55.399999999999999 111.104 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' CB ' ' A' ' 83' ' ' SER . 6.5 m -119.93 111.42 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.117 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.35 150.85 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 65.319999999999993 111.135 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.55 110.85 1.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 74.140000000000001 112.496 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.34 -29.82 47.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 74.040000000000006 110.871 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.586 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -129.75 107.42 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.932 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 110.879 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.798 0.249 . . . . 71.010000000000005 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 pp -164.25 153.94 14.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.898 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.729 HG22 ' CB ' ' A' ' 75' ' ' ALA . 10.2 t -129.78 167.08 18.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 111.156 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 160.66 76.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.703 . . . . 73.349999999999994 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.665 2.244 . . . . 64.129999999999995 112.379 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 137.59 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 63.420000000000002 110.924 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 123.18 48.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 72.319999999999993 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.14 37.73 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 70.129999999999995 112.511 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.773 ' HB2' HD11 ' A' ' 25' ' ' ILE . 30.8 p90 -164.44 173.16 12.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 64.109999999999999 110.895 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.9 mmt180 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.209999999999994 110.864 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' HD23 ' A' ' 23' ' ' LEU . 31.6 m -135.01 126.15 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 52.149999999999999 111.128 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.78 42.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 60.130000000000003 111.139 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.93 127.39 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 111.141 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.57 -149.55 5.06 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 72.099999999999994 112.485 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 71.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.13 -175.03 2.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.861 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -26.72 64.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 62.310000000000002 110.918 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -40.09 29.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 71.409999999999997 110.833 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.26 43.69 5.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 65.25 112.514 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.65 8.61 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 61.409999999999997 110.857 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m 59.45 99.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 65.420000000000002 111.103 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 p -122.19 173.83 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 111.112 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CG1' ' A' ' 64' ' ' VAL . 11.1 mp -131.13 124.55 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.912 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -89.33 143.74 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.861 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 9' ' ' PHE . 9.5 tp -96.29 133.59 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 73.200000000000003 111.167 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.8 -17.73 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.899 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -122.3 -169.49 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 73.030000000000001 110.894 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.5 t -116.33 130.56 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.329999999999998 111.121 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 70' ' ' PHE . 9.8 t -119.97 -10.98 9.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 111.176 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.745 ' CD ' HD13 ' A' ' 50' ' ' LEU . 10.4 mm-40 -84.14 2.89 37.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 71.400000000000006 110.897 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.783 HG22 ' HA ' ' A' ' 42' ' ' MET . 1.0 OUTLIER -111.79 17.5 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.138 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -121.77 146.93 46.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.889 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -151.28 155.32 38.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 72.040000000000006 111.133 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.47 -35.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.497 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 78' ' ' VAL . 18.6 p -105.39 151.01 24.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 61.200000000000003 110.819 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.07 32.52 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.896 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 173.28 -68.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 71.129999999999995 112.489 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.09 76.74 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 63.109999999999999 112.521 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.63 92.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.331 . . . . 60.399999999999999 111.086 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.13 120.3 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.019999999999996 110.862 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -164.76 -165.85 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.901 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.783 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.7 ttp -112.39 122.71 48.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 110.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.31 -68.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 40.409999999999997 112.55 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.29 18.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.344 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -68.33 -47.46 67.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 111.049 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.38 -25.81 64.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 61.439999999999998 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.62 -36.9 76.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 42.210000000000001 111.114 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -93.26 -22.71 18.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 65.140000000000001 111.108 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 15.29 36.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 31.140000000000001 112.485 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.045 HD21 HG21 ' A' ' 99' ' ' ILE . 2.6 mt -69.77 111.83 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 63.439999999999998 110.961 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -142.64 178.07 7.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 110.915 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.63 126.92 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.131 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.3 -16.6 5.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.495 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 25' ' ' ILE . 30.2 m-20 -99.14 121.87 41.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.75 0.309 . . . . 71.030000000000001 110.887 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.73 138.55 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 44.130000000000003 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.57 120.49 37.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 110.928 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.645 HG22 ' HB2' ' A' ' 59' ' ' PHE . 7.1 p -119.84 -37.42 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 71.239999999999995 111.152 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 50.95 30.3 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 75.030000000000001 110.896 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' HB2' HG22 ' A' ' 57' ' ' VAL . 23.1 m-85 -141.75 143.98 33.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.5 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.58 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.119 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.87 3.56 5.87 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.76 . . . . 62.549999999999997 112.462 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 60.2 38.38 20.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.981 0.419 . . . . 75.049999999999997 110.901 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 57' ' ' VAL . 3.7 t -127.36 127.22 43.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 61.329999999999998 111.132 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 23' ' ' LEU . 8.1 p -136.52 155.14 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 65.420000000000002 111.131 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -82.02 -74.65 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 111.121 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.54 -168.64 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.856 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 68' ' ' ALA . 3.9 pp -53.28 -37.82 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 110.931 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' N ' HD12 ' A' ' 67' ' ' LEU . . . -57.71 -34.97 70.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 73.140000000000001 111.127 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' ' OG1' ' A' ' 65' ' ' THR . . . -68.02 -33.29 74.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 29' ' ' THR . 41.5 t80 -82.19 -28.88 31.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.841 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 74' ' ' VAL . 21.3 t30 -74.85 -34.27 62.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.899 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -73.45 -39.12 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 70.239999999999995 111.189 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 74' ' ' VAL . 31.5 m -71.14 -41.81 75.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 52.210000000000001 111.117 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 78' ' ' VAL . 13.3 p -68.17 -36.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 111.115 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' CB ' HG22 ' A' ' 3' ' ' THR . . . -57.05 -39.32 74.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 111.073 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -78.29 -29.34 47.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.864 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -77.69 -27.19 50.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 74' ' ' VAL . 54.6 t -50.34 103.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 71.239999999999995 111.12 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -154.91 155.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 110.874 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 112.92 3.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.645 2.23 . . . . 44.240000000000002 112.355 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m 59.73 39.82 20.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 52.409999999999997 110.884 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . . . -101.56 110.79 22.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 75.019999999999996 111.108 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' HG22 ' A' ' 100' ' ' VAL . 2.1 p -91.55 141.28 28.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.150000000000006 110.866 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 tp -150.96 131.56 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.65 0.738 . . . . 72.349999999999994 111.117 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 108.98 2.18 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.109999999999999 112.361 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.81 148.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.116 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 57' ' ' VAL . 3.3 p -110.1 116.07 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 71.040000000000006 111.132 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.28 160.55 26.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.26 147.96 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.519999999999996 110.892 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.3 ttt180 -117.75 78.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.510000000000005 110.876 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.99 39.44 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 64.230000000000004 110.854 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.83 13.21 32.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 73.310000000000002 112.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 90' ' ' ARG . 87.0 t -98.83 145.21 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.040000000000006 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.57 112.55 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 29.2 tpp -143.51 150.58 39.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.861 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.3 p -140.61 131.25 25.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.842 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 139.67 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 53.109999999999999 111.127 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -83.79 123.15 29.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 72.040000000000006 111.107 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.045 HG21 HD21 ' A' ' 50' ' ' LEU . 2.2 pp -114.7 126.37 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 61.039999999999999 111.155 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 83' ' ' SER . 60.7 t -88.94 114.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.51 131.31 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 55.43 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.55 110.78 1.91 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 72.219999999999999 112.479 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -84.11 -27.65 28.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.875 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 103' ' ' GLU . 3.1 mm? -129.64 94.3 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 110.887 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.897 179.916 . . . . . . . . 0 0 . 1 stop_ save_